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The propensity of the anterior chamber to show rapid and transient
fluctuations in dimension has been demonstrated. Closure of the
irido-cornea I angle is a dynamic process, which may be precipitated
by either anterior translational movement of the iris-lens diaphragm
or peripheral iris bombe. The basic aetiological factor common
to both mechanisms is pupil block, a manifestation of relative
autonomic activity in the anterior segment. Changes in autonomic
activity in the anterior chamber, with particular emphasis on
parasympathetic tone, have consequently been proposed as the ultimate
effector of angle-closure. The rationale of this thesis was
therefore to determine the efficacy of autonomic nerve function,
at both systemic and ocular level, in a representative sample
of patients from each of the major categories within the heterogeneous
group comprising the primary glaucomas: closed-angle glaucoma,
ocular hypertension, and open-angle glaucoma. Sub-classification
of each category was performed depending upon angular configuration,
into narrow-angles and wide-angles.
Generalised autonomic status was determined by a series of tests
based upon cardiovascular reflexes, permitting accurate, reproducible
quantification of nerve function. Ocular autonomic status was
determined by two complementary methods: assessment of the pupillary
reflex arc, as an indivisible unit, by the duration of the pupillary
cycle in response to light; and application of the principle of
denervation hypersensitivity, using topical autonomic agonists,
to parasympathetic and sympathetic nervous systems in the anterior
segment. In addition, the prevalence of diabetes mellitus in
each of the primary glaucomas was established; this was essential,
both to clarify inconsistencies and omissions in the present
literature on this subject, and also as diabetes mellitus is the
commonest cause of autonomic neuropathy in this country. All
assessments were concurrently performed on a comparable, age-
and sex-matched control group.
The results showed systemic parasympathetic dysfunction to be
prevalent in each category of the primary glaucomas, with
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significantly-increased prevalence in patients with narrow-angles.
Parasympathetic neuropathy of the anterior segment was similarly
present in all categories; sympathetic neuropathy of the anterior
segment was present in all categories except OAGWA. The duration
of the pupillary reflex cycle was significantly prolonged only
in narrow-angle primary glaucomas: CAG and OHNA.
The association between diabetes mellitus and glaucoma was restricted
to NIDDM and IGT - the prevalence of IDDM in the primary glaucomas
was comparable to the control group - and was shown to be
significantly-increased in narrow-angle categories only, in marked
contrast to previous descriptions.
The results are discussed, and are shown to explain currently-
proposed mechanisms of angle-closure. Although autonomic
dysfunction in the primary glaucomas may be secondary to diabetes
mellitus in a minority of cases, no predisposing cause is present
in the remainder; primary glaucoma may therefore represent a
manifestation of primary autonomic failure. As autonomic dysfunction
is common to each of the primary glaucomas, an association between
closed-angle glaucoma, ocular hypertension, and open-angle glaucoma
is proposed, in close agreement with previous experimental
observations.
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Glaucoma is derived from the Greek "glaukoma", an opacity of the
crystalline lens. The term is first mentioned as a diagnosis
by Hippocrates in "Aphorisms", and was applied to a change in colour
within the pupillary area, inevitably Leading to blindness.
There was thus no definitive distinction between glaucoma and
cataract until the anatomical site of the latter was established
by Brisseau in 1707. The failure of lens extraction (Daniel,1752)
to improve vision in certain areas precipitated a search for the
primary site of glaucoma in other structures.
Glaucoma has been defined as: "an eye disease in which the complete
clinical picture is characterised by increased intraocular pressure,
excavation and degeneration of the optic disc, and typical nerve
fibre bundle damage, producing defects in the field of vision.
Any or all of these signs may be present at a given examination." (1)
The historical association of these features in the diagnosis
of the primary glaucomas is documented in the following paragraphs.
1.2 The glaucomatous disc
The invention of the ophthalmoscope by Helmholz in 1854 ensured
rapid advances in research directed towards the pathogenesis
of glaucoma, a disorder characterised by optic disc changes.
Edward Jaeger first described the glaucomatous disc (2), however
the lack of stereopsis inherent within monocular ophthalmoscopy
precipitated the conclusion that the glaucomatous disc represented
a swelling of the papillary tissues, a description subsequently
confirmed by von Graefe (3). In fact, the papillary tissues
are excavated. Misinterpretation of relative depth assessment
resulting from monocular indirect ophthalmoscopy was revealed
by the investigations of Weber (4), and disc excavation confirmed
by pathological examination. The correct mechanism of papillary
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excavation was first suggested by Schnabel, who described initially-
selective nerve fibre breakdown without involvement of supporting
tissues as the basic anatomical factor leading to cavernous optic
atrophy (5). However he mistakenly considered the optic nerve
disease to result from absorption of pathological fluid from the
vitreous. Remarkable perspicacity was shown by Priestly Smith
in 1879, with this view of optic atrophy associated with glaucoma:
"The glaucomatous cup is not a purely mechanical result of exalted
pressure, but is in part at least, an atrophic condition which,
though primarily due to pressure, includes vascular changes and
impaired nutrition in the area of the disc and around its margin." (6)
1.3 Elevation of intraocular pressure
The second major feature which may be associated with glaucoma
is raised intraocular pressure. This association was first
suggested by At-Tabarie, an Arab, in the 10th century (7).
The sign was initially documented in the English literature by
Banister (1626), and subsequently by Platner, Professor of Anatomy
at the University of Leipzig (1738). "Hardness of the eye" was
repeatedly recognised in the early years of the 19th century as
a characteristic feature of the disease (8,9,10); the presence
of elevated intraocular pressure in glaucoma was finally established
by Mackenzie in 1835 (11). Raised intraocular pressure, considered
by von Graefe in the late 1850's as the "essence" of glaucoma,
was ascribed to hypersecretion of intraocular fluid. This view
was subsequently disproved by detailed investigation of ocular
outflow fluid dynamics. The conclusion by Schwalbe that the
anterior chamber directly communicated with anterior ciliary veins
(12) was disputed by Leber, who recognised the intercession of
a trabecular meshwork between the anterior chamber and the anterior
ciliary veins, and realised the importance of this structure in
determining subsequent outflow (13). Leber reasoned that aqueous
dynamics depended upon a balance between production of aqueous
humour by filtration, and elimination via the outflow route (14).
He discovered increased resistance to outflow in enucleated
glaucomatous eyes; this factor in the pathogenesis of glaucoma
correlated with the association of changes in the configuration
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of the anterior chamber angle (specifically peripheral anterior
synechiae) with glaucoma by Knies in 1876 (15). The Lebei—Knies
theory, that elevation of intraocular pressure resulted principally
from disorders of aqueous outflow, remains a cornerstone of glaucoma
therapeutics.
Digital tonometry in the estimation of ocular tension had been
performed for centuries. This was still considered the preferred
method of intraocular pressure assessment by some observers until
the early years of this century (16). The initial application
of impression tonometry on human eyes is attributed to Donders
in 1863. Inherent sources of inaccuracy by this technique were
recognised by Weber in 1867; indentation by its very nature displaces
intraocular fluid and thus alters the intraocular pressure.
This stimulated Weber to produce the first applanation tonometer;
regrettably, the necessity of minimal fluid displacement during
assessment of intraocular tension was not widely accepted and
this instrument fell into disuse. The theory was pursued by
Maklakoff, who introduced an applanation tonometer with which
the size of the applied surface is determined for a given force
- the Maklakoff principle (17). This tonometer remains in clinical
practice in certain areas of the USSR.
The development of an accurate impression tonometer by Schiotz
(18) enabled widespread quantification of intraocular pressure
for the first time, and delayed further advances in applanation
tonometry for half a century. Inherent flaws in impression
tonometry, expressed by Weber fifty years earlier, were reiterated
by Schiotz in 1920: "I cannot imagine any method available for
living eyes by which errors due to variations of the envelope
could be eliminated."
The conception of an alternative type of applanation tonometer
by Goldmann (1955) revolutionised estimation of intraocular pressure
(19); image division inside the pressure body fixes the value
of the applanation circle diameter. The theory of applanation
tonometry is derived from the Imbert-Fick law, which states:
"If a plane surface is applied with force F to a thin, spherical
membrane within which a pressure Pt exists, for an equilibrium
condition the expression Pt=F/A is valid, where A is the area
of the applied surface." (20)
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The physiological properties of the cornea and its wetting liquid
necessitate the addition of two terms to the equation:
Pt = F/A - Pm + Pn
Pm = pressure caused by characteristic rigidity of the eye
Pn = pressure dependent upon:
i. surface tension of liquid
ii. wetting properties of cornea
iii. flattening surface of pressure body (21,22)
The cornea resists "flattening", and attraction caused by the
tear meniscus tends to draw the tonometer towards the cornea;
these opposing forces cancel one another when the applanation
circle diameter equals 3.06mm, the diameter employed in the Goldmann
applanation tonometer. At this applanation area, Po = 0.98Pt where
Po = real intraocular pressure. A minimal amount of fluid
(approximately 500nl) is displaced from the eye during Goldmann
tonometry.
Other forms of applanation tonometer based upon similar principles
are the hand-held Draeger (23,24) and Perkins models (25).
Tonometers employing other principles have been developed, such
as the Mackay-Marg (26) and non-contact tonometer (27), although
neither are as widely-used nor as accurate as the Goldmann applanation
tonometer.
1.4 The visual field
Visual field defects in glaucoma correspond to damage of the nerve
fibre bundles. This was described by Landesberg in 1869 (28),
and subsequently confirmed by Bjerrum in 1889 (29). Characteristic
defects of the visual field in open-angle glaucoma result from
damage to individual nerve fibre bundles at the optic nerve head (30).
Essentially, two alternative (or additive) hypotheses have been
proposed to explain the aetiology of nerve fibre bundle defects:
i. the vasogenic hypothesis (31,32)
ii. the mechanical hypothesis (33,34,35)
The visual field is: "that portion of space in which objects are
simultaneously visible to the steadily fixating eye." (36)
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Thus visual field assessment examines the function of the visua I
system in this whole field, not merely determining the limits
of the field (37).
von Graefe described paracentral field defects in chronic glaucoma
in 1856, using a primitive campimeter (38). The first perimeter
was introduced by Foerster in 1857; the introduction by Bjerrum
of the 2-meter screen in 1889 permitted the discovery of scotomas
encircling fixation and associated with the blind spot, a
characteristic feature of glaucomatous damage. Another significant
observation was made by Peter in 1927, with the detection of small
scotomas, 12-20° from fixation, as an early sign of glaucomatous
nerve fibre bundle damage (39). The relationship between intraocular
pressure and visual fields was further reinforced by Samoj loff
(40). The earliest defects of the nerve fibre bundle in open-angle
glaucoma are paracentral, associated with arcuate nerve fibres
(41,42), however other characteristic defects associated with
damage to these fibres include nasal steps (43), arcuate scotomas,
and sector defects in the visual field.
1.5 Historical differentiation of the primary glaucomas
The aforementioned features apply equally to both open- and closed-
angle glaucoma, however the latter entity has several distinct
characteristics resulting from its intrinsically-acute onset.
Probably due to the silent progression of open-angle glaucoma,
the closed-angle form comprised approximately 70% of known cases
in the mid-19th century. In fact, von Graefe did not include
the open-angle form, which he termed "amaurosis with excavation
of the optic nerve" (44) within the glaucomas until 1861 (45).
This observation was credited to Donders who suggested the term
"glaucoma simplex" for this disease entity after noting the "palpable
tension" to be raised in those eyes. von Graefe had, however,
classified acute glaucoma into two categories which now correspond
to the acute and subacute (or intermittent) forms. He considered
the disease to be inflammatory, resulting from either a choroiditis
or iridochoroiditis. Elevated intraocular pressure was presumed
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to be a natural consequence of inflammatory exudation effecting
a relative increase in intraocular volume.
Thus a considerable proportion of the early research into glaucoma
concentrated on the closed-angle, or "inflammatory", form. The
mechanism of angle-closure was not fully recognised until the
late 1920's, however earlier individual astute observations ensured
ultimate accuracy in the description of events. A predisposition
to glaucoma in certain individuals was predicted in 1890 (46);
growth of the lens in eyes with a small cornea effected a progressive
decrease in circumlental volume. Shallowing of the anterior
chamber in the fellow eyes of patients with closed-angle glaucoma
was noted by Czermak in 1893 (47). The importance of pupil block
in the aetiology of angle-closure was independently reported by
Seidel (48) and Curran (49). The latter stated that:
"Normally the aqueous passes through the pupil from the posterior
to the anterior chamber, but it is here contended that in glaucoma
this passage is impeded on account of the iris hugging the lens
over too great a surface extent. Some of the aqueous gets through
while some passes back, forcing the lens and the iris still more
forward."
Based on his own hypothesis that angle-closure was dependent upon
shallowing of the anterior chamber secondary to pupil block, Curran
reasoned that the manufacture of an alternative route of aqueous
flow from the posterior to the anterior chamber (an iridectomy)
would prevent forward movement of the iris-lens diaphragm. This
therapeutic measure was successfully employed and followed over
a ten-year period (50). Barkan classified glaucoma into open-
and closed-angle on the basis of gonioscopic appearances in 1938
(51), however the credit for recognising the essential importance
of pupil block in the pathogenesis of angle-closure, with subsequent
anterior translational movement of the iris-lens diaphragm, lies
with Curran:
"In many cases of chronic glaucoma, including acute attacks, the
chief mechanical factor is lack of proper drainage from the posterior
to the anterior chamber, on account of the iris being too closely
adapted to the lens over a great surface extent, thus impeding
the flow of aqueous through the pupil, and allowing some to permeate
the vitreous and help to push the lens and iris forward, making
the anterior chamber shallow, and partly occluding the filtering
angle as a secondary effect." (50)
Integral component forces which summate to effect pupil block were
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finally elucidated by Mapstone in 1968 (52,53); changes in the
dimensions of the anterior segment subsequent to displacement
of the iris-lens diaphragm were confirmed by slit-image Polaroid
photography in 1984 (54).
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CHAPTER 2
CLASSIFICATION OF THE GLAUCOMAS
The glaucomas are a heterogeneous group of ocular diseases with
common characteristics, defined in the introductory text. The
non-specificity inherent within the definition indicates a relative
lack of knowledge regarding pathogenetic mechanisms. Definitive
classification of a heterogeneous group is obviously impossible.
The following classification is not comprehensive, but seeks to
place the various forms of glaucoma in an orderly and acceptable
sequence, from which the rationale of this research may be more
easily understood. Primary glaucomas are those not associated
with known concomitant or antecedent disease. 70% of all glaucomas
are primary.
2.1 Ocular hypertension
Ocular hypertension is defined as: "statistically significant
elevated ocular pressures occurring in the presence of an open angle
without characteristic field loss and without changes in the optic
disc that are characteristic of glaucoma." (55)
By this definition, ocular hypertension is not a glaucoma per se,
however it may be a premonitory indicator of subsequent glaucoma
in certain instances and consequently is an essential integral
part of this classification. Established class i ficat ions have
included ocular hypertension within the primary glaucomas (56);
this principle will be observed. Obviously as ocular hypertension
is asymptomatic, the diagnosis is determined by specific assessment
of the intraocular pressure, generally during a routine eye
examination.
Ocular hypertension may be subdivided on the basis of the anatomical
configuration of the anterior chamber angle into:
i. ocular hypertension with wide i rido-cornea I angles
ii. ocular hypertension with narrow i ri do-cornea I angles
Angle assessment is explained in detail later.
9
2.2 Congenital glaucoma
This category of glaucoma results from defects developing at birth
or during gestation. Sub-classification is usually on the basis
of genetic or non-genetic aetiologies (57,58).
2.3 Open-angle glaucoma
Open-angle glaucoma is defined as: "statistically significant
elevated ocular pressures occurring in the presence of an open
angle associated with a characteristic field loss and changes
in the optic nerve head." (55)
i. Primary open-angle glaucoma
a. with wide irido-corneal angles
b. with narrow irido-cornea I angles
ii. Open-angle glaucoma with low tension
iii. Open-angle glaucoma in association with the following conditions:
a. Pigment dispersion syndrome and pigmentary glaucoma
b. Exfoliation glaucoma
c. Retinitis pigmentosa
d. Fuchs' endothelial dystrophy




iv. Secondary open-angle glaucoma
Glaucomatous damage developing as a result of known pre-existing







g. Associated with alpha-chymotrypsin
h. Associated with tumours
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2.4 Closed-angle glaucoma
This form of glaucoma occurs as a result of "obstruction to outflow —
brought about solely by closure of the angle with apposition of
the peripheral iris to the trabecular meshwork." (59)
Diagnostic features associated with closed-angle glaucoma include:
i. Symptoms
a. Pain: either unilaterally localised to the eye, orbit,
or frontal bone, or present as a generalised headache.
b. Depression of visual acuity: this feature has variable
expression, from moderate, with blurred vision or "haloes"
as a result of corneal oedema, to severe, with almost
total loss of vision.
c. Nausea/vomiting
ii. Signs
a. Elevated intraocular pressure - frequently > 50 mmHg
b. CircumcorneaI ciliary injection
c. Corneal oedema
d. Pupil mid-dilated and non-reactive
e. Cells in the aqueous humour without keratic precipitates
f. Iris atrophy
g. Anterior chamber angle-closure - either gonioscopicaIly
or by the slit-lamp method of Van Herick (60,61)
h. Glaukomflecken of Vogt: grey spots appearing immediately
posterior to the anterior lens capsule in the pupillary
zone, representing focal necrosis of lens epithelium
i. Posterior synechiae
j. Optic atrophy
Individual features are associated with specific periods in the
progression of acute glaucoma; for example, optic atrophy is a
later feature resulting from a prolonged episode.
2.41 Primary closed-angle glaucoma
i. With pupil block
a. Acute: closure of the anterior chamber angle occurs
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rapidly, producing acute and frequently dramatic symptoms.
b. Subacute: intermittent, usually short-lived attacks
occur which spontaneously resolve; the angle may not
completely close.
c. Chronic: this is frequently asymptomatic, with gradual,
silent closure of the anterior chamber angle.
ii. Without pupil block
Angle-closure may occur secondary to the mechanical effect
of iris "bunching" during mydriasis, in the presence of
anterior displacement of the iris root - the plateau iris.
2.42 Secondary closed-angle glaucoma
Glaucomatous damage developing as a result of known pre-existing
or concomitant ocular or systemic disease.
a. Trauma






h. Associated with ocular procedures: scleral buckling,
panretinal photocoagulation
i. Malignant glaucoma from ciliary block
j. Associated with iris tumours/cysts
k. Anterior segment inflammation, with secondary peripheral
anterior synechiae
I. Posterior polymorphous dystrophy
m. Iridocorneal endothelia I dyst rophy
2.5 Combined mechanisms
In this category, features of both open- and closed-angle glaucoma
are present, but the relative contribution of each is not fully
determined.
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2.6 Anterior chamber angle assessment
This classification differs from those of previous authors in one
important respect; in addition to all accepted features inherent
within classifications of the glaucomas, ocular hypertension and
primary open-angle glaucoma have been subdivided on the basis
of the anatomical configuration of the anterior chamber angle.
The angle was first seen by Trantas in 1907 using an ophthalmoscope
with a strong convex tens inset (62), however examination of the
angle was not practical until the advent of the contact glass.
This shifts the refracting surface of the corneal system to the
convex surface of the glass, thus diminishing the degree of total
internal reflection. In 1920, Koeppe used a binocular, stationary
microscope and slit-lamp to study the condition of the trabeculae
covering Schlemm's canal (63). A monocular instrument termed
the "gonioscope" was devised by Tronosco in 1925, the origin of
gonioscopy (64). The importance of detailed observation of the
anterior chamber angle was placed in perspective by Barkan (51,65).
Two methods of gonioscopy are principally used today; the direct
and the indirect method. The direct method employs a Koeppe
lens; the patient rests supine, the lens is positioned on the
eye and the examiner uses a microscope (a gonioscope) and separately
hand-held illuminator to observe the chamber angle. The indirect
method requires the patient to be seated at a slit-lamp. A contact
lens is placed on the eye, and the chamber angle is viewed via
a mirror built into the contact lens. The two principle lenses
in use are the Goldmann 1-mirror and the Zeiss 4-mirror gonioprism;
the latter instrument was used in angle assessment during the
present study. (Plate 1)
Estimation of the width of the anterior chamber angle is necessary
for a number of reasons: decisions regarding the safety of mydriasis;
interpretation of symptoms suggestive of angle-closure; determining
the necessity of follow-up evaluation if the angle width is noted
to change. Present systems of grading the anterior chamber angle
have undoubtedly improved diagnostic accuracy - with consequent
increased efficacy of treatment.
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There are currently four methods of angle assessment in general
use:
i. Gonioscopic angle-grading - Scheie system, Shaffer system
Spaeth system
ii. Slit-lamp angle-grading - Van Herick system.
2.61 Scheie system
This was based on the amount of angle recess which could be
visualised (66).
Grade Structures visible gonioscopicaI ly
0 Entire angle visible
1 Final roll of iris obscures part of ciliary body
2 Trabecular meshwork is the most posterior
structure visible
3 Posterior part of trabecular meshwork not visible
4 No structures visible posterior to Schwalbe's
line
2.62 Shaffer system
The angle is graded by the angular width of the recess (67).
Grade Description Angle width
0 Closed 0°
1 Extremely narrow 10°
2 Narrow 20°
3 Wide open 20-35°
4 Wide open 35-45°
In this grading system, a line tangential to the inner surface
of the trabecular meshwork is used as a reference point. Angle
width is estimated by drawing a tangent to the anterior iris surface,
approximately one third of the distance from the angle recess,
and the angle measured as the intersection of both tangents.
This technique assesses the approach to the angle recess, but
does not define the angularity of the recess.
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2.63 Spaeth system
This is based on a semi-quantitative appraisal of three separate
variables (68).
i. Location of attachment of the iris to the ciliary body or
the corneal endothelium.
Symbols are used to indicate the most anterior point of contact between
the anterior iris surface and the inner lining of the globe.
Symbol Point of iris contact
A Iris touching corneal endothelium anterior
to the trabecular meshwork
B Point of iris contact posterior to Schwalbe's
li ne
C Iris root at the level of the scleral spur
D Deep angle recess; ciliary body visible
ii. Configuration of the peripheral iris
Symbol Configuration
q Concave curvature
r Regular or relatively flat
s Steep or convex curvature
iii. Width of angle separation between trabecular endothelial
surface and anterior iris
This is assessed by the same criteria as the Shaffer system, however
the actual angle in 10-degree intervals is given, rather than
a numerical classification.
2.64 Van Herick system
Gonioscopic angle-grading correlates closely with the technique
of van Herick, in which the anterior chamber angle recess is assessed
by slit-lamp biomicroscopy (60,61). The slit-beam is aligned
vertically and positioned immediately on the corneal aspect of
the corneoscleral limbus. The angle opening is viewed at an
angle of 60° from the light beam. A narrow slit-beam is essential,
and peripheral corneal width is used as the reference measurement
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for estimation of the depth of the anterior chamber angle. The
measurement is taken immediately prior to the point of disappearance
of the corneal-iris space at the periphery.
Distance between posterior
cornea and peripheral






0 0 C losed
< 0.25 1 Very narrow
0.25 2 Narrow
0.5 3 Wide open
> 0.5 4 Wide open
Slit-lamp grading of the anterior chamber angle was performed in all
four quadrants. The anterior chamber angle is known to be narrowest
in the superior quadrant (69), where most goniosynechiae are found
(70). The remainder of the angle is reasonably uniform.
Angle assessment during this study was performed by the slit-lamp
technique of van Herick, coupled with Shaffer gonioscopic classification
using a Zeiss 4-mirror gonioprism. Angles in the nasal and temporal
quadrants were used to define angular configuration, thus providing
an acceptable average of the total angle width.
This research thesis is restricted to investigation of the primary
glaucomas: ocular hypertension, primary closed-angle glaucoma,
and primary open-angle glaucoma. In the latter category, patients
with low tension, pigmentary, and exfoliation glaucoma, discrete




EPIDEMIOLOGY OF THE GLAUCOMAS
Epidemiology may be defined as the determination of the natural
history of disease by a study of population samples; the elucidation
of predisposing factors governing its distribution; and attempted
determination of the borderline between normal and abnormal.
This chapter has been included to place the primary glaucomas
in perspective in relation to the general population.
Open-angle glaucoma is primarily a disease of the aged. Several
population studies have been documented, with reasonably comparable
results. Hollows and Graham examined a defined population in
the Rhondda valley in 1963 (71). They defined open-angle glaucoma
as: "a. Glaucomatous cupping of the optic disc
b. Visual field defects of the following types
i. Siedel
ii. Bj errum
iii. Roenne's nasal step
iv. Tubular
c. Pressure ^ 21 mmHg
d. An anterior chamber free of abnormal mesoderm and
unobstructed by the root of the iris."
With this definition, a prevalence rate of 0.28% was established.
The inclusion of low tension glaucomas increased the prevalence
to 0.43%. Similar surveys by Luntz in Oxford (72) and Walker
in Birmingham (73) reported prevalences of 0.9% and 0.31% respectively.
The Bedford glaucoma survey of 1968 showed a prevalence of 0.76%
for open-angle glaucoma, increasing to 0.82% if patients with
low tension glaucoma were included (74). This compares favourably
with the study by Bengtsson in Dalby (1981), where the prevalence
of open-angle glaucoma was 0.86% (75).
Ocular hypertension was defined by Hollows and Graham on the following
basis:
"a. Intraocular pressure ^ 21 mmHg in one or both eyes by
indentation and/or applanation tonometry
b. No glaucomatous field defects
c. Anterior chamber angle of the eye or eyes with a pressure
of £ 21 mmHg was free of abnormal mesoderm
d. No history suggestive of angle-closure." (71)
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Using this definition, a prevalence of 8.61% was recorded for
ocular hypertension. The prevalence of ocular hypertension in
the general population has been variously reported as 1% (72),
1.3% (73), 3% (74), 5% (76), and 8.9% (77).
The frequency distribution of intraocular pressure is positively
skewed, with a tail in the upper pressure range (71,74,78,79,80).
This skewed distribution occurs even if subjects with glaucomatous
field loss are excluded (81,82). Two possible models are suggested.
In the first, the distribution is assumed to reflect a continuous
curve that is logarithmic normal, the upper range corresponding
to subjects with ocular hypertension and glaucoma. The skewed
frequency distribution is interpreted in the second model as
representing the distributions of two separate populations: normal
and ocular hypertension/glaucoma. With the latter interpretation,
the normal Gaussian curve has "a mean of 16 mmHg ( ± 3 mmHg).
Accordingly, 97.5% of the normal population will have an intraocular
pressure of ^ 21 mmHg. There is evidence suggesting two populations;
it has been shown by Hollows and Graham (71), and Armaly (82),
that the distribution is symmetrical in young subjects, with gradually
increasing asymmetry from age 40 years onwards.
Ocular hypertension is believed by some authors to be a preglaucomatous
condition (83,84). The risk of patients with ocular hypertension
subsequently developing glaucoma has been reported between 0.5-20%:
Armaly and Graham, 0.5% (85,86); Linner and Stromberg, 2% (87);
Perkins, 3.23% (88); David, 10.2% (89); Walker, 20% (73). Although
there is no doubt that patients with ocular hypertension have
a higher risk of developing glaucoma than the remainder of the
population, the factors determining this increased risk remain
mostly unknown. Heredity is certainly one factor. Several
patterns of inheritance have been described in glaucoma (90);
the most common mode of inheritance in open-angle glaucoma seems
to be autosomal recessive with variable penetrance (91). Studies
of both children and siblings of glaucoma patients have confirmed
increased prevalence of glaucoma (92,93,94,95,96). The risk
of developing glaucoma is also related to the initial level of
intraocular pressure (89), acute blood loss (97), a history of
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diabetes mellitus (78,97,98), and central retinal artery diastolic
pressure (99).
In contrast, open-angle glaucoma is shown to be four times as
common as closed-angle glaucoma; the latter has reported prevalences
of 0.08% (71), 0.09% (100), 0.10% (75), and 0.17% (74). Narrow
irido-cornea I angles are considered to be a significant predisposing
factor in the pathogenesis of closed-angle glaucoma. This anatomical
configuration is relatively-rare: in van Herick's series, the
prevalence of angles of grades 1 and 2 was only 0.64% and 1%
respectively (60,61); in the study by Spaeth, only 1.1% of all
angles were so narrow that the iris was in contact with the endothelial
surface of the trabecular meshwork, although significant narrowing
of the anterior chamber angle was noted in 6% of cases (68).
However these studies have also shown a marked tendency for the
anterior chamber angle to become narrow with increasing age.
Francois (1948) reported 31% of cases to have a "small" angle
recess (101). Although the overall prevalence of narrow angles
was only 1.1% in Spaeth's study, narrow angles were present in
10% of those aged 88-92 years, 5% in the age category 83-87 years,
and 4% in the age group 78-82 years.
Clearly there is a marked discrepancy between the prevalence of
closed-angle glaucoma and that of narrow angles. The importance
of narrow angles alone in the pathogenesis of closed-angle glaucoma
was investigated by Mapstone in 1979; in 50 eyes from 27 patients
with narrow irido-cornea I angles (and no other features associated
with angle-closure) subjected to a pilocarpine 2%/phenylephrine 10%
provocative test, only one developed angle-closure (102). This
suggested that although narrow angles may facilitate the subsequent
development of closed-angle glaucoma, in isolation they are of
little diagnostic value; other predisposing factors are essential.
The hypothesis that narrow angles were not an essential prerequisite
for angle-closure was confirmed by the demonstration of closed-angle




DIABETES MELLITUS AND THE PRIMARY GLAUCOMAS
4.1 Introduction
Prior to detailing the known associations between diabetes mellitus
and the primary glaucomas, it is necessary to discuss the prevalence
of diabetes within the general population, in order that viable
comparisons can be made. In excess of thirty prevalence surveys
have been performed in several affluent countries over the past
thirty-five years. Male prevalence rates range from 1.18% in
Edinburgh (104) to 10.67% in a retirement community of Southern
California (105,106). Similarly, female prevalence rates vary
from 0.84% (107) to 7.8% (108). Variations in the method of
diagnosis, plus differences in the mean age of subjects, lead
to difficulties in comparison.
The associations between diabetes mellitus and the primary glaucomas
are examined in detail as follows:
4.2 Open-angle glaucoma in patients with diabetes melLitus
4.3 Ocular hypertension in patients with diabetes mellitus
4.4 Diabetes mellitus in patients with open-angle glaucoma
4.5 Diabetes mellitus in patients with ocular hypertension
4.6 Closed-angle glaucoma in patients with diabetes mellitus
4.7 Diabetes mellitus in patients with closed-angle glaucoma
4.8 Mechanisms to explain the association between diabetes mellitus
and the primary glaucomas
4.2 Open-angle glaucoma in patients with diabetes mellitus
The earliest association between diabetes mellitus and open-angle
glaucoma was made by Grafe in 1924 with the observation that
proliferative retinopathy was less common in cases of diabetes
with raised tension (109). In 1935, Waite and Beetham studied
the visual system of 2,002 diabetics by central and peripheral
field assessment, fundoscopy, refraction, and Schiotz tonometry
(110). They concluded that 0.5% of diabetics had "clinical glaucoma"
ie primary or secondary glaucoma. Re-examination of the data
shows that 6% of patients had intraocular pressures > 25 mmHg.
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Twenty years Later, Palomar published a Literature review encompassing
416 diabetics, in which he concluded that glaucoma did not occur
more "frequently in patients with diabetes mellitus (111).
The association was placed in perspective by Armstrong et al in
1960; of 393 diabetic patients studied, the prevalence of primary
open-angle glaucoma was 4.1%, whilst the prevalence of all primary
glaucomas was 4.8% (112). Using the same criteria in the diagnosis
of glaucoma, 280 patients from the general medicine out-patient
department were assessed to obtain control values; in this group
the prevalence of open-angle glaucoma was 1.4%.
In any form of medical investigation relating to diabetes mellitus,
the population under consideration must be subdivided according
to type of diabetes; type 1 (IDDM) or type 2 (NIDDM). The only
study to differentiate the prevalence of glaucoma within diabetics
according to type of diabetes was performed by Nielsen in 1983
(113). This epidemiological study of 533 diabetics (166 type 1,
367 type 2) on the island of Falster, Denmark, showed the prevalence
rate of primary open-angle glaucoma to be 6.0%; primary open-angle
glaucoma occurred in 8.2% of patients with type 2 diabetes compared
with 1.2% of patients with type 1 diabetes (p < 0.01). Neovascular
glaucoma occurred in 2.1% of all diabetics, with no significant
difference in prevalence between type 1 and type 2.
4.3 Ocular hypertension in patients with diabetes mellitus
The presence of higher intraocular pressures in diabetics compared
with non-diabetics has been confirmed by several reports (114,
115,116,117). In contrast, Bouzas et al (1971) concluded that
the mean intraocular pressure in diabetics did not significantly
differ from the normal population (118); this is difficult to
interpret in view of the overwhelming evidence suggesting the
opposite conclusion. In 1962, de Rose and Becker noted increased
intraocular pressure in 20% of adult diabetics without known glaucoma
(119). Of 78 newly-diagnosed diabetics, initial applanation
pressures of > 20 mmHg were recorded in 21%, and > 23 mmHg in 5%,
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by Kolker in 1963 (119). A study by Hetherington and Shaffer
in 1964 recorded intraocular pressures of > 20 mmHg in 18% and > 23 mmHg
in 12% of diabetics (120). These figures compare favourably with
those of Oates, Kolker and Becker (1965); of 78 diabetics, pressures
of > 20 mmHg occurred in 18% of patients and > 23 mmHg in 6% (119).
If patients with proliferative retinopathy were excluded from
this sample (for reasons which will be explained later), of the
43 remaining patients, 26% had intraocular pressures > 20 mmHg and
12% > 23 mmHg.
In juvenile diabetic patients simitar increased applanation intraocular
pressures have been recorded. Safir et al (1964) examined 64
diabetic children aged 8-19 years; 30% were shown to have intraocular
pressures in excess of 20 mmHg, and 15% greater than 23 mmHg (121).
In 61 diabetic children aged 4-16 years studied by Morton and
Becker (1964), 28% had applanation pressures > 20 mmHg, and 15%
> 15 mmHg (119). A similar study by Sears (1965) involving 34
juvenile diabetics showed intraocular pressures > 20 mmHg in 21% and
> 23 mmHg in 6% (119).
The exact relationship between intraocular pressure and retinopathy
in patients with diabetes mellitus remains unclear; higher intraocular
pressures have been reported in diabetics without retinopathy
than in those with retinopathy (117,122,123). Proliferative
retinopathy is rare in diabetics with primary open-angle glaucoma
(109,124,125), and has significantly increased prevalence in diabetics
with lower intraocular pressures, compared with those in the higher
pressure category (117,126).
The study of 533 diabetic patients by Nielsen in 1983 reported
the prevalence of ocular hypertension to be 3.0%, with significantly
higher prevalence in patients with NIDDM (p < 0.05); 4.1% in type 2
diabetics compared with 0.6% in type 1 diabetics (113).
4.4 Diabetes mellitus in patients with open-angle glaucoma
In addition to establishing the prevalence of glaucoma in diabetics,
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to which reference has already been made, Armstrong el al (1960)
also investigated the prevalence of diabetes mellitus in patients
with open-angle glaucoma. Known diabetes mellitus was present
in 12.6% of patients, with a further 5.7% diagnosed by oral glucose
tolerance test; the total prevalence of diabetes in patients with
open-angle glaucoma was thus 18.3% (112). The prevalence of
known diabetes in patients with open-angle glaucoma has been variously
reported between 6-18% (112,125,127,128). Several studies have
also confirmed the increased prevalence of asymptomatic diabetes
in the glaucoma population (129,130). Lieb et al (1967) investigated
533 patients with open-angle glaucoma; diabetes mellitus was present
in 8% of this group compared with 1% in the general population (131).
The prevalence of diabetes in 490 patients with open-angle glaucoma
attending King's College, London (1980) was 7.6% (122). The
discrepancy between the figure quoted by Armstrong et al and those
of the latter two studies is easily explained; Armstrong specifically
tested for asymptomatic and previously-undiagnosed diabetes mellitus.
Becker (1971) examined a series of 100 consecutive patients with
primary open-angle glaucoma but without known diabetes mellitus
(132). A positive oral glucose tolerance test was obtained in
20% of the patients, which is comparable to the 18.3% determined
by Armstrong et al. These patients were then subclassified on
the basis of intraocular pressure control; the prevalence of diabetes
was 14% if the mean intraocular pressure was > 25 mmHg, 25% in those
with a mean < 25mmHg, and 36% if the mean was < 20mmHg. On the
basis of these results, he postulated that either open-angle glaucoma
patients with a positive OGTT were easier to control with medical
therapy, or those patients spontaneously had lower intraocular
pressures. Conclusions from this study are summarised as follows:
i. Primary open-angle glaucoma in patients with diabetes mellitus
Primary open-angle glaucoma, raised intraocular pressure, increased
intraocular pressure response to topical corticosteroid provocation,
and cup:disc ratios of > 0.3 are significantly more prevalent
in patients with diabetes mellitus. Becker's study also showed
increased frequency of clinical glaucoma relative to ocular
hypertension in diabetes, which prompted the hypothesis of greater
susceptibility of progression to glaucoma, apart from any direct
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association between diabetes and ocular hypertension,
ii. Diabetes mellitus in patients with primary open-angle glaucoma
Diabetes mellitus is more prevalent in patients with primary open-
angle glaucoma (20%) and in patients with positive corticosteroid
provocative tests.
As a considerable proportion of the patients in this study were
asymptomatic, with diagnoses confirmed by 06TT, one may assume
(although this is not stated) that the majority were type 2 diabetics.
The distinction between type 1 and type 2 diabetes mellitus in
relation to the primary glaucomas is essential, as will be explained
in the final conclusions of the thesis.
A.5 Diabetes mellitus in patients with ocular hypertension
The prevalence of diabetes mellitus in patients with ocular
hypertension is not well documented. Morgan and Drance (1975)
considered diabetes to be less frequent in ocular hypertensives
than in normal controls (97). In contrast, diabetes mellitus
has been shown to be significantly associated with progression
of ocular hypertension to overt glaucoma; in the Des Moines study
by Armaly (1969), the only four cases of ocular hypertension which
progressed to glaucoma were subsequently shown to have a positive
oral glucose tolerance test (133). In a similar study by Wilensky
et al (1974), of 15 ocular hypertensives who later developed field
loss necessitating the diagnosis of glaucoma, 33% had a positive
oral glucose tolerance test (98).
There are no accurate estimates of diabetes prevalence in patients
with ocular hypertension.
4.6 Closed-angle glaucoma in patients with diabetes mellitus
Angle-closure is assumed to occur in diabetics as a consequence
of the iritis and rubeosis which may be associated with this disease
(122) - despite the fact that the prevalence of iritis in diabetics
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is reported to be not significantly different from that in a non-
diabetic population (110). There is no doubt that rubeotic vessels
in the anterior chamber angle may lead to secondary angle-closure;
equally, there is no evidence to suggest that this is the only
mechanism for the genesis of angle-closure in diabetes mellitus.
Other reports have stated that angle-closure appears to be no
more frequent in diabetics than in the general population (119,134).
The only epidemiological study of this subject, to date, is that
by Nielsen (1983), which quoted the prevalence of closed-angle
glaucoma in diabetics to be 0.18% (113) - similar to the prevalence
in the general population (71,74,75,100).
4.7 Diabetes mellitus in patients with closed-angle glaucoma
There are no accurate estimates detailing the prevalence of diabetes
mellitus in patients with a history of closed-angle glaucoma.
This is remarkable when one considers that the prevalence of open-
angle glaucoma in diabetics is quoted as 4.1% (112), whereas the
prevalence of diabetes mellitus in patients with open-angle glaucoma
is reported between 6-20% (125,127,128,132).
4.8 Mechanisms to explain the association between diabetes mellitus
and the primary glaucomas
It has been proposed that the association may be due to a common
genetic background; studies have suggested a relationship, particularly
in juvenile diabetics, between glucose tolerance, suppression
of plasma Cortisol, and dexamethasone provocation (135,136,137).
Topical corticosteroids are known to increase intraocular pressure in
certain human eyes (138,139,140,141), a response genetically
transmitted (142,143), and closely related to primary open-angle
glaucoma (144).
The increased intraocular pressure in diabetics has also been
attributed to increased aqueous flow (123,145), and decreased outflow
facility (146). The definitive mechanism is not known.
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CHAPTER 5
AUTONOMIC NERVE FUNCTION IN GLAUCOMA
5.1 Introduction
Angle-closure may occur as a direct result of relative parasympathetic
and sympathetic activity in the anterior segment of the eye.
The basis of this contention is discussed in the first section
of this chapter. The next logical step was to assess whether
the change in autonomic activity, or presence of autonomic neuropathy,
was localised to the eye, or part of a generalised systemic dysfunction.
This problem was resolved by investigating the integrity of autonomic
nervous function using two separate, though complementary, approaches:
a. Assessment of systemic autonomic nerve function
b. Assessment of ocular autonomic nerve function
The association between autonomic nerve function and glaucoma
is divided into three sections:
5.2 Autonomic effects in the pathogenesis of angle-closure
5.3 Systemic autonomic nerve function
5.4 Ocular autonomic nerve function
5.2 Autonomic effects in the pathogenesis of angle-closure
Curran (1931) suggested that angle-closure occurred as a secondary
event, following anterior translational movement of the iris-lens
diaphragm (50). The essential event precipitating shallowing
of the anterior chamber is pupil block. The importance of pupil
block in angle-closure is well-established (147,148,149,150),
however the mechanism remained little known until comparatively
recently. In 1968, Mapstone resolved pupil block force into
three separate components (52):
i. Force due to contraction of the sphincter muscle
ii. Force due to contraction of the dilator muscle
iii. Modulus of elasticity of the iris stroma
(Figure 1)
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Pupil block is thus a posteriorly-directed vector, the direction
and magnitude determined by the relative contribution of the three
contributing elements. The importance lies in the £§!§tiye
contribution of each separate force. Independent component forces
are not of equal potential magnitude; the sphincter muscle, when
maximally-stimulated, may develop twice the power of the maximally-
stimulated dilator muscle (151).
Sequential changes in the dimensions of the anterior chamber are
impossible to quantify during the genesis of a spontaneous attack
of closed-angle glaucoma. Deductions regarding pathogenesis
must therefore be derived from models of experimental angle-closure -
the rationale of provocative testing (152). Autonomic provocation,
involving both sympathetic and parasympathetic nervous systems
simultaneously, was developed during the 1970's based upon the
theoretical principles of pupil block (152,153,154). Determination
of the individual component forces of pupil block thus permits
their isolation and manipulation. Contraction of the pupil may
be resolved into a series of complementary forces, effecting increased
iris-lens apposition (155). Summation of diametrically-opposed
forces subsequent to isometric contraction of the iris musculature
produces the posteriorly-directed vector of pupil block. The
magnitude of pupil block force has been calculated, and shown
to be maximal at a pupillary diameter between 3.8 mm and 4.2 mm (156).
The only known method of maintaining pupillary diameter at mid-
dilatation is to maximally stimulate both parasympathetic and
sympathetic nervous systems in the anterior segment, the basis
of the pilocarpine-phenylephrine provocative test (152,157).
The position of the iris-lens diaphragm at equilibrium is determined
by the production of aqueous humour, the facility of outflow,
and the degree of pupil block. (Figure 2) Assuming a constant
production of aqueous, both pupil block and facility of outflow
are increased during the pilocarpine-phenylephrine provocative
test. As aqueous flow from the posterior to anterior chamber is
less than the rate of outflow from the anterior chamber (158),
the resultant pressure differential effects forward movement of the
iris-lens diaphragm and consequently shallowing of the anterior
chamber (159,160). (Figure 3) The first stage of angle-closure
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(ie iri do-corneaL contact) is thus facilitated (161,162). The
pilocarpine-phenylephrine provocative test, with a sensitivity of
93% and a predictive value of 94%, has the added advantage of
immediate reversal; guttae 0.5% thymoxamine, a sympathetic alpha-
blocking agent (163), rapidly negates the alpha-sympathomimetic
actions of guttae 10% phenylephrine, permitting elimination of
antagonistic contraction of iris musculature with consequent decline
in pupil block force (164).
It can be seen that manipulation of the autonomic nervous system
in the anterior segment of the eye produces an effective model
of angle-closure. Mapstone postulated in 1981 that the events
preceding irido-corneal contact occurred as a direct result of
autonomic activity, with specific emphasis on parasympathetic
tone (155). Methods of autonomic function assessment are detailed
in the following sections.
5.3 Systemic autonomic nerve function
5.31 Introduction
"I propose the term 'autonomic nervous system' for the sympathetic
system and the allied nervous system of the cranial and sacral
nerves and for the local nervous system of the gut." (165)
John Langley was responsible for the classification of the sympathetic
nervous system into pre- and post-gang I ionic nerves in 1895, and
the introduction of the concept of a parasympathetic nervous system
in 1905.
Autonomic failure is relatively rare. Bradbury and Eggleston
first described "idiopathic orthostatic hypotension" - now known
as progressive autonomic failure - in 1925 (166,167). Progressive
autonomic failure with multiple system atrophy was documented by
Shy and Drager in i960 (168), and progressive autonomic failure
with Parkinson's disease by Fichefet in 1965 (169). As the essential
pathogenetic mechanisms have not been identified, autonomic failure
is generally categorised by a diagnostic classification. On this
basis, these three disorders constitute the category of primary
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autonomic failure. Other aetiological factors, principally within
the general categories of secondary and drug-related autonomic
failure, are listed in table 1.
The commonest cause of autonomic neuropathy is diabetes mellitus (170).
Cardiac denervation was noted in a patient with diabetes mellitus
by Eichhorst in 1892 (171), and features subsequently attributed
to diabetic autonomic neuropathy were observed in ensuing years;
neurogenic bladder disturbance (172), vasomotor instability (173,174,
175), loss of testicular sensation (176), abnormal sweating (177),
and impotence (178,179). The association between autonomic nerve
function and diabetes is attributed to the observations of Jordan
in 1936 (180) and Rundles in 1945 (181). Significant contributions
were subsequently made in 1959 by Keen (182), and in 1960 by
Sharpey-Shafer and Taylor (183), however major advances in both
diagnosis and prognostic evaluation have been restricted to the past
fifteen years.
Pathological studies of autonomic nerves are relatively infrequent.
As a result of the rarity of autonomic neuropathy outwith the
diabetic population, many reports are confined to descriptions of
one or two cases. In primary autonomic neuropathy, severe loss
of intermediolateral cells in the spinal cord has been evident
(184,185,186), supporting the clinical diagnosis of sympathetic
neuropathy. With regard to the parasympathetic nervous system,
loss of Edinger-Westphal and dorsal vagal nuclei were reported by
Shy and Drager in 1960 (168). In diabetic autonomic neuropathy,
pathological evidence is more extensive, however pathogenetic
mechanisms remain inconclusive. Segmental demyeIination and axonal
degeneration in the rami communicantes (187,188,189,190), vacuolated
neurones in sympathetic ganglia, and marked loss of myelinated fibres
in both sympathetic trunks and the vagus nerve has been demonstrated
(191).
The pathogenesis of autonomic neuropathy in diabetes mellitus is not
known, although the mechanism is considered to be similar to that
in somatic neuropathy (192). Two hypotheses have been postulated;
these may be complementary rather than mutually exclusive.
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i. Vascular hypothesis
Small vessel disease has been proposed as the mechanism of diabetic
retinopathy, nephropathy, and neuropathy (193,194). The importance
of these changes in relation to autonomic nerve function is not
known; microvascular pathology in autonomic ganglia has been described
as both significantly present (195), and significantly absent (196).
ii. Metabolic hypothesis
Metabolic disturbances known to be associated with diabetes mellitus
include myoinositol deficiency (197), increased glycosylation of
structural protein (198), accumulation of sorbitol (199,200), and
defects in lipid metabolism (201). Although these factors may
affect nerve function, their importance in autonomic neuropathy is
not known.
Autonomic insufficiency has an insidious onset, which is impossible
to identify accurately due to the compensatory mechanisms inherent
within the autonomic nervous system. Until comparatively recently,
tests of autonomic nerve function have been difficult to interpret
and virtually impossible to quantify. A series of autonomic
function tests are described in table 2 (202,203 204,205,206,207,208,
209,210,211,212,213,214,215). The invasive and complex nature
of these tests not only severely limits any subsequent clinical
application, but also defies definitive interpretation in all but
the most severe cases of autonomic neuropathy.
The recent development of non-invasive autonomic assessment, based
upon cardiovascular reflexes, permits accurate, objective and
reproducible measurement of autonomic function. As in all reflex
assessments, this depends upon a standardised input stimulus,
coupled with measurement of the subject's output reaction. Results
are based on blood pressure and heart-rate responses to a variety
of stimuli. A necessary corollary is that detected abnormalities
cannot be localised to either the afferent, internuncial, or efferent
components of the reflex. There is considerable evidence to
sustain the conclusion that autonomic assessment by cardiovascular
reflex responses correlates well with generalised autonomic function
(216,217). In addition, the demonstration of significant systemic
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postganglionic axonal lesions by chemical assay of noradrenergic
responses to edrophonium stimulation, in diabetic patients with
sympathetic neuropathy manifesting marked postural fall in systolic
blood pressure, provides biochemical evidence in support of this
contention (218).
Six autonomic function tests, based upon cardiovascular reflexes,
were used to assess systemic autonomic status. Although each test
has been used individually to give a measure of autonomic function,
assessment based upon a series of complementary tests has been
advocated by Ewing et al (1982) to preclude misleading deductions
from single tests (219). This provides a comprehensive assessment
of both sympathetic and parasympathetic function. The series
of tests in this assessment are shown in table 3.
Diagnostic criteria for cardiovascular autonomic function tests
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Table 1
CLASSIFICATION OF AUTONOMIC FAILURE
Primary
a. Progressive autonomic failure
b. Progressive autonomic failure with multiple system atrophy




c. Neurological infection: syphilis, Chagas' disease





h. Metabolic diseases: Fabry's disease, porphyria
i. Central nervous system lesions: especially involving
the hypothalamus or the spinal cord
j. Renal disease
k. Hereditary sensory neuropathies
I. Drug effects:
i. Adrenergic neurone blocking drugs: eg guanethidine
ii. a-adrenergic blocking drugs: eg phenoxybenzamine
iii. 8-adrenergic blocking drugs: eg propranolol
iv. Ganglion blocking drugs: eg mecamylamine
v. Vasodilator anti-hypertensive drugs: eg prazocin
vi. Centrally-acting anti-hypertensive drugs: eg methyldopa
vii. Tranquillisers: eg phenothiazine derivatives
viii= Antidepressant drugs: eg tricyclics




i. Amyl nitrite inhalation 202,203
ii. Tilt-table 204
iii. Phenylephrine hydrochloride
(50-100 yg) iv injection
Angiotensin II (0.25-2.0 yg)
iv injection 205
iv. Hyperventilation 183
v. Cold pressor test 206
vi. Mental stress 207
vii. Quinizarin sweat test 208
viii. Direct sweat test





ix. Tyramine (250-6000 yg) iv
injection 211,212,213
x. Atropine sulphate (0.02 mg/kg)
iv injection 214
xi. Norepinephrine bitartrate
(0.05 yg/kg) iv injection 215
Table3
CARDIOVASCULARAUT NOMICFUNCTIONTES S iheti^_nerve_function
i.Valsalvamanoeu re ii.Heart-ratev iationduringepbreath n iii.Immediateheart-rateresponstostanding iv.Immediateheart-rateresponstolying Sympathetlc_nerve_function i.Systolicbloodpressurere ponststanding ii.Diastolicbloodpressureresp nstsustaine isometricuscularcontra tion
5.32 Parasympathetic nerve function
5.321 Valsalva ratio
This test is based upon the circulatory response to forced, controlled
respiration against resistance. The responses are differentiated
into four separate phases, defined by Hamilton et al in 1936 (220).
The heart-rate decreases and blood pressure increases for 2-3 seconds
(Plate 2) due to the initial rise in intrathoracic pressure (phase 1).
This is followed by a gradual increase in heart-rate in response
to the reduction in venous return (Plate 3); subsequent decreased
cardiac output leads to a fall in blood pressure (phase 2).
The release of intrathoracic pressure in phase 3 results in a
marked rise in the potentia I capacitance of the pulmonary venous
plexus; a further decrease in cardiac output necessarily follows,
with inevitably decreased systemic blood pressure and increased
heart-rate (Plate 4). Phase 4 is characterised by increased
cardiac output, rebound hypertension resulting from persistence
of raised peripheral vascular resistance, and bradycardia as a
vagal efferent response to increased baroreceptor afferent impulses
(Plate 5).
The Valsalva manoeuvre had been used as a test of cardiac function
during the 1950's (221,222), however the "Valsalva ratio", described
by Levin in 1966 (223), enabled the heart-rate changes inherent
within the technique to be placed on a measurable and comparable
basis. The Valsalva ratio is calculated as the maximum R-R interval
after the test (representing the bradycardia in phase 4) to the
minimum R-R interval during the test (representing the tachycardia
in phase 2). Systemic administration of intravenous atropine
abolishes the heart-rate response (224), whilst cardiac sympathetic
blockade has no effect (225). Rebound hypertension in phase 4,
as a result of increased cardiac output during a period of raised
peripheral vascular resistance, requires both parasympathetic and
sympathetic blockade to be effectively negated (226,227).
Pharmacological blockade thus confirms the importance of the
parasympathetic nervous system in control of heart-rate changes
during this reflex.
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There are basically two forms of abnormal response to the test.
The first may occur in patients with congestive heart failure,
who exhibit a "square-wave" response (217); the blood pressure
in this case directly reflects changes in intrathoracic pressure,
and heart-rate remains constant. The second type of abnormal
response is related to autonomic neuropathy. Damage to the
cardiovascular reflex arc results in decreasing blood pressure
during strain (as venous return is inhibited by increased intrathoracic
pressure) followed by a gradual increase in blood pressure upon
discontinuing the Valsalva manoeuvre; there is no rebound hypertension
and no significant change in heart-rate.
Although other indices have been derived from the Valsalva manoeuvre,
such as the post-strain bradycardia ratio (228) and the tachycardia
ratio, these are significantly correlated with the Valsalva ratio
(229,230), which thus remains a well-established, effective and
reproducible measure of parasympathetic autonomic function.
Clinically, a ratio of less than 1.10 is defined as abnormal,
1.11-1.20 as borderline, and 1.21 upwards as normal (219); the
ratio is known to decrease minimally with age (223,231). Cardiac
parasympathetic function has been assessed by this technique in
other disorders; alcoholism (232), renal disease (233), and
rheumatoid arthritis (234). Valsalva ratios agree closely with
other clinical parameters of autonomic dysfunction (235,236).
5.322 Heart-rate variation during deep breathing
The association between heart-rate and respiration was first
described by Ludwig in 1847 (237). Clynes (1960) suggested that
respiratory sinus arrhythmia was not primarily determined by
haemodynamic or central influences; control was effected by two
separate reflexes, the first related to inspiration and the second
to expiration, with unidirectional and biphasic characteristics
(238). Stretch receptors in the chest initiate afferent impulses,
mediating reflex inhibition of the cardioinhibitory centre in
the medulla oblongata. The phasic relationship between heart-rate
and respiration is explained by a differential equation relating
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vagal inhibition and heart-rate.
df* +i . •>A it2 r02 - (V 0 + AV) dt2
r0 = heart-rate with absence of vagal inhibition
V0 = normal vagal tone
AV = change in vagal tone by respiration
y = output of the pacemaker
This explanation was modified by Davies and Neilson (1967), by
considering heart-rate and resting respiration to be related
exclusively by a biphasic inspiratory heart-rate transient with an
amplitude of 16 beats per minute; expiration was assumed to exert
little effect on heart-rate (239). They also suggested that
although stretch receptors are involved, most of the afferent
impulses emanate from vasoreceptors on the left side of the heart
responding to the alterations in blood flow which parallel respiratory
cycles.
Beat-to-beat variation in heart-rate was first used to assess the
integrity of the autonomic nervous system by Wheeler and Watkins
in 1973 (240). Pharmacological autonomic blockade confirmed
that the reflex was mediated by the parasympathetic nervous system;
intravenous atropine abolishes the response, however intravenous
propranolol has no effect (240). Several different techniques
of assessing cardiac vagal function have employed the reflex evoked
by respiratory sinus arrhythmia. The relative merits of each
method are discussed:
i. Mean-square successive difference
Gundersen and Neubauer (1977) proposed this technique as an estimate
of autonomic function (241). Heart-rate is recorded by electro¬
cardiography with the subject at rest, and the mean of the squares
of the differences between successive intervals of 150 consecutive
beats is calculated. This method may also be measuring the intrinsic
rhythmicity of the sino-atrial node, independent of parasympathetic
control, and consequently is not an accurate estimate of vagal
function.
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ii. Standard deviation of resting heart-rate
In this method, a continuous electrocardiogram is recorded on
magnetic tape for approximately five minutes with the subject
at rest. The electrocardiogram is then analysed, with the exclusion
of arrhythmias by an arrhythmia computer, and the mean and standard
deviation of the R-R interval calculated. The standard deviation
is then used as a measure of R-R interval variation (242). This
technique has been used by several authors (243,244,245,246,247),
however the standard deviation only assesses beat-to-beat variation
if the heart-rate remains unaltered, and thus a dependence upon
resting heart-rate is implicit. Subsequent studies have shown
poor reproducibility and a wide range of "normal" values (248).
iii. Variation of heart-rate in response to a single deep breath
It has been suggested that the variation in heart-rate is maximal
in response to a single deep breath (228). This assertion awaits
detailed analysis.
iv. Heart-rate variation during deep breathing
Maximum and minimum heart-rates are measured during deep breathing
at rest, and the differences expressed as beats per minute.
The original method was advocated by Wheeler and Watkins in 1973,
using an instantaneous heart-rate meter (240). The protocol
was modified slightly by Hilsted and Jensen (1979); heart-rate
was recorded by electrocardiography, and maximum/minimum levels
calculated directly from the trace using an ECG ruler (249).
This had the advantage of providing a documentary record of the
reflex. Differences between maximum/minimum heart-rates of
10 beats per minute or less are indicative of autonomic dysfunction
(250).
Sundkvist (1979) modified the method to calculate the ratio of
the maximum R-R interval to the minimum R-R interval in each
respiratory cycle - the E:I ratio (251); this is merely another
form of expressing the maximum/minimum heart-rate variation.
Methods of assessing parasympathetic function by respiratory sinus
arrhythmia have been compared in several recent publications
(252,253,254); each independently concluded that the best technique
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was measurement of the difference between maximum and minimum
heart-rates in beats per minute, using continuous electrocardiography.
Heart-rate variation during deep breathing diminishes with age
(241,245,246,255,256,257,258,259), however the minimum "normal"
difference in heart-rate between inspiration and expiration is
11 beats per minute at age 65 years (260). Thus the
clinical diagnosis of abnormality when the heart-rate variation
is ^ 10 beats per minute, advocated by Ewing and Clarke in 1982 (219),
is equally applicable to older age groups.
5.323 Immediate heart-rate response to standing
Alteration in posture from lying to standing evokes reflex heart-rate
and blood pressure responses (261). The immediate heart-rate
response to standing was first described by Page and Watkins in 1977
(262), and subsequently investigated as a method of autonomic nerve
function assessment by Ewing et al in 1978 (263). In the original
technique, the subject rested supine for approximately three minutes
then was requested to stand unaided, whilst a continuous electro¬
cardiogram was recorded on magnetic tape. Subsequent analysis
showed a consistent response during the manoeuvre, with relative
tachycardia occurring at approximately beats 10-15 after standing,
and relative bradycardia maximal at beats 25-35. The response
is reproducible in normal control subjects, but absent in diabetics
with autonomic neuropathy. This computerised technique was compared
with a simplified method for routine clinical application. The
same rationale was employed, however the continuous cardiac trace
was recorded by a direct-writing electrocardiograph, and the longest
and shortest R-R intervals (corresponding to the bradycardia at
beat 30 and tachycardia around beat 15) manually measured using
a ruler; the longest R-R interval is divided by the shortest R-R
interval to obtain the 30:15 ratio. The method correlated closely
with the computerised technique, and thus obviated the necessity
of complicated equipment.
Autonomic mechanisms responsible for this response were initially
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proposed to be dependent upon a vagal reflex, a hypothesis examined
by Ewing et al in 1980, subdividing the reflex into several component
effects by selective pharmacological blockade (264). Although
responses to change in posture from the supine to the standing
position had been previously studied (265,266,267,268,269), the
circulatory reflexes actually during the movement - rather than
merely before and after change in posture - had received scant
attention. On separate days, the manoeuvres were repeated under
conditions of selective pharmacological blockade:
i. The parasympathetic nervous system was blocked by intravenous
atropine: 1.8 mg followed by a booster dose of 1.2 mg.
ii. The sympathetic nervous system was blocked by intravenous
propranolol: 10 mg.
iii. Total cardiac autonomic blockade by both intravenous atropine
and propranolol.
In addition, comparisons between active standing, and passive
postural change (using a tilt table) were performed.
The results clearly indicated that the immediate heart-rate response
to standing was dependent upon immediate decrease in cardiac vagal
inhibition followed by vagal reactivation. Intravenous atropine
reduced the relative tachycardia at beats 10-15, and totally
eliminated the rebound bradycardia. The manoeuvre was not affected
by intravenous propranolol, however if the vagus was blocked,
increased sympathetic discharge effected a minor cardiac acceleration
between beats 15-30 (264). The rebound bradycardia is dependent
entirely upon the effect of muscular exercise; initial tachycardia
occurred during both active and passive change in posture, however
bradycardia was abolished by passive tilt.
Modifications of this reflex have been proposed as clinical tests:
the maximum-minimum ratio, the relative heart-rate increase (250),
and the acceleration and brake indices (270). There is no evidence
to suggest any advantages conferred by these methods in comparison
to the 30:15 ratio, and considerable evidence to the contrary.
The 30:15 ratio is only slightly reduced in older subjects (260),
and is not related to resting heart-rate (248). Consequently,
it provides an excellent cardiovascular measure of systemic
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parasympathetic nerve function.
5.324 Immediate heart-rate response to Lying
This is the most recent of the cardiovascular autonomic function
tests, the underlying mechanism having been elucidated in 1982
(271). Short episodes of muscular exercise were known to be
associated with an immediate decrease in vagal tone, followed
by vagal reactivation (264,272,273,274). Similar techniques
employed in the investigation of the immediate heart-rate response
to standing were used to determine the mechanisms in this response:
selective pharmacological blockade by intravenous atropine and
propranolol; comparisons between active and passive change in
posture from the standing to the lying position; reproducibility
studies; and assessment of the relationship with age.
Patients maintained a relaxed, erect posture for approximately
three minutes then were requested to lie down unaided. Continuous
electrocardiograms were recorded, both on magnetic tape for
computerised analysis, and by direct-writing electrocardiography.
The heart-rate changes during the manoeuvre were then compared
by differences between successive R-R intervals. An initial
relative tachycardia occurs, represented by decrease in R-R interval
at about the 3rd-4th beat after commencing the manoeuvre, followed
by a relative bradycardia, maximal at about the 25th-30th beat.
Selective pharmacological blockade confirmed that the reflex
was mediated by initial vagal withdrawal, followed by vagal
reactivation; intravenous atropine abolished the reflex, whilst
propranolol alone effected no change in the early stages of the
response. Comparisons between active and passive postural change
established the importance of muscular exertion in evoking the
response.
Although similarities are evident between the lying/standing
and standing/lying manoeuvres, there are separate cardiovascular
reflexes in operation. Whereas vagal withdrawal occurs within
3-4 beats in the standing/lying manoeuvre, the minimum R-R interval
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difference is not present until beats 10-15 during lying/standing.
Immediate vagal reactivation does not occur during the 30:15 test,
presumably as muscular activity - the stimulus to vagal withdrawal-
continues to exert an effect. The sympathetic nervous system
is known to exert effects only in the later stages of the immediate
heart-rate response to lying. Sympathetic efferent discharge
is increased during standing at rest, and decreased in the supine
position (271). Examination of R-R intervals 50-60 beats after
the manoeuvre during pharmacological blockade procedures suggests
that the sympathetic nervous system effects this stage of the
reflex response, with decreased sympathetic activity causing
lengthening of the R-R interval.
Investigation of patients with various stages of diabetic autonomic
neuropathy has confirmed the value of this test as a sensitive
measure of early parasympathetic dysfunction (271,275). In
normal subjects, the measure is reproducible, and not significantly
affected by age (271,275).
5.33 Sympathetic nerve function
5.331 Systolic blood pressure response to standing
Change in posture from the supine to the erect position evokes
characteristic cardiovascular reflexes. Gravitational pooling
of blood in the venous capacitance vessels of the lower extremities
precipitates an immediate fall in venous return and consequently
cardiac output. Homeostasis in the maintenance of systemic
blood pressure is effected by increased sympathetic efferent
impulses; the resultant raised peripheral vascular resistance
reverses the decrease in venous return, and in conjunction with
direct chronotropic cardio-accelerator effects, preserves adequate
cardiac output (268,276,277). Aortic and carotid sinus baroreceptors
mediate these reflexes (278), with contributions from cardiopulmonary
low-pressure receptors (279). Upon standing, parasympathetic
activity decreases and sympathetic activity increases. The
role of autonomic failure in the development of orthostatic
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hypotension was recognised by Bradbury and Eggleston in 1925 (166),
and orthostatic hypotension has subsequently been associated
with several neurological disorders (280).
The assessment is performed according to the following technique.
After resting supine for approximately three minutes, the subject
is requested to stand unaided. Systolic blood pressure is recorded
at rest, using a cuff sphygmomanometer, and immediately on standing.
Splanchnic vasoconstriction is an integral component of the reflex;
its importance in blood pressure control has been clearly demonstrated
(281,282). Impaired constriction of splanchnic vessels is present
in diabetics with postural hypotension (283).
The evidence regarding postural hypotension in relation to age
is conflicting. Although decreased efficacy of postural reflexes
is present in some elderly subjects (248,266), there is currently
considerable debate regarding the exact degree of age-related postural
fall in blood pressure. Some authors suggest that postural
hypotension is directly age-related (266,284); others refute this
contention, whilst accepting that postural fall in blood pressure
is more prevalent in an elderly population (285). Similarly,
the degree of postural change varies; using a level of 20 mmHg
decrease in systolic blood pressure between lying and standing,
the prevalence of postural hypotension in older "normal" subjects
is variously reported as 24% (286), 22% (285), and 0% (287)
although the latter figure was obtained from a marginally younger
sample. If a level of 40 mmHg difference in systolic blood pressure
is accepted as diagnostic, 5% of the population aged > 65 years
are affected (286).
Apart from differences in diagnostic criteria and patient populations,
the prevalence of postural hypotension is affected by other factors;
during change in posture, activation of the renin-angiotensin system
may assist in the maintenance of blood pressure, and symptoms of
postural hypotension are also limited by autoregulation of cerebral
blood flow, possibly via myogenic and metabolic mechanisms (288).
Thus compensatory mechanisms remain effective to various degrees
in patients with sympathetic nerve dysfunction.
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The exclusion of other known causes of orthostatic hypotension
(eg significant decrease in circulating blood volume, drug effects,
and neurological disease) is an essential prerequisite. Assuming
this precaution is taken, postural changes in systolic blood
pressure provide an effective cardiovascular assessment of sympathetic
nerve function.
5.332 Diastolic blood pressure response to sustained isometric
muscular contraction
Changes in the immediate metabolic environment of exercising,
ischaemic muscle provide the afferent stimulation for subsequent
reflex increases in heart-rate and blood pressure (289). The
vagus and sympathetic nerves mediate the efferent component of
this reflex, effecting increased cardiac output by both inotropic
and chronotropic actions and peripheral vasoconstriction.
Isotonic or dynamic exercise produces relatively moderate increases
in mean arterial pressure with marked tachycardia (290), however
isometric exercise produces opposite effects: marked increase
in mean arterial blood pressure with minimally-increased heart-rate
(291). Lind et al (1968) has shown that cardiovascular responses
occur during sustained isometric exercise providing 30% of maximum
voluntary contraction is maintained; the response is not dependent
upon the mass of muscle under examination (289). Sustained
contraction of the forearm muscles is utilised as the basic
experimental model, as this is both reproducible and well-documented
in normal subjects (292). 30% of maximum voluntary handgrip
has been equated with carrying a 10 kg weight (293). The rise
in blood pressure results from two discrete autonomic effects:
peripheral vasoconstriction via sympathetically-stimulated alpha-
adrenoceptors (294), and heart-rate dependent increased cardiac
output (289). After a period of sustained isometric muscular
contraction at the requisite level, blood pressure rises significantly
if the reflex pathway is intact (248). The distinction between
normal and abnormal responses is most evident using diastolic
blood pressure as the diagnostic index (295). The "normal"
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tolerance intervals were established by Ewing et al in 1974 (295);
in a normal population (age range 25-54 years), the mean increase
in diastolic pressure was 33 ± 9 mmHg in males, and 24 ± 9 mmHg
in females. The test is easily performed; after establishing
the maximal voluntary contraction using a handgrip dynamometer,
30% of maximal voluntary contraction is maintained for as long
as possible whilst blood pressure recordings are taken at one-minute
intervals from the non-exercising arm.
Several studies have confirmed the value of this technique in
the assessment of sympathetic autonomic function (235,248,296).
Apart from obstruction to outflow secondary to mitral stenosis,
the presence of cardiac pathology does not negate the reflex
rise in diastolic blood pressure; the latter is only diminished
or abolished by significant sympathetic autonomic neuropathy,
thereby preventing peripheral vasoconstriction. The technique
is safe, with reversion to normal levels of blood pressure within
sixty seconds of discontinuing the manoeuvre (295). Heart-rate
changes during this test have been documented, however the normal
responses are variable, and are thus unsuitable for diagnostic
application (295,297).
The rise in diastolic blood pressure precipitated by sustained
forearm muscular contraction provides a reproducible, non-invasive
and effective cardiovascular measure of sympathetic nerve function.
5.4 Ocular autonomic nerve function
Autonomic nerve function in the anterior segment of the eye was
assessed by two complementary techniques: the pupil cycle time;
and utilisation of the principles of denervation hypersensitivity,
a phenomenon which may develop subsequent to neuropathy.
5.41 Pupil cycle time
Regular pupillary oscillations are induced by illumination of
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the pupil margin with a thin beam of light. There are basically
three types of pupillary movement in controlled lighting conditions:
i. Hippus
A physiological pupillary unrest in stable lighting conditions.
Characteristic features include irregularity, continuous duration,
and variable amplitude (298,299,300).
ii. Pupillary oscillation in drowsy subjects
This is characterised by persistence in the absence of light,
episodic regularity, variable amplitude, and extended cycle time
(301,302,303).
iii. Edge-light pupil cycle time
Although this phenomenon was first recorded by Lambert in 1760
using focussed candle-light (298), the edge-light pupil cycle
time was placed in a clinical perspective by Stern in 1944 (304):
"If a fine pinpoint of light is projected on the eye with the
slit lamp in such a way that it just enters the pupil near the
margin of the iris, a light reaction follows, the pupil contracts.
That means that the iris margin moves towards the centre of the
pupil and prevents the light pencil from entering the pupil.
As no light now reaches the retina the stimulus for the contraction
of the pupil is no longer present, the pupil dilates - and thus
again allows the light pencil to reach the retina."
Stark and Cornsweet (1958) applied a servoanalytic hypothesis
to explain the pupil oscillations occurring with edge illumination,
concluding that the phenomenon was a manifestation of the pupillary
reflex arc (305,306). Localisation of autonomic nerve function
assessment to the eye necessitates a brief description of
the ocular anatomy of the autonomic nervous system, with particular
reference to the pupil reflex; this response is initiated by
receptors in the rods and cones, afferent impulses travelling
via the optic nerve - probably in non-myeIinated peripheral fibres.
Following nasal decussation at the optic chiasm, the afferent
limb continues via the optic tract without synapse through the
superior brachium and thence to the pretectal nucleus. Synapse
occurs at this point with decussation, and the interneurone passes
to the Edinger-Westphal nuclei of both oculomotor nerves, via
the posterior longitudinal bundle. The Edinger-Westphal nucleus
is situated in the midbrain, at the postero-superior part of
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the oculomotor nuclear complex. The efferent parasympathetic
pupillomotor fibres travel with the oculomotor nerve, synapse
at the ciliary ganglion, and innervate the sphincter pupillae
via the short ciliary nerves (307). Postganglionic fibres in
the short ciliary nerves pass to the ciliary, choroidal and iridic
plexuses. Parasympathetic fibres from the Edinger-Westphal nucleus
to the iridic plexus are both crossed and uncrossed, explaining
the consensual pupillary response to light (308). Parasympathetic
fibres controlling accomodation (ie innervating the ciliary muscle),
and mediating the pupillary constriction which accompanies
accomodation, may synapse in the episcleral ciliary ganglia (309),
however this view has been questioned (310).
The first neurone in the sympathetic relay passes from the
hypothalamus via the ipsilateral intermediolateral columns of
the spinal cord to the cilio-spinal centre of Budge, situated
at the root of the first thoracic nerve (311). Preganglionic
nerves (the second neurone) leave the spinal cord at the level
of the first two thoracic nerves, traverse the inferior and middle
cervical ganglion, and synapse at the superior cervical ganglion.
The postganglionic fibres (the third neurone) pass via the internal
carotid plexus to the superior orbitaI fissure. At this point
the sympathetic nerves pass into the orbit with the ophthalmic
division of the trigeminal nerve, and enter the eye with the
long ciliary branches of the nasociliary nerve to subsequently
innervate the dilator pupillae.
Several different applications of the basic principle underlying
the pupil oscillation occurring with edge illumination have been
used to assess the pupillary reflex arc. Early observers employed
a vertical slit-beam to measure the pupil cycle time (312,313).
Sakuma (1965) obtained similar results with a technique which
omitted light from the central portion of the pupil (314).
The technique was placed on a clinical basis by Miller and Thompson
in 1978 (315). They explained the mechanism underlying edge-light
pupil cycle time as an overcompensation of the pupil in response
to marginal illumination, resulting in a "high-gain" state; when
the pupil is in this state, there is instability of the pupillary
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reflex feedback loop and spontaneous pupillary oscillations occur.
The technique is simply performed by seating the subject at the
slit-lamp in a dimly-illuminated room, directing a thin, horizontal
slit-beam to just overlap the inferior pupillary margin, and
timing the resultant pupillary oscillations.
"Normal" pupil cycle time has a mean of 822 ± 69 ms in a population
aged less than 50 years, with the 95th percentile set at 954 ms
(315). The pupil cycle time is known to increase slightly with
age; in the age group 50-79 years, the mean pupil cycle time
was 872 ± 83 ms (316). The pupil cycle time is reproducible,
and accurate to within ± 3% (317); it is not dependent upon tight
adaptation, accomodation, amplitude of oscillation, initial pupil
size, visual acuity, iris colour, refraction, or degree of pupillary
unrest. Variation in stimulus intensity only alters the pupil
cycle time to a maximum of ± 0.3%.
Pupil cycle time is actually measuring the time required for
a single pupillary reflex ie initial constriction of the pupil
followed by dilation. This involves a series of independent
components summating to effect the reflex: afferent impulses
transmitted by the optic nerve; synapses and interneurones within
the midbrain; efferent discharge via parasympathetic outflow
with the third nerve; and the mechanical efficacy of iris stroma
and musculature. Prolongation of the pupil cycle time cannot
be localised to any single constituent of the pupillary reflex
pathway without additional information. It does, however, localise
the defect to one or more of the constituents of the reflex.
Previous authors have used the pupillary reflex arc to assess
the afferent limb of the reflex, by infrared videopupiIlography
(318), and measurement of the relative afferent pupillary defect
(319,320,321). In attempting to localise the defect, central
and peripheral visual field assessments in patients with glaucoma
are essential, as afferent pupillary defects are known to occur
in glaucoma (322), and have been attributed to defects in the
anterior visual pathway usually proximal to the optic chiasm
(323).
The pupil cycle time has been used as an objective measure of
the pupillary reflex arc in patients with lesions of the afferent
limb of the reflex; it is significantly prolonged in patients
with optic nerve compression from chiasmal tumours or Grave's
disease (324), optic neuritis (313,325,326), and retrobulbar
neuritis (327,328). This study is, to my knowledge, the first
to use the technique in the investigation of disorders involving
the efferent parasympathetic limb of the reflex.
5.42 Denervation hypersensitivity
5.421 Introduction
Denervation hypersensitivity is defined as an increased response
of a tissue (the effector) to a chemical neurotransmitter or
agonist after the tissue has been deprived of its nerve supply.
Adrenergic and cholinergic supersensitivity of autonomicaIly-
denervated irides has been known since the early years of the
20th century; in 1904, Meltzer described paradoxical pupil dilatation
with adrenaline (329), and in 1905 Markus (330) and Anderson (331)
separately noted undue sensitivity of the denervated .pupil to
cholinergic drugs. Sensitisation of the denervated pupillary
sphincter to acetylcholine was confirmed by Shen and Cannon in
1936 (332). Scheie (1940) subsequently observed enhanced
cholinergic sensitivity of the tonic pupil (333); topically-applied
2.5% methacholine was shown to constrict tonic pupils, whilst normal
pupils were unaffected by concentrations up to 15%. Adie's tonic
pupil was considered to be specifically associated with a
postganglionic parasympathetic defect, following the experimental
demonstration of marked cholinergic sensitivity subsequent to
removal of the ciliary ganglion or short ciliary nerves by Scheie
and Adler in 1940 (334).
The law of denervation was placed in perspective by Cannon in 1939:
"When in a series of efferent neurones, a unit is destroyed,
an increased irritability to chemical agents develops in the
isolated structure or structures, the effects being maximal in
the part directly innervated." (335)
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This stressed that supersensitivity of a tissue was maximal if
the innervating neurone was damaged, compared with preceding
neurones in the relay. The description was expanded in the
definitive taw of denervation supersensitivity by Cannon and
Rosenbluth in 1949:
"When in a functional chain of neurones one of the elements is
severed, the ensuing total or partial denervation of some of
the subsequent elements in the chain causes a supersensitivity
of all the distal elements, including those not denervated, and
effectors if present, to the excitatory or inhibitory action
of chemical agents and nerve impulses; the supersensitivity is
greatest for the links which immediately follow the cut neurones
and decreases progressively for more distant elements." (336)
Thus although sensitivity is greatest when the innervating neurone
is affected, increased sensitivity occurs even if the lesion
is more proximally situated in the synaptic chain.
In the presence of significant neuropathy, one may logically
assume an intact effector tissue to exhibit hypersensitive responses
to topically-applied chemical neurotransmitters. It is appropriate
to briefly review the applications of the principle of denervation
hypersensitivity to ocular structures innervated by the
parasympathetic and sympathetic nervous systems.
5.422 Parasympathetic nervous system
Denervation hypersensitivity of the parasympathetic nervous system
in the anterior segment of the eye is present in Adie's tonic
pupil (337,338), and familial dysautonomia - the Riley-Day syndrome
(339,340). Parasympathetic denervation of the iris in Adie's
syndrome has been shown to occur following degeneration of the
ciliary ganglion (310,341), resulting in a segmental palsy of
the iris sphincter (342). Hypersensitivity to methacholine
in this disorder may persist for at least 25 years (343).
Recent reports have reviewed the efficacy of methachoLine in
the diagnosis of denervation supersensitivity. These have concluded
that methacholine elicits cholinergic hypersensitivity in 63%
of Adie's pupils, whereas 0.125% pilocarpine increases diagnostic
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sensitivity to 69% (344,345,346). Methacholine demonstrates
high specificity with moderate sensitivity for cholinergic denervation.
5.423 Sympathetic nervous system
Interruption of the sympathetic innervation to the eye results
in Horner's syndrome (347), with ipsilateral ptosis, miosis,
and facial anhidrosis (348). The physiological properties of
adrenaline were described by Langley in 1901 (349). Topical
ocular application of the drug was noted to produce effects
equivalent to those resulting from cervical sympathetic nerve
stimulation; paradoxically, the efficacy of topical adrenaline
was enhanced by sympathetic nerve section (350). These observations
were explained by Cannon's law of denervation hypersensitivity.
This principle enabled the development of topical drug combinations
to indirectly determine the site of damage within the sympathetic
three-neurone efferent chain: the central neurone, from the
hypothalamus to the cilio-spinal centre of Budge; the preganglionic
neurone, from the cervicaI/thoracic cord to the superior cervical
ganglion; and the postganglionic neurone, from the superior cervical
ganglion via the carotid plexus and long ciliary nerves to the
iris. The drugs used, with presumed mechanisms of action, are
shown in table 5.
Thus two mutually-exclusive drug effects may be utilised in the
assessment of sympathetic innervation to the dilator pupillae:
i. Indirectly-acting sympathomimetics, which effect mydriasis
by either releasing noradrenaline from presynaptic nerve stores
(1% hydroxyamphetamine), or preventing re-uptake of noradrenaline
(cocaine).
ii. Directly-acting sympathomimetics, which exert direct effects
on adrenoceptors of the dilator pupillae (0.1% adrenaline,
1% phenylephrine).
Impaired efficacy of the dilator pupillae is clinically manifest
as delayed pupillary dilatation in darkness (351). Denervation
hypersensitivity has been assessed with 0.1% adrenaline,
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10% phenylephrine, and 1% phenylephrine. Although 0.1% adrenaline
is reported to elicit "maximal dilatation of the pupil" (352),
subsequent studies have shown inconclusive results due to poor
corneal penetration and variation in individual sensitivity (353).
10% phenylephrine produces marked dilatation of the denervated
pupil, however similar effects are seen in normal pupils (353).
1% phenylephrine proved a more sensitive determinant of hyper¬
sensitivity; once again, mydriatic effects on the normal pupil
await accurate definition (353,354,355). Postganglionic lesions
exhibit markedly greater sensitivity to these topical drugs than
central or preganglionic defects (356,357), and therefore a
postganglionic lesion may be easier to identify (358).
Present indications suggest that hypersensitivity is not a transient
phenomenon. Sympathetic denervation hypersensitivity to
0.1% adrenaline may persist for over 20 years (358); parasympathetic
denervation hypersensitivity has been documented on repeated
testing over a 25 year period (343).
The presence of sympathetic and parasympathetic autonomic neuropathy
may thus be accurately assessed in the anterior segment of the
eye by clinical application of the laws of denervation hypersensitivity.
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DIAGNOSTICCRITERIAINCAR IOVASCULARAUTONOMICFUNCTIONTES S AbnormalBorderlineN mal
P§E§§Z!DQ§£!)§£i£_Q££££_lyQ££i2Q i.Valsalvaratio$1.101.11-1.20£.2 ii.Heart-ratev iationdur ngeepbreathin (beats/minute)̂10.010.1-14.9>,15.0 iii.Immediateheart-rateresponsetostan ng (30:15ratio)$1.00.01-1.03Js1.04 iv.Immediateheart-rateresponsetolying (S:Lratio)$1.07.08-1.24̂1 25 Sympathet2c_nerve_function i.Decreaseinsystolicbloodpressurensta ding (mmHg)̂30.029.9-10.1$10. ii.Increaseidiastolicbloodpressureiresp ns tosustainedhandgrip (mmHg)$10.00.1-15.916.0
Table5


























Autonomic integrity in the primary glaucomas was investigated.
Several studies were performed on patients with primary open-angle
glaucoma, primary closed-angle glaucoma, and ocular hypertension.
The aims were:
i. to define the relationship between diabetes mellitus,
the commonest cause of autonomic neuropathy in this country,
and the primary glaucomas.
ii. to examine the efficacy of autonomic nerve function
systemicaIly, by a series of tests based upon cardiovascular
reflexes, specifically designed to quantify parasympathetic
and sympathetic nerve function.
iii. to assess ocular autonomic nerve function by:
a. pupil cycle time - an accurate, reproducible measurement
of the pupillary reflex arc.
b. denervation hypersensitivity - by definition, manifest
only in the presence of significant neuropathy.
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SECTION II
DIABETES MELLITUS IN THE PRIMARY GLAUCOMAS
CHAPTER 6
DIABETES MELLITUS IN THE PRIMARY GLAUCOMAS
6.1 Introduction
Known associations between diabetes mellitus and open-angle glaucoma
have been detailed in the introductory text. The lack of
controlled studies investigating the prevalence of diabetes mellitus
in patients with closed-angle glaucoma and ocular hypertension
prompted rectification of this omission. In addition, the
relationship with open-angle glaucoma required further investigation;
diabetic diagnostic criteria used in the United States of America
10-20 years ago are not applicable today, thus direct comparisons
of prevalence rates are impossible. As the aim of this study
was to assess autonomic function in the primary glaucomas, an
estimate of the prevalence of diabetes mellitus - the commonest
cause of autonomic neuropathy in this country - was an essential
prerequisite.
Diabetes mellitus has been defined as a state of sustained
hyperglycaemia (359). It is not the purpose of this introduction
to examine the complexities of diabetes mellitus in detail, merely
to clarify criteria employed in the diagnosis. Until comparatively
recently, the diagnosis of diabetes mellitus was based upon
differing diagnostic criteria applied to different forms of the
oral glucose tolerance test (360), thereby confusing the determination
of diabetes on an individual basis, and precluding comparisons
of diabetic prevalence within discrete populations. Substantial
variations in clinical diagnostic criteria are a subject of
controversy; several studies have attempted to establish the
relationship between the size of the glucose loading dose and
subsequent plasma glucose levels (361,362). In North America,
the 100 gram oral glucose load is widely used (363); in Europe,
the test is performed with a 50 gram glucose loading dose (364).
Recently, the National Diabetes Data Group and the World Health
Organisation Expert Committee on Diabetes Mellitus have standardised
the diagnosis of diabetes mellitus within specific criteria,
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advocating oral glucose tolerance testing with a 75 gram glucose
load (365,366). This has been well-received (367,368,369),
and permits accurate comparisons of diabetic prevalence on a
global basis for the first time.
The criteria proposed by the National Diabetes Data Group and
the World Health Organisation subdivide the population into three
categories:
i. normal
ii. impaired glucose tolerance
iii. diabetes mellitus
Impaired glucose tolerance represents a region of diagnostic
uncertainty, encompassing the following former diagnoses: chemical
diabetes, asymptomatic diabetes, subclinical diabetes, borderline
diabetes, latent diabetes. Studies have shown that between
2-4% per year will progress to overt diabetes mellitus (370).
Adequate categorisation of individual diabetic status requires
information relating to the three specific characteristics of
diabetes mellitus:
i. type - subdivided by treatment; IDDM (type 1) and NIDDM (type 2)
ii. duration of diabetes
iii. control of diabetes
Several studies have indicated that glycosylated haemoglobin
is a reliable index of diabetic control (371,372,373). Improved
control has been correlated with a reduction in glycosylated
haemoglobin (374,375). Providing care is taken in the experimental
model to eliminate recent glycaemic fluctuations (376), this
technique gives an accurate estimate of prevailing glucose
concentrations throughout the life of the red blood cell (377);
in consequence, glycosylated haemoglobin is a clinically-useful
indicator of long-term diabetic control.
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6.2 Patients and methods
Patients were included in the study on the basis of the following
criteria:
i. a history of closed-angle glaucoma
ii. ocular hypertension
a. with narrow irido-corneal angles
b. with wide irido-corneal angles
iii. open-angle glaucoma
a. with narrow irido-corneal angles
b. with wide irido-corneal angles
After informed consent had been obtained, diabetic status was
assessed in 74 age- and sex-matched control subjects (mean age
66.2 ± 10.1 years) and 375 patients with primary glaucoma
(mean age ± SD): 123 CAG (66.5 ± 10.1 years), 90 OHNA (67.5 ± 9.2
years), 96 OHWA (64.8 ± 9.6 years), 24 OAGNA (71.5 ± 8.4 years),
and 42 OAGWA (67.0 ± 8.2 years). The control group consisted of
hospital staff, and patients attending the casualty department
who were subsequently determined to have no detectable abnormality,
or mild ocular changes within acceptable limits for an elderly
population; this included early macular degenerative changes
and refractive errors. Ocular examination included:
i. Anterior segment assessment
a. slit-lamp examination of cornea, anterior chamber,
iris integrity/dynamics, and lens
b. gonioscopy by Zeiss 4-mirror gonioprism to determine
angle configuration and exclude angle abnormalities
c. intraocular pressure by Goldmann applanation tonometry
ii. Posterior segment assessment
a. direct ophthalmoscopy of optic disc, cup:disc ratio,
retinal vessels and macula
b. indirect ophthalmoscopy, after pupillary dilation,
to assess posterior pole and retinal periphery
c. visual field examination: peripheral field by Goldmann
perimetry; central field by either Goldmann perimeter
or Friedmann II analyser
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Subjects taking medication with known diabetogenic effects (365)
were excluded from the study. Subjects with known diabetes
mellitus were excluded from oral glucose tolerance test, but
were included in the final results; exclusion of this group would
have effected significant underestimation of the prevalence of
diabetes mellitus. At the time of diabetic assessment, no subjects
were influenced by extraneous factors known to bias the results
of the oral glucose tolerance test.
The diagnosis of diabetes mellitus was made in accordance with
National Diabetes Data Group and World Health Organisation criteria
(365,366). The following protocol was observed:
i. All tests were performed in the morning with the patients
at rest, after at least three days of unrestricted diet
(> 150 grams of carbohydrate per day) and physical activity.
ii. The subject had fasted for at least ten hours, but not
greater than sixteen hours.
iii. The subject was not permitted to smoke during the test.
iv. A fasting venous blood sample was taken, and transferred
to a standard tube containing sodium fluoride.
v. A 75-gram glucose load was administered over a 5 minute
period, the glucose dose in a concentration of not greater
than 25 g/dl.
vi. The commencement of drinking the glucose solution was
considered zero time, and 2.5 ml blood samples were collected
at 1 hour intervals for 2 hours.
vii. Blood samples were immediately centrifuged, and assessment
of venous plasma was undertaken using a YSI Model 23AM
glucose analyser (Yellow Springs Instrument Company, Ohio, USA).
This technique permits direct readout of glucose concentrations,
using an oxidase enzyme hydrogen peroxide sensor. The
basis of this method of glucose determination is the
conversion of glucose and oxygen to gluconic acid and
hydrogen peroxide:
a. D-glucose + 02 —: »■ gluconic acid + H202glucose oxidase
b. H202 —*- 2H+ + 02 + 2e
62
c. AH + 02 —► 2H20 - Ae
The current generated is directly proportional to the glucose
level in the diluted sample (378,379). An accuracy of ± 0.05 mmol/l
was obtained. Diagnostic criteria for diabetes mellitus and
impaired glucose tolerance, in non-pregnant adults, are shown
in table 6. If the fasting venous plasma glucose concentration was
significantly elevated (> 7.8 mmol/l) on more than one occasion,
06TT was not required to establish the diagnosis of DR. The
diagnosis of IGT or DR was made on the basis of 2 abnormal OGTT, or
elevated fasting venous plasma glucose (> 7.8 mmol/l) on 2 occasions.
Patients subsequently included within the classification of DR or
IGT were assessed for long-term control of glucose metabolism
by estimation of glycosylated haemoglobin. A micro-column
chromatographic technique was used (Boehringer Rannheim, Lewes,
England); by this method, the normal range of glycosylated haemoglobin
is 5-8% (380,381). Factors known to produce falsely-elevated values
of glycosylated haemoglobin include uraemia (382,383), Lead
poisoning (38A), alcoholism (385), and high daily doses of aspirin
(386); no subjects had a history of the aforementioned factors
necessitating exclusion from the study.
Assessment of glycosylated haemoglobin was also performed on:
i. the age- and sex-matched control group, to verify the
normal range for this particular laboratory
ii. a randomly-selected group of patients with CAG, OHNA, OHWA,
OAGNA, and OAGWA, in whom the diabetic status was "normal"
by OGTT, to determine the degree of long-term glycaemic
control in these patients
The method of glycosylated haemoglobin assessment was as follows:
i. A 5 ml sample of venous blood was taken, and transferred
to a standard tube containing potassium EDTA.
ii. Separation of labile HbAt
In order to separate the labile fraction, the sample of
venous blood was washed with glucose-free solutions.
During this procedure the labile fraction dialyses out
of the erythrocyte. 0.2 ml of EDTA venous blood was
mixed with 2.0 ml of 0.9% sodium chloride solution; this
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was allowed to stand for 2 hours with regular gentle mixing
to prevent erythrocyte sedimentation. The mixture was
then washed with 4 ml (EDTA-free) 0.9% sodium chloride
solution, centrifuged for 3 minutes, and the supernatant
removed with a suction pump; this procedure was performed
3 times.
iii. Haemolysis
0.05 ml of the washed sample of EDTA venous blood was
pipetted into a test tube, to which was added 0.2 ml of
the standard haemolysing reagent (0.1% detergent). This was
permitted to stand for 10 minutes with occasional shaking.
iv. Measurement of HbAj
All equipment, eluent solutions, and haemolysates to be
tested were brought to a temperature of 23°C using a constant-
temperature rack (HbAj rack no. 611948) before performing
the assay. Chromatography was subsequently performed
under strict temperature control (± 0.25°C) in a water bath,
as reproducibility depends upon maintenance of constant
temperature within ± 1°C (387). The collection tube
was placed beneath the column, and the flow rate adjusted
to 6 drops per minute. 0.05 ml of haemolysate and 0.20 ml
of the phosphate buffer eluant for HbA! (40 mmol/l; pH 6.7)
were pipetted directly onto the disc. The eluate was
permitted to drain completely and discarded. A fresh
collection tube was placed beneath the column and 4.00 ml
of the phosphate buffer was added; the eluate was collected
(over approximately 30 minutes) and mixed thoroughly.
The absorbance of HbAi was measured within 10 minutes,
according to the following conditions:
a. assay temperature: 23°C
b. wavelength: Hg 405 nm
c. spectrophotometer: 415 nm
d. cuvette: 1 cm light
e. measured against water
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v. Measurement of "other haemoglobins"
A fresh collection tube was placed beneath the column.
4.00 ml of sodium chloride solution (400 mmol/l) was added
to the column, and the eluate collected. This was diluted
with 15.00 ml of redistilled water, mixed thoroughly,
and the absorbance of HbA2 measured within 5 minutes,
following the conditions described above.
vi. Calculation of HbAj concentration
This was performed according to the following formula:
% HbAl ~
a + TT x 100Aj + (4.75 x A2)
Aj = absorbance of HbA ,-fraction
A2 = absorbance of "other haemoglobins"
Aj + (4.75 x A2) = absorbance of total haemoglobin



















The results of diabetic assessment in the primary glaucomas are
described as follows:
6.31 The prevalence of diabetes mellitus in the primary glaucomas
6.32 The duration of diabetes mellitus in the primary glaucomas
6.33 Intraocular pressure variation in glaucoma by diabetic status
6.34 Glycosylated haemoglobin levels in the primary glaucomas
6.35 The prevalence of a familial history of diabetes mellitus
in the primary glaucomas
6.36 Glaucoma treatment and diabetic status
6.31 The prevalence of diabetes mellitus in the primary glaucomas
The results of 75 gram OGTT in 123 patients with CAG, 186 patients
with OH, 66 patients with OAG, and 74 age- and sex-matched control
subjects are shown in table 7. The prevalence of diabetes mellitus
in patients with CAG, OH, and OAG was compared by x2 test with
that of the control group; Yates' correction was incorporated
in all x2 analyses. In order to prevent inaccuracies resulting
from multiple comparisons with a control, significant p values
were multiplied by the number of comparisons made, thereby obtaining
a corrected p value (p1). Ocular hypertension and open-angle
glaucoma were then subdivided by i ri do-cornea I angle assessment
into narrow angles (NA) and wide angles (WA); the prevalence
of diabetes mellitus within these sub-groups was similarly compared
with the control group. Diabetes prevalence in the primary
glaucomas is summarised in the following paragraphs; the actual
p value plus the corrected p value (p1) are quoted for significant
results, to allow for multiple comparisons.
6.311 The prevalence of diabetes mellitus in patients with
closed-angle glaucoma
Diabetes mellitus shows significantly-increased prevalence in
patients with a history of closed-angle glaucoma compared with




iii. (NIDDM + IGT):
p = 0.03; p' > 0.05
p = 0.03; p' > 0.05
p = 0.003; p' < 0.05
6.312 The prevalence of diabetes mellitus in patients with ocular
hypertension
The prevalence of diabetes mellitus in patients with OH is not
significantly different from an age- and sex-matched control group:
i. NIDDM: p > 0.05
ii. IGT: p > 0.05
iii. (NIDDM + IGT): p > 0.05
Subdivision of ocular hypertension by angle measurement clarifies
the association between OH and diabetes mellitus. The prevalence
of diabetes mellitus in patients with 0HNA and 0HWA were separately
compared with that of the age- and sex-matched control group:
a. 0HNA
i. NIDDM: p > 0.05
ii. IGT: p = 0.01; p' < 0.05
iii. (NIDDM + IGT): p = 0.007; p' < 0.05
b. 0HWA
i. NIDDM: p > 0.05
i i . IGT: p > 0.05
iii. (NIDDM + IGT) : p > 0.05
The prevalence of impaired glucose tolerance and total abnormal
glucose tolerance (NIDDM + IGT) is significantly increased in
patients with 0HNA, however no relationship is present between
diabetes mellitus and OHWA.
6.313 The prevalence of diabetes mellitus in patients with
open-angle glaucoma
The prevalence of diabetes mellitus in patients with open-angle












No significant relationship is present between diabetes mellitus
and OAGNA or OAGWA.
a. OAGNA
i. NIDDM: P > 0.05
i i . IGT: P > 0.05
i i i . (NIDDM + IGT) : P > 0.05
OAGWA
i. NIDDM: P > 0.05
i i. IGT: P > 0.05
i i i . (NIDDM + IGT) : P > 0.05
6.314 The prevalence of diabetes mellitus in the primary glaucomas
by angle measurement
When the primary gIaucomas are classified according to angle
measurement, salient differences in the prevalence of diabetes
mellitus are accentuated (table 8). The significance of comparing
the prevalence of abnormal glucose tolerance (NIDDM + IGT) in CAG,
narrow-angle patients (0HNA and OAGNA), and wide-angle patients
(0HWA and OAGWA), with an age- and sex-matched control group are
as follows: the prevalence of abnormal glucose tolerance was
significantly increased in CAG (p = 0.003; p' < 0.05) and narrow-angle
patients (p = 0.003; p' < 0.05), whilst the prevalence in subjects
with wide-angles was not significantly different from the control
group (p > 0.05).
6.32 The duration of diabetes mellitus in the primary glaucomas
Comparisons of mean duration of diabetes mellitus, between the
control group and each of the primary glaucoma categories, were
made by Student's unpaired t test. No significant differences
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Table 8
DIABETIC STATUS IN THE PRIMARY GLAUCOMAS BY ANGLE CONFIGURATION
Normal NIDDM IDDM IGT
Closed-angle glaucoma
patients
(n=123) 75 22 1 25
Narrow-angle subjects
OHNA + OAGNA
(n=114) 71 16 0 27
Wide-angle subjects
OHWA + OAGWA
(n=138) 107 15 0 16
6.33 Intraocular pressure variation in glaucoma by diabetic status
To determine the significance of diabetes mellitus on intraocular
pressure, mean intraocular pressure in non-diabetic subjects
was compared with mean intraocular pressure in diabetic subjects
by Student's unpaired t test, within the control group and each
of the primary glaucoma categories separately. Dunnett's multiple
comparison procedure was applied to the levels of significance
thus obtained, to obviate incorrect conclusions resulting from
multiple comparisons with a control (388,389); the tables constructed
by Dunnett for use in multiple comparisons with a control only
extend to a maximum joint confidence coefficient of 99%, therefore
every value of p < 0.01 will be included within this category.
Three comparisons were performed:
i. non-diabetic v NIDDM
ii. non-diabetic v IGT
iii. non-diabetic v (NIDDM + IGT)
No significant differences in intraocular pressures were shown
between non-diabetic and diabetic subjects (NIDDM or IGT) in the
control group, patients with ocular hypertension (OHNA and OHWA),
and patients with open-angle glaucoma (OAGNA and OAGWA). However
significant differences in intraocular pressures between non-diabetic
and diabetic subjects were present in patients with closed-angle
glaucoma; mean IOP ± SEM is quoted in brackets.
i. Subjects with NIDDM (19.64 ± 0.88) had significantly higher
intraocular pressures than non-diabetics (17.58 ± 0.53),
however this was non-significant when allowance was made for
multiple comparisons: p = 0.04; p' > 0.05.
ii. Subjects with IGT (20.24 ± 0.98) had significantly higher
intraocular pressures than non-diabetics (17.58 ± 0.53):
p = 0.016; p' < 0.05.
iii. Subjects with NIDDM or IGT (19.96 ± 0.66) had significantly
higher intraocular pressures than non-diabetics (17.58 ± 0.53):
p = 0.006; p' < 0.05.
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6.34 Glycosylated haemoglobin levels in the primary glaucomas
The results of glycosylated haemoglobin estimation in 60 patients
with CAG, 78 patients with OH, 30 patients with OAG, and 31 age-
and sex-matched control subjects are shown in table 9. Comparisons
of glycosylated haemoglobin results were made between the control
group and each of the primary glaucoma categories; significance
was assessed by Student's unpaired t test, and corrected for multiple
comparisons by Dunnett's procedure. Glycosylated haemoglobin
levels were significantly higher than control values in CAG
(p = 0.001; p' < 0.01), OH (p < 0.001; p' < 0.01), 0HNA (p < 0.001;
p' < 0.01), OAG (p = 0.002; p' < 0.01), and OAGNA (p = 0.001;
p' < 0.01). Glycosylated haemoglobin levels were not
significantly different from control values, when multiple comparisons
were taken into account, in 0AGWA (p = 0.036; p' > 0.05), or
OHWA (p > 0.05).
The control group and primary glaucoma categories were then subdivided
on the basis of diabetic status into diabetic and non-diabetic
subjects; comparisons of glycosylated haemoglobin levels were
made between the control group and each of the primary glaucoma
categories for diabetic and non-diabetic subjects separately.
Significantly-increased glycosylated haemoglobin levels in CAG,
OH, 0HNA, OAG, and OAGNA were only present in diabetic subjects;




RESULTS OF GLYCOSYLATED HAEMOGLOBIN ESTIMATION IN 60 PATIENTS WITH
CAG, 78 PATIENTS WITH OH, 30 PATIENTS WITH OAG, AND 31 AGE- AND
SEX-MATCHED CONTROL SUBJECTS
































6.35 The prevalence of a familial history of diabetes melLitus
in the primary glaucomas
The prevalence of diabetes mellitus in the family history of
372 patients with primary glaucoma and 84 age- and sex-matched
control subjects is shown in table 10. Comparisons were made
between the prevalence of familial diabetes mellitus in the control
group and each of the primary glaucoma categories; significance
was assessed by x2 test with Yates' correction. To prevent
inaccuracies from multiple comparisons with a control, significant
p values were multiplied by the number of comparisons made to
obtain a corrected p value (p'). There was a significantly-
increased prevalence of familial diabetes mellitus in patients
with OHWA (p = 0.04) compared with the age- and sex-matched control
group, however this result was non-significant when multiple
comparisons were taken into account Cp* > 0.05). The prevalence
of diabetes mellitus in the family history of patients with CAG,
0HNA, OAGNA, and OAGWA was not significantly different from the
control group (p > 0.05).
The prevalence of familial diabetes in the primary glaucomas and
the control group was subdivided according to type of diabetes
into type 1 (IDDM) and type 2 (NIDDM); results are shown in tables
11 and 12 respectively. Comparisons were made between the control
group and each of the primary glaucoma categories for the prevalence
of familial NIDDM and familial IDDM separately; significance was
assessed by x2 test with Yates' correction, and adjusted for
multiple comparisons as described above. This indicated that
the increased prevalence of diabetes mellitus in the family history
related exclusively to NIDDM; there was a significantly-increased
prevalence of NIDDM in the family history of patients with CAG
(p = 0.006; p' < 0.05) and OHWA (p = 0.003; p' < 0.05) compared
with the control group. The prevalence of familial NIDDM in
patients with 0HNA, OAGNA and OAGWA was not significantly different
from the control group (p > 0.05). The prevalence of familial IDDM
in every category of the primary glaucomas was not significantly
different from the control group (p > 0.05).
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Table 10
THE PREVALENCE OF DIABETES MELLITUS IN THE FAMILY HISTORY OF 372













































THE PREVALENCE OF INSULIN DEPENDENT DIABETES MELLITUS IN THE FAMILY












































THE PREVALENCE OF NON-INSULIN DEPENDENT DIABETES MELLITUS IN THE












































6.36 Glaucoma treatment and diabetic status
The only drug treatments for glaucoma taken by patients included
in the study were guttae pilocarpine 2%/4% and/or guttae timolol
maleate 0.25%/0.5%. The possible association between treatment
and diabetic status was assessed by comparing the prevalence of
diabetes mellitus (NIDDM, IGT, and NIDDM + IGT separately) in
primary glaucoma patients on treatment with the prevalence in
untreated primary glaucoma patients; this was performed for guttae
pilocarpine 2%/4% and guttae timolol maleate 0.25%/0.5% separately,
in each category of the primary glaucomas. Significance was
assessed by x2 test with Yates' correction.
No significant differences (p > 0.05) in the prevalence of diabetes
mellitus (NIDDM, IGT, or NIDDM + IGT) were present between primary
glaucoma patients treated with guttae pilocarpine 2%/4% and/or




Deductions regarding the significance of the prevalence of diabetes
mellitus in the primary glaucomas obviously depend upon comparison
with a compatible control group. The prevalence of type 2 diabetes
in the control group of the present study (8.1%) agrees with similar
studies of diabetes prevalence in this age range (105,106,108).
Thus the prevalence of diabetes mellitus in the control group
provides an accurate standard for subsequent comparisons. Impaired
glucose tolerance has been defined relatively recently (365,366);
the prevalence of impaired glucose tolerance in the "normal"
population is not established, and therefore the prevalence of
impaired glucose tolerance in the present control group is impossible
to verify with comparable studies.
Single-blind prospective studies to determine the prevalence of
abnormal glucose tolerance (ie DM or IGT) have revealed definite
associations between type 2 diabetes mellitus and primary glaucoma;
no association was shown with type 1 diabetes mellitus. The
prevalence of type 1 diabetes mellitus was 0.8% in patients with
CAG, which parallels prevalence levels in the general population
(104,107). In contrast, the prevalence of type 2 diabetes mellitus
and impaired glucose tolerance was 17.2% and 20.5% respectively -
significantly higher than in the control group. One may reasonably
conclude that abnormal glucose tolerance is significantly associated
with CAG. This conclusion is contrary to suggestions by previous
authors (119,134), however - to my knowledge - detailed prospective
studies have not been previously published establishing the prevalence
of diabetes mellitus/impaired glucose tolerance in patients with CAG.
The prevalence of abnormal glucose tolerance is also significantly
increased in patients with ocular hypertension (29.8%). Subdivision
of this category on the basis of irido-cornea I angle measurement
localises the association exclusively to patients with narrow
angles; the prevalence of abnormaI glucose tolerance in patients
with 0HNA (37.8%) is significantly higher than in the control
group (p < 0.01), whereas no significant differences are present
between the prevalence of abnormal glucose tolerance in patients
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with OHWA (21.9%). The prevalence of abnormal glucose tolerance
is not significantly different from the control group in patients
with OAG (28.2%).
When one considers the OH and OAG groups as a single entity, and
classify on the basis of angle measurement into narrow-angle and
wide-angle categories, differences in diabetic prevalence are
accentuated. Significant differences in the prevalence of abnormal
glucose tolerance are present between the control group and patients
with narrow-angles (p = 0.003; p' < 0.05), between patients with
narrow-angles and wide-angles (p = 0.01; p' < 0.05), and between
patients with CAG and wide-angles (p = 0.007; p' < 0.05).
No significant differences in the prevalence of abnormal glucose
tolerance are present between the control group and patients with
wide-angles, and between patients with CAG and narrow-angles.
Discrepancies between the prevalence of diabetes mellitus in glaucoma
patients obtained in this study, and those quoted in the introductory
text, are easily explained. One cannot equate the results of
studies performed under different experimental criteria; studies
of diabetic prevalence such as those of Armstrong (112) and Becker
(132) utilised a 100 gram glucose loading dose, substantially
larger than the present standard of 75 grams. Allowing for the
problem of equivalent comparison, previously-quoted prevalences
of diabetes mellitus (18.3% and 20% respectively) are similar
to the prevalence of abnormal glucose tolerance (23.8%) in patients
with 0AGWA (the commonest form of OAG) in the present study.
Unfortunately, previous studies omitted to concurrently examine
a suitable control group for comparison. Diabetic prevalence
levels of 18.3% and 20% seem conclusive until one determines the
prevalence of abnormal glucose tolerance, using a lesser glucose
loading dose, in an age- and sex-matched control group to be 17.5%.
It must be stressed that abnormal glucose tolerance is not equivalent
to diabetes mellitus - the prevalence of overt diabetes mellitus
in the control group was 8.1% - however assessment with an increased
glucose load, as in the aforementioned studies, is recognised
to significantly increase subsequent plasma glucose levels.
The problem of comparison between different diagnostic criteria
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is thus insurmountable. To verify the true relationship between
diabetes mellitus and glaucoma, if any, one must concurrently
assess patients with primary glaucoma and suitable control subjects
by a standard technique - as in the present investigation.
The family history of glaucoma patients provides further evidence
of the association with type 2 diabetes mellitus; a significantly-
increased prevalence of type 2 diabetes mellitus is present in
the familial history of patients with CAG and OHWA.
Glycosylated haemoglobin provides a long-term measure of glycaemic
control. Results of glycosylated haemoglobin assessment support
the association between glaucoma and diabetes mellitus established
by oral glucose tolerance testing. HbA! was significantly higher
than control values in CAG (p1 < 0.01), OH (p1 < 0.01), and OAG
(p1 < 0.01). Subclassification on the basis of angle assessment
restricted this association to narrow-angle categories, after
correction for multiple comparisons with a control; 0HNA (p1 < 0.01)
and 0AGNA (p' < 0.01). These differences were related specifically
to diabetic status; no significant differences in glycosylated
haemoglobin levels were shown between non-diabetic subjects with
primary glaucoma and the control group.
Several conclusions inevitably follow from the results:
i. There is a significantly-increased prevalence of type 2
diabetes mellitus and impaired glucose tolerance in patients
with CAG, and therefore an association between diabetes
mellitus and CAG is probable. This association is supported
by the relationship between I0P and abnormal glucose tolerance
in patients with CAG; patients with abnormal glucose tolerance
have significantly-higher I0P than non-diabetic patients.
ii. The significantly-increased prevalence of abnormal glucose
tolerance in patients with OH is restricted to narrow-angle
subjects.
iii. The prevalence of abnormal glucose tolerance is not
significantly different from "normal" in patients with
OAG.
iv. The prevalence of abnormal glucose tolerance was similar
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in patients with CAG (38.5%), OHNA (37.8%), and OAGNA (37.5%);
prevalence in CAG and OHNA was significantly higher than
normal, and in OAGNA just failed to reach significant levels
after correction, however glycosylated haemoglobin levels
were significantly higher (p' < 0.01) in all three groups
than control values. The prevalence of abnormal glucose
tolerance was not significantly different in OHWA (21.9%) and
OAGWA (23.8%) from the control group (17.6%); glycosylated
haemoglobin levels in OHWA and OAGWA were also not significantly
different from control values. Results are therefore
polarised, with abnormal results present only in narrow-angle
forms of primary glaucoma,
v. An association between the wide-angle form of OH and diabetes
mellitus does exist, exemplified by the significantly-
increased familial history of type 2 diabetes mellitus
in patients with OHWA.
One may reasonably conclude that type 2 diabetes mellitus is
associated with glaucoma, an association predominantly with narrow-
angle primary glaucomas; no association was established between
diabetes mellitus and OAGWA. The significance of the association




SYSTEMIC AUTONOMIC NERVE FUNCTION IN THE PRIMARY GLAUCOMAS
CHAPTER 7
SYSTEMIC AUTONOMIC FUNCTION IN THE PRIMARY GLAUCOMAS
7-1 Introduction
The rationale for investigating systemic autonomic nerve function
in the primary glaucomas has been explained in the introductory
text. The development of autonomic function tests during the
past twelve years has permitted accurate quantification of
parasympathetic and sympathetic cardiovascular reflexes. These
tests are objective, reproducible, non-invasive, and designed
specifically for clinical application. Previously-quoted "normal"
values are shown in table 4. As the "normal" values were determined
in a population with a mean age significantly less than the present
study, autonomic function assessments were performed on an age-
and sex-matched control group to determine age-dependence by
regression analysis. The data were fitted to mathematical models
using the computer programme SPSSx on an IBM 4341 computer, to
obtain "tog normal" distributions from which tolerance intervals
were derived for each of the autonomic function tests (390).
The close correlation between generalised autonomic function and
assessment of cardiovascular reflexes permits reasonable inferences
to be drawn regarding systemic autonomic integrity.
7.2 Patients and methods
Patients were included in the study on the basis of the following
criteria:
i. a history of closed-angle glaucoma
ii. ocular hypertension
a. with narrow irido-corneal angles
b. with wide irido-corneal angles
iii. open-angle glaucoma
a. with narrow irido-corneal angles
b. with wide irido-corneal angles
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After informed consent had been obtained, cardiovascular autonomic
function was assessed in 85 age- and sex-matched control subjects
(mean age 66.1 ± 10.2 years) and 380 patients with primary glaucoma
(mean age ± SD): 124 CAG (66.5 ± 10.1 years), 90 OHNA (67.5 ± 9.2
years), 99 OHWA (64.8 ± 9.6 years), 24 OAGNA (71.5 ± 8.4 years), and
43 OAGWA (67.0 ± 8.2 years). The control group consisted of
hospital staff, and patients attending the casualty department
who were subsequently determined to have no detectable abnormality,
or mild ocular changes within acceptable limits for an elderly
population; this included early macular degenerative changes
and refractive errors.
A comprehensive past, present and family history was obtained
from each subject. The present history included details regarding
presentation, current treatment, visual acuity, and visual symptoms.
A detailed general systemic enquiry and drug history was also
documented. If the patient was diabetic, the type, duration,
and treatment were noted. Past medical history specifically
recorded ophthalmic disease, cardiovascular or neurological disorders,
diabetes mellitus and other predisposing factors to autonomic
dysfunction. Family history included a general category, followed
by specific details regarding ophthalmic disease (particularly
glaucoma), neurological or cardiovascular disorders, and diabetes
mellitus; if the latter was present, the type of diabetes and
number in each category were noted.
Subjects known to have medical disorders predisposing to autonomic
nerve dysfunction or taking medication with effects on the autonomic
nervous system (table 1) were excluded from the control group.
Diabetics attending casualty with no other abnormality were not
excluded from the control group; exclusion of the "normal" acceptable
proportion of subjects with diabetes mellitus in this age range
would have markedly biased control values. Patients with CAG,
OHNA, OHWA, OAGNA, and OAGWA on medication with autonomic effects,
or with medical disorders predisposing to autonomic nerve dysfunction
(apart from diabetes mellitus), were similarly excluded.
The history excluding the ophthalmic section was obtained on arrival.
This expedient served two purposes: firstly, subjects were assessed
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assesments were performed on a single-blind basis as the examiner
was not aware of the subject's diagnosis during the test.
Systematic general medical examination was then performed, with
emphasis on:
i. Cardiovascular system: to exclude subjects with cardiovascular
pathology; valvular disorders, such as mitral stenosis,
and congestive cardiac failure are particularly relevant,
as these may adversely affect cardiovascular autonomic
reflexes.
ii. Central and peripheral nervous system: with assessment
of sensory and motor somatic nerves, and cerebellar function.
Subjects with significant cardiovascular or neurological abnormalities
were excluded from autonomic function assessment; this included
any form of "stroke" or cardiovascular accident, which may effectively
negate cardiovascular reflexes.
Ocular examination was performed on all subjects, as follows:
i. Anterior segment assessment
a. slit-lamp examination of cornea, anterior chamber,
iris integrity/dynamics, and lens
b. gonioscopy by Zeiss 4-mirror gonioprism to determine
angle configuration and exclude angle abnormalities
c. intraocular pressure by Goldmann applanation tonometry
ii. Posterior segment assessment
a. direct ophthalmoscopy of optic disc, cup:disc ratio,
retinal vessels and macula
b. indirect ophthalmoscopy, after pupillary dilation,
to assess posterior pole and retinal periphery
c. visual field examination: peripheral field by Goldmann
perimetry; central field by either Goldmann perimeter
or Friedmann II analyser.
Six tests of autonomic integrity were employed (table 3).
Determination of normal sinus rhythm is an essential prerequisite
to cardiovascular autonomic nerve function assessment.
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7.21 Parasympathetic nerve function
7.211 Valsalva manoeuvre
A standardised Valsalva manoeuvre was performed by the subject
blowing into a mouthpiece connected to a modified sphygmomanometer
and maintaining a pressure of 40 mmHg (5.3 kPa) for 15 seconds.
A continuous electrocardiogram (Cambridge VS500B electrocardiograph,
Picker International, England) was recorded, commencing 20 seconds
prior to the manoeuvre and terminating 25 seconds after the manoeuvre.
The patients were seated during the test, and rested for at least
2 minutes between consecutive assessments. The Valsalva ratio
is the ratio of the longest R-R interval after the manoeuvre to
the shortest R-R interval during the test. These were measured
directly from the electrocardiogram, and the final ratio was the
mean of 3 consecutive assessments.
The physiological principles underlying this reflex have been
detailed in the introductory text. Normal heart-rate responses
recorded by electrocardiography are shown in plates 2-5:
Phase 1: initial relative bradycardia for 2-3 seconds
Phase 2: gradually-increasing tachycardia
Phase 3: increased tachycardia for 2-3 seconds on release of
intrathoracic pressure
Phase 4: bradycardia
The Valsalva ratio represents the ratio of the longest R-R interval
in phase 4 divided by the shortest R-R interval in phase 2.
7.212 Heart-rate variation during deep breathing
The technique of Wheeler and Watkins (240), modified by Hilsted
and Jensen (249), was used to evaluate parasympathetic nerve function
by heart-rate variation during deep breathing. The subject was
seated quietly at rest for 3 minutes prior to the test, then was
requested to breathe deeply at a rate of approximately 6 breaths
per minute (5 seconds inspiration, 5 seconds expiration) whilst
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a continuous electrocardiogram was recorded. In normal subjects,
a relative tachycardia occurs during inspiration, with a relative
bradycardia in expiration. (Plate 6) Maximum and minimum R-R
intervals were measured directly from the electrocardiogram using
an ECG ruler, and expressed as beats per minute. Six consecutive
measured cycles were calculated, and the final result was the
mean of the differences between maximum and minimum heart-rates.
7.213 Immediate heart-rate response to standing
During alteration in posture from lying to standing a characteristic
cardiovascular reflex response occurs under vagal control. This
consists of an initial increase in heart-rate, maximal at about
the 15th beat after standing (plate 7), followed by a relative
bradycardia around the 30th beat (plate 8). The patient rested
supine for approximately 3 minutes prior to the test, then was
requested to stand unaided. An electrocardiogram was recorded
from 20 beats prior to the manoeuvre until 40 beats after standing.
The R-R intervals were measured to determine the shortest around
the 15th beat and longest at about beat 30, and the result expressed
as the 30:15 ratio.
7.214 Immediate heart-rate response to lying
Shortening of the R-R interval occurs during the 3rd-4th beat
after commencing the manoeuvre, followed by a gradual increase
in R-R interval. (Plate 9) Subjects were requested to stand
for 2 minutes, then lie down unaided. Heart-rate was recorded
by continuous electrocardiography from 20 beats prior to the
manoeuvre until 40 beats after lying down. The results were
calculated as the ratio of the longest R-R interval during the
5 beats before Lying to the shortest R-R interval during the 10 beats
after lying down, and the result expressed as the standing:lying
ratio (S:L ratio).
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7.22 Sympathetic nerve function
7.221 Systolic blood pressure response to standing
After 3 minutes lying supine on an examination couch, the patient's
blood pressure was measured using a cuff sphygmomanometer, then
again immediately after standing upright. The difference between
the systolic pressure lying and standing is the postural change
in blood pressure.
7.222 Diastolic blood pressure response to sustained handgrip
The physiological mechanisms involved in this cardiovascular reflex
are detailed in the introduction. Equipment necessary to conduct
the test includes a handgrip dynamometer (plate 10) and a cuff
sphygmomanometer. The subject remained seated throughout the
test; blood pressure was taken 3 times, and average resting systolic
and diastolic pressures were recorded. The subject was then
requested to grip the dynamometer maximally on 3 separate occasions;
a linear displacement transducer converted mechanical to electrical
energy, and a meter recorded maximal voluntary contraction (MVC)
using this principle. (Plate 11) The handgrip dynamometer was
set to a value of 33% MVC and the subject requested to grip
continuously at this level for as long as possible, up to a maximum
of 5 minutes; blood pressure was recorded from the non-exercising
arm at 1-minute intervals. The test was terminated by either:
i. the patient being unable to maintain sustained handgrip
ii. a diastolic pressure increase of ^ 16 mmHg
iii. 5 minutes of continuous handgrip at 33% MVC
Following release of handgrip, blood pressure was recorded twice,
and average systolic and diastolic pressures calculated.
Sustained handgrip was not found to be a suitable test of sympathetic
nerve function in patients aged > 60 years; this age category
is comprised of an evei—increasing female preponderance, who were
shown to be unable, or unwilling, to maintain sustained isometric
contraction. Consequently, the test was only performed on patients
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Less than 55 years of age, and the normal values established by
Ewing et al (295), for a control group aged 25-54 years, were
used as the diagnostic criteria. Essentially, a diastolic blood
pressure increase of ^ 16 mmHg is normal, ^ 10 mmHg is abnormal,
and the intermediate range designated "borderline".
7.3 Results
The results of cardiovascular autonomic function assessment in
380 patients with primary glaucoma and 85 age- and sex-matched
control subjects are described as follows:
7.31 Age-adjusted normal tolerance intervals for cardiovascular
autonomic function tests
7.32 Parasympathetic nerve function
7.33 Sympathetic nerve function
7.34 Significance of sex on systemic autonomic nerve function
assessment
7.35 Diabetes mellitus and systemic autonomic nerve function
7.36 Cardiovascular autonomic nerve function in the primary
glaucomas; comparisons with the age-adjusted normal tolerance
limits
7.37 The prevalence of autonomic nerve dysfunction in the primary
glaucomas
7.38 Glaucoma treatment and cardiovascular autonomic nerve function
7.31 Age-adjusted normal tolerance intervals for cardiovascular
autonomic function tests
7.311 Log normal distribution and linear regression on age
The results of each test of cardiovascular autonomic nerve function
in the age- and sex-matched control group were assessed for dependence
on age by regression analysis. The data were fitted according to
various mathematical models using the computer programme SPSSx on an
IBM 4341 computer to obtain a normal distribution after adjustment
for age, thus permitting determination of the "normal" range.
Logarithms of the data were used to derive a tolerance interval
for the following reasons:
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i. Logarithms (after adjusting for age, where appropriate)
are more nearly normally distributed than original readings,
thus reducing skewness. Although this has only limited
importance in statistical inferences about means (eg t-test),
it is obviously of marked importance in the calculation
of percentiles of the distribution - particularly at "extreme"
values, the "tails" of the distribution.
ii. Tolerance limits on y = log (x), after age-adjustment where
appropriate, must always give positive values of x after
y y
transforming back to the original units, as e or 10 are
always positive.
Plots of the logarithmic values on age were linear, allowing the
2.5th, 5th, 95th, and 97.5th percentiles to be calculated by linear
regression analysis:
E, . = a + bx(y)
y = a + bx + error
Residual (r) = y - predicted value
= y - (a + bx)
r = y - (a + bx)
s z
Sy I x
r = standardised residual
s
s , = residual standard deviation
y | x
A "log normal" distribution was obtained for the results of each
of the cardiovascular autonomic function tests, except systolic
blood pressure response to standing; as postural changes in blood
pressure may include negative values, a logarithmic distribution
could not be described and thus a distribution based upon natural
values was determined.
7.312 Determination of tolerance limits in cardiovascular autonomic
function tests
Tolerance limits were calculated from the log normal distribution
(after adjusting for age, if necessary) for all variables except
systolic blood pressure response to standing; the latter was
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calculated from natural values, as explained above.
i. In variables which did not depend significantly on age,
approximate tolerance limits were obtained by:
mean ± 1.67 SD (for 90% limits)
mean ± 2.00 SD (for 95% limits)
The values 1.67 and 2.00 were obtained from percentiles of t
at 60 degrees of freedom.
ii. In variables which depended significantly on age, approximate
tolerance limits were obtained by:
a. Linear regression of log1 „(variable), or of systolic
blood pressure response to standing untransformed,
was performed on age to give:
y = a + bx
Residual = y - y
b. Tolerance limits from:
y ± 1.67 x s | (for 90% limits)
y I x
y ± 2.00 x s | (for 95% limits)
y I x
where s , is the residual standard deviation after
y | x
regression.
Translating back from the transformation yields the "normal
range" for each of the cardiovascular autonomic function
tests.
7.313 Parasympathetic nerve function
i. Valsalva ratio
Logj0(Valsalva ratio) was shown to depend significantly
on age. Linear regression analysis, permitting determination
of 2.5th, 5th, 95th, and 97.5th percentiles, was calculated
from:
RLVR = (log10VR - (0.43359 - 0.00409 x age))/0.06960
assumed to have the standard Normal distribution.
RLVR = standardised residual log10(VR)
Tolerance limits at age 65 years are shown in table 13,
and the logarithms of the percentiles (allowing for regression
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on age), translated back to natural values, with 2.5th, 5th,
95th and 97.5th percentiles in figure 4.
ii. Heart-rate variation during deep breathing
Logj0(heart-rate variation during deep breathing) was shown
to depend significantly on age. Linear regression analysis,
permitting determination of 2.5th, 5th, 95th, and 97.5th
percentiles, was calculated from:
RLHRV = (log10HRV - (1.49598 - 0.00397 x age))/0.16415
assumed to have the standard Normal distribution.
RLHRV = standardised residual log10(HRV)
Tolerance limits at age 65 years are shown in table 13,
and the logarithms of the percentiles (allowing for regression
on age), translated back to natural values, with 2.5th, 5th,
95th, and 97.5th percentiles in figure 5.
iii. 30:15 ratio
Logl0(30:15 ratio) did not depend significantly on age.
Linear regression analysis, permitting determination of
2.5th, 5th, 95th, and 97.5th percentiles, was calculated
from:
RL30:15 ratio = (logl030:15 ratio - (0.08869 - 0.00031 x age))/
0.03751, assumed to have the standard Normal distribution.
RL30:15 ratio = standardised residual logl0(30:15 ratio)
Tolerance limits at age 65 years are shown in table 13,
and the logarithms of the percentiles (translated back to
natural values) with 2.5th, 5th, 95th, and 97.5th percentiles
in figure 6.
iv. S:L ratio
Log10(S:L ratio) did not depend significantly on age.
Linear regression analysis, permitting determination of
2.5th, 5th, 95th, and 97.5th percentiles, was calculated from:
RLS:L ratio = (logi0S:L ratio - (0.08535 - 0.00008 x age))/
0.03191, assumed to have the standard Normal distribution.
RLS:L ratio = standardised residual log10(S:L ratio)
Tolerance limits at age 65 years are shown in table 13,
and the logarithms of the percentiles (translated back to
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natural values) with 2.5th, 5th, 95th, and 97.5th percentiles
in figure 7.
7.314 Sympathetic nerve function
Systolic blood pressure response to standing
Systolic blood pressure response to standing was shown to depend
significantly on age. Linear regression analysis, permitting
determination of 2.5th, 5th, 95th, and 97.5th percentiles, was
calculated from:
RPH = (PH - (-6.12798 + 0.21258 x age))/12.56912
assumed to have the standard Normal distribution.
PH = postural hypotension (or systolic blood pressure response
to standing)
RPH = standardised residual (postural hypotension)
Tolerance limits at age 65 years are shown in table 13, and the
percentiles (allowing for regression on age) with 2.5th, 5th,
95th, and 97.5th percentiles in figure 8.
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Table 13
AGE-ADJUSTED NORMAL TOLERANCE LIMITS (AT AGE 65 YEARS), DEFINED BY
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7.32 Parasympathetic nerve function
The results of cardiovascular parasympathetic nerve function
assessment in 380 patients with primary glaucoma and 85 age- and
sex-matched control subjects is shown in table 14. In each test
of autonomic function, comparisons were made between the results
of the control group and each category of the primary glaucomas
separately; significance was assessed by Student's unpaired t
test. Dunnett's multiple comparison procedure was used to obtain
a corrected p value (p1), thereby obviating inaccuracy from multiple
comparisons with a control. The significance of the results of
parasympathetic nerve function tests in 380 patients with primary
glaucoma compared with results in 85 age- and sex-matched control
subjects is summarised in the following paragraphs; the actual p value
plus the corrected p value C p') are quoted for significant results.
7.321 Valsalva ratio
There were no significant differences (p > 0.05) between the control
group and patients with CAG, OHWA, and OAGWA. Results of Valsalva
ratio in the control group were significantly higher than in patients
with OHNA (p = 0.01; p' < 0.05), and 0AGNA (p = 0.01; p' < 0.05).
7.322 Heart-rate variation during deep breathing
Heart-rate variation during deep breathing was significantly higher
in the control group than in patients with CAG (p < 0.001; p' < 0.01),
OHNA (p < 0.001; p' < 0.01), 0HWA (p < 0.001; p' < 0.01), 0AGNA
(p = 0.002; p" < 0.05), and OAGWA (p < 0.001; p' < 0.01).
7.323 30:15 ratio
30:15 ratio in the control group was significantly higher than in
patients with CAG (p < 0.001; p' < 0.01), OHNA (p < 0.001; p' < 0.01),
and 0HWA (p = 0.01; p" <.0.05). No significant differences were
noted between the control group and patients with 0AGNA (p = 0.016;




S:L ratio in the control group was significantly higher than in
patients with CAG (p < 0.001; p' < 0.01) and 0HNA (p = 0.02;
p' > 0.05), although only the former remained significant after
allowing for multiple comparisons. No significant differences were
noted between the control group and patients with 0HWA (p > 0.05),
0AGNA (p > 0.05), and OAGWA (p > 0.05).
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Table14
RESULTSOFCARDIOVASCULARPA ASYMPATHETICFUNCTIONASSESSMENTI380TIENTSW TM RYGL UCOMA AND85GE-SEX-MATCHEDCONTROLUBJE TS (Groupmeanvalues±SEM) Controlgroup (n=85) Closed-angleglaucoma patients (n=124) Ocularhypertensive patients All (n=189) OHNA (n=90) OHWA (n=99) Open-angleglaucoma patients All (n=67) OAGNA (n=24) OAGWA (n=43)Valsalva ratio 1.49±0 04 1.42±0 03 1.41±0 03 1.36±0 03 1.45±0 03 1.38±0 04 1.31±0 05 1.43±0 05Heart-rate variationdu ing deepbr athing 18.24±0.93 12.05±0.67 13.13±0.55 11.57±0.74 14.54±0.77 13.32±0.83 13.03±.49 13.48±.00
30:15 ratio 1.17±0 01 1.11±0 0 1.13±0 01 1.12±0 01 1.13±0 01 1.13±0 01 1.12±0 0 1.14±0 02
S:L ratio 1.21±0 0 1.15±0 01 1.19±0 01 1.17±0 01 1.20±0 01 1.18±0 01 1.19±0 03 1.17±0 02
7.33 Sympathetic nerve function
The results of cardiovascular sympathetic nerve function assessment
in 380 patients with primary glaucoma and 85 age- and sex-matched
control subjects is shown in table 15. In each test of autonomic
function, comparisons were made between the results of the control
group and each category of the primary glaucomas separately;
significance was assessed by Student's unpaired t test, corrected
for multiple comparisons by Dunnett's procedure. The significance
of the results of sympathetic nerve function tests in 380 patients
with primary glaucoma compared with results in 85 age- and sex-matched
control subjects is summarised in the following paragraphs.
7.331 Systolic blood pressure response to standing
Postural changes in systolic blood pressure in the control group
were not significantly different (p > 0.05) from those in patients
with CAG, OHNA, OHWA, OAGNA, and OAGWA.
7.332 Diastolic blood pressure response to sustained handgrip
Diastolic blood pressure responses to sustained handgrip in the
control group were not significantly different (p > 0.05) from those
in patients with CAG, OHNA, OHWA, and OAGWA. Increase in diastolic
blood pressure following sustained handgrip was significantly higher
in patients with OAGNA than the control group (p < 0.001; p' < 0.01).
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Table15
RESULTSOFCARDIOVASCULARSYMPATHETICFUNC IONA SES MENTI380PATI NTSWITHPRIMARYGL COMA AND85AGE-SEX-MATCHEDCONTROLSUBJ CTS (Groupmeanvalues±SEM) Controlgroup (n=85) Closed-angleglaucoma patients (n=124) Ocularhypertensive patients All (n=189) OHNA (n=90) OHWA (n=99) Open-angleglaucoma patients All (n=67) OAGNA (n=24) OAGWA (n=43)Decreaseinsystolic bloodpressuren standing (mmHg) 8.36±1.42 10.72±.18 11.14±0.98 11.53±.43 10.77±.36 11.28±.21 13.25±.73 10.12±.62
Increaseidiastolic bloodpressuredu ing sustainedhandgrip (mmHg) 19.72±.55 22.41±1.61 21.69±1.11 24.18±.07 20.30±1.25 24.26±.21 34.19±.76 18.68±.48
7.34 Significance of sex on systemic autonomic nerve function
assessment
In each test of cardiovascular autonomic nerve function, comparisons
were made between the results of males versus females, in the
control group and each category of the primary glaucomas separately;
significance was assessed by Student's unpaired t test. No
significant differences were noted in any test between the
results of male and female subjects.
7.35 Diabetes mellitus and systemic autonomic nerve function
The significance of diabetic status on cardiovascular autonomic
function assessment was examined by comparing the results of
non-diabetic patients with those of patients with NIDDM, IGT,
and (NIDDM + IGT) separately. This was performed for each test
of cardiovascular autonomic function individually, in the control
group and each category of the primary glaucomas. Significance
was determined by Student's unpaired t test, corrected by Dunnett's
procedure.
7.351 Control group
No significant differences were noted in comparisons of autonomic
function test results between non-diabetic subjects and those with
NIDDM, IGT, or (NIDDM + IGT).
7.352 Closed-angle glaucoma
No significant differences were noted in comparisons of autonomic
function test results between non-diabetic patients and those with
NIDDM, IGT, or (NIDDM + IGT).
7.353 OHNA
No significant differences were noted in comparisons of autonomic
function test results between non-diabetic patients and those with
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NIDDM. Significant differences in autonomic function test results
between non-diabetic patients and those with IGT or (NIDDM + IGT)
are as follows; mean ± SEM is quoted in brackets.
i. Non-diabetic v IGT
Patients with IGT (1.22 ± 0.04) had significantly lower
Valsalva ratio than non-diabetics (1.42 ± 0.04): p = 0.005;
p' < 0.05.
Patients with IGT (8.46 ± 1.36) had significantly lower
heart-rate variation during deep breathing than non-diabetics
(13.13 ± 0.95): p = 0.009; p' < 0.05.
ii. Non-diabetic v (NIDDM + IGT)
Patients with (NIDDM + IGT) (1.25 ± 0.04) had significantly
lower Valsalva ratio than non-diabetics (1.42 ± 0.04):
p = 0.006; p' < 0.05.
Patients with (NIDDM + IGT) (9.04 ± 1.05) had significantly
lower heart-rate variation during deep breathing than
non-diabetics (13.13 ± 0.95): p = 0.006; p' < 0.05.
7.354 0HWA
No significant differences were noted in comparisons of autonomic
function test results between non-diabetic patients and those with
IGT. The only significant difference in autonomic function test
results between non-diabetic patients and those with NIDDM or
(NIDDM + IGT) was in 30:15 ratio. This result was not significant
after allowing for multiple comparisons; patients with NIDDM
(1.07 ± 0.01) or (NIDDM + IGT) (1.09 ± 0.02) had significantly lower
30:15 ratio than non-diabetics(1.15 ± 0.01), before correction:
p = 0.02; p' > 0.05.
7.355 0AGNA
No significant differences were noted in comparisons of autonomic
function test results between non-diabetic patients and those with
NIDDM, IGT, or (NIDDM + IGT).
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7.356 OAGWA
No significant differences were noted in comparisons of autonomic
function test results between non-diabetic patients and those with
NIDDM, IGT, or (NIDDM + IGT) .
7.36 Cardiovascular autonomic nerve function in the primary
glaucomas; comparisons with the age-adjusted normal tolerance
limits
The age-adjusted normal tolerance limits, at the lower 5th percentile,
for each of the cardiovascular autonomic function tests (figures 4-8)
were applied to the results obtained from patients with primary
glaucoma, to determine the proportion of patients in each glaucoma
category outwith the normal tolerance limits. Results of
parasympathetic function tests are shown in table 16, and sympathetic
function tests in table 17. Normal tolerance limits were not
determined for diastolic blood pressure responses to sustained
handgrip; this test was found to be impractical in patients aged
> 60 years, as explained on page 89.
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Table16
THEPROPORTIONOFIMARYGLAUCOMAATIENTSANDCO T OLSUBJ CW HBNORMARESULTCA DIOVASCULAR PARASYMPATHETICNERVFUNC ION,DEFINEDBTHAG -ADJUST DORMALTOLE NCELIMI SWER 5thPERCENTILE Controlsubjects (n=85) Closed-angleglaucoma patients (n=124) Ocularhypertensive patients All (n=189) OHNA (n=90) OHWA (n=99) Open-angleglaucoma patients All (n=67) OAGNA (n=24) OAGWA (n=43)Valsalva ratio 0% 14.3% 8.8% 7.3% 10.0% 11.5% 5.0% 15.7%Heart-rate variationdu ing deepbr athing 1.3% 38.5% 32.0% 42.7% 22.2% 23.9% 25.0% 23.2%
30:15 ratio 0% 7.9% 11.0% 15.7% 6.7% 4.8% 8.7% 2.6%
S:L ratio 1.3% 15.5% 7.0% 7.2% 6.8% 14.5% 13.0% 15.4%
Table17
THEPROPORTIONOFIMARYGLAUCOMAATIENTSANDCO T OLSUBJ CW HABN RMARES LTSCARDIOVAS ULA SYMPATHETICNERVEFUNCTION,DEFIN DBYTHAG -ADJUS ENORMALTOL RANCLI IEWER 5thPERCENTILE Systolicbloodpressure responsetostanding Controlgroup (n=85)2.6% Closed-angleglaucoma patients (n=124)11.5% Ocularhypertensive patients All (n=189)8.8% OHNA (n=90)9.0% OHWA (n=99)8.5% Open-angleglaucoma patients All (n=67)3.0% OAGNA (n=24)4.2% OAGWA (n=43)2.4%
7.37 The prevalence of autonomic nerve dysfunction in the primary
glaucomas
Values outwith the normal tolerance limits for each of the
cardiovascular autonomic function tests (figures 4-8) were designated
"abnormal". Autonomic nerve dysfunction was defined by the
presence of at least one abnormal result of cardiovascular autonomic
function tests. The proportions of patients with evidence of
parasympathetic nerve dysfunction, sympathetic nerve dysfunction,
and combined parasympathetic plus sympathetic nerve dysfunction
by cardiovascular autonomic function assessment in 380 patients
with primary glaucoma, and 85 age- and sex-matched control subjects,
are shown in table 18.
7.38 Glaucoma treatment and cardiovascular autonomic nerve function
As stated previously, the only drug treatments for glaucoma taken
by patients included in the study were guttae pilocarpine 2%/4%
and/or guttae timolol maleate 0.25%/0.5%. The possible association
between treatment and cardiovascular autonomic nerve function
was assessed by comparing the results of each test of cardiovascular
autonomic function separately (ie Valsalva ratio, heart-rate
variation during deep breathing, 30:15 ratio, S:L ratio, systolic
blood pressure response to standing, and diastolic blood pressure
response to sustained handgrip) in primary glaucoma patients on
treatment with the results in untreated primary glaucoma patients;
this was performed for guttae pilocarpine 2%/4% and guttae timolol
maleate 0.25%/0.5% separately, in each category of the primary
glaucomas. Significance was assessed by Student's unpaired t test.
No significant differences (p > 0.05) in the results of any
cardiovascular autonomic function test were present between primary
glaucoma patients treated with guttae pilocarpine 2%/4% and/or




THEPREVALENCEOFAUTONOMICN RVEDYSFU CTIONI380A IENTSWITHIMARYGLA C A AND85GE-SEX-MATCHEDCO TROLUBJE TS
Controlsubjects (n=85) Closed-angleglaucoma patients (n=124) Ocularhypertensive patients All (n=189> OHNA (n=90) OHWA (n=99) Open-angleglaucoma patients All (n=67) OAGNA (n=24) OAGWA (n=43)




The utilisation of cardiovascular reflexes to define systemic
autonomic function provides an accurate, reproducible, and
quantifiable measurement of a nervous system previously virtually
impossible to isolate. Heart-rate is determined at all times
by the balance between sympathetic and parasympathetic influences
(391,392,393). The relative importance of each component during
characteristic cardiovascular reflexes has been determined by
selective pharmacological autonomic blockade.
All assessments were performed on a single-blind basis. Evaluation
of appropriate control subjects was necessary, not only to ensure
objectivity and negate subjective bias, but also to provide a series
of standard "normal" values in autonomic function assessment for
this age category. Although heart-rate variation during deep
breathing has been examined in the elderly by Smith (244) and
Wieling et al (260) (forced respiratory sinus arrhythmia in relation
to age, shown in plate 12), reference values for other parameters
of autonomic nerve function are applicable to a younger age range.
Tolerance limits for the results of each of the 5 tests of
cardiovascular autonomic function in the control group are shown
in table 13. Valsalva ratio, heart-rate variation during deep
breathing, and systolic blood pressure response to standing were
significantly correlated with age; consequently, tolerance limits
based on the lower 5th percentile are shown in those categories
relative to the mean age of the control group. If the tolerance
limits of autonomic function assessment for this control group
are compared with those advocated for younger age categories
(table 4), remarkable similarities are apparent. In the following
list, the tolerance limits of the present control group are compared
with established diagnostic criteria of abnormality in a younger
age range: Valsalva ratio, 1.13 cf 1.10; heart-rate variation during
deep breathing (beats/minute), 9.2 cf 10.0; 30:15 ratio, 1.01 cf 1.00;
S:L ratio, 1.06 cf 1.07; decrease in systolic blood pressure on
standing (mmHg), 29.38 cf 30.00.
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The assessment of cardiovascular autonomic nerve function is thus
equally possible in an elderly population; verification of tolerance
limits, based on the lower 5th percentile, permits reasonable
inferences from subsequent comparisons with "normal" values.
Primary glaucoma, with few exceptions, is prevalent in older
age-groups; it was therefore essential to establish effective
tolerance limits of cardiovascular autonomic nerve function directly
applicable to this population.
Comparisons between the primary glaucomas and the control group
show significant differences in the results of every test of
parasympathetic function:
i. Valsalva ratio
The mean Valsalva ratio was significantly higher in the
control group than in patients with OHNA and OAGNA.
ii. Heart-rate variation during deep breathing
Heart-rate variation during deep breathing was significantly
diminished in every category of the primary glaucomas:
CAG, OHNA, OHWA, OAGNA, and OAGWA.
i i i . 30:15 rat i o
The mean 30:15 ratio was significantly higher in the control
group than in patients with CAG, OHNA, OHWA, and OAGNA.
iv. S:L ratio
The mean S:L ratio was significantly higher in the control
group than in patients with CAG and OHNA, although only
the former remained significant after allowing for multiple
comparisons.
Results of cardiovascular parasympathetic function assessment
were significantly lower than reference values in each sub-group
of the primary glaucomas; the decreased efficacy of parasympathetic
cardiovascular reflexes was particularly prominent in patients
with CAG and OHNA. This association of impaired parasympathetic
function in patients with narrow irido-corneal angles is similar
to the association between diabetes mellitus and primary glaucoma.
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No significant differences were noted in comparisons of sympathetic
function results between the primary glaucomas and the control
group. Systolic blood pressure responses to standing were simitar
in all categories, and the mean diastolic blood pressure increase
during sustained handgrip was significantly higher in patients
with OAGNA than the control group. There are two possible
explanations for these results. The first is that cardiovascular
tests of sympathetic nerve function based upon blood pressure
responses, although highly specific, are recognised to be less
sensitive than cardiovascular assessments of parasympathetic nerve
function (219); this is an important consideration and cannot
be disregarded. The second explanation is that cardiovascular
sympathetic dysfunction is not present to any significant degree
in patients with primary glaucoma. One may only conclude that,
within the limits imposed by decreased sensitivity, cardiovascular
sympathetic nerve dysfunction is not associated with the primary
glaucomas.
Diabetes mellitus is associated with parasympathetic nerve function
in the primary glaucomas. Although the results of autonomic
function tests were not significantly influenced by diabetic status
in the control group, definitive conclusions are restricted by
the limited number of subjects with diabetes mellitus in this
category. In OHNA and OHWA, results of parasympathetic function
tests were significantly lower in diabetic than non-diabetic patients,
although only OHNA remained significant after multiple comparisons
were taken into account. It is note-worthy that in patients
with OHNA, results of parasympathetic function tests were also
significantly lower in patients with IGT than non-diabetics.
As approximately 2-4% of patients with IGT progress to overt
diabetes mellitus per year (370), the association with autonomic
nerve dysfunction - an important indicator in the prognosis of
diabetes mellitus (229) - in these patients is significant.
No association was present between diabetes mellitus and sympathetic
nerve function in the primary glaucomas.
Individual tests of cardiovascular autonomic function have different
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degrees of sensitivity, manifesting abnormality at different stages
in the evolution of autonomic nerve dysfunction. This is clearly
shown by the proportions of "abnormal" results for each of the
autonomic function tests in the primary glaucomas (tables 16 and 17).
Previous descriptions of diabetic autonomic neuropathy have commented
on the predictable progression of impaired autonomic efficacy
(228,229); parasympathetic dysfunction occurs initially, with
involvement of the sympathetic nervous system at a later stage
in the pathogenesis of autonomic neuropathy. Heart-rate variation
during deep breathing tends to be the first parasympathetic test
to exhibit abnormality (235), with Valsalva ratio the last affected
(216). The established course of events in diabetic autonomic
neuropathy is closely mirrored by results obtained in the primary
glaucomas, with most abnormal results in response to forced deep
breathing and least following Valsalva manoeuvre. A similar
gradual, stepwise progression of autonomic dysfunction is thus
present in the primary glaucoma population as shown by patients
with diabetes mellitus.
S:L ratio is a relatively-recent measure of parasympathetic integrity.
Initial results have suggested that this test may be a sensitive
indicator of parasympathetic nerve function, with abnormal values
occurring at an early stage in the disease process (275); this
is supported by the present results of parasympathetic evaluation
in the primary glaucomas. The view that a series of tests to
accurately determine autonomic nerve function is preferable to
any single measure (219,235) - which may give misleading results -
is also supported by this study. Prevalence statistics from
parameters of nerve function with different levels of sensitivity
would obviously have given conflicting results; a series of
established tests more-accurately defines the degree of autonomic
function in the individual patient.
The most significant observation to be highlighted by these results
is the marked prevalence of systemic parasympathetic dysfunction
in the primary glaucomas, particularly in patients with narrow
irido-corneal angles (table 18). The proportion of patients with
impaired sympathetic reflexes was significantly lower.
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Thus there is a significant association between systemic autonomic
dysfunction and primary glaucoma; this is principally an abnormality
of the parasympathetic nervous system, although combined dysfunction
of both parasympathetic and sympathetic cardiovascular reflexes
is present to a lesser degree in patients with CAG, OHNA and OHWA.
Parasympathetic dysfunction is an integral feature of all sub-groups
of the primary glaucomas studied, with significantly-increased
prevalence in narrow-angle categories.
The definitive aetiology of autonomic dysfunction in patients
with primary glaucoma is not known, however there is undoubtedly
a close relationship between diabetic status and cardiovascular
autonomic nerve function; in OHNA and OHWA, results of autonomic
function tests were significantly lower in diabetic than non-diabetic
patients. The distribution of systemic autonomic dysfunction
parallels that of diabetes mellitus in the primary glaucomas,
with maximal prevalence in narrow-angle categories. When one
considers that diabetes mellitus is the commonest cause of autonomic
neuropathy in this country (170), and that 20-40% of diabetics
have evidence of autonomic dysfunction (183,249,295,394), these
results concur with established features of autonomic neuropathy.
One may conclude that systemic dysfunction of the autonomic nervous
system is associated with CAG, OAG, and OH, with increased prevalence
in patients with narrow irido-corneal angles. As autonomic nerve
assessment by cardiovascular reflex responses correlates closely
with generalised autonomic function (192,216), one may
reasonably assume that the autonomic dysfunction associated with
primary glaucoma is not restricted to the cardiovascular system.
The relevance of diminished efficacy of the autonomic nervous
system, particularly the parasympathetic nervous system, in the
pathogenesis of glaucoma will be examined in the final discussion.
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SECTION IV




Measurement of the pupil cycle time permits simple, non-invasive,
objective assessment of the pupillary reflex arc. Providing the
ultimate effector, the iris musculature, is structurally normal
with intact innervation, the pupil cycle time is dependent upon
velocity of nerve conduction, synaptic delay, and the number of
nerve impulses transmitted. A thin slit-beam focussed at the
pupillary margin produces pupil oscillations which can be accurately
timed with a stop-watch. The underlying mechanism is described
in figure 9. The beam is positioned to just overlap the pupillary
margin; light stimulating the retinal receptors initiates the pupil
reflex, with subsequent constriction of the pupil. Elimination
of afferent stimulation results in reflex dilation of the pupil,
light re-enters the eye and a second cycle is initiated.
The diagnostic criteria for ocular hypertension, open-angle glaucoma
and closed-angle glaucoma, stipulated on pages 9-11, were strictly
applied; central and peripheral visual field assessment of all eyes
of patients with ocular hypertension, and fellow eyes of patients
with closed-angle glaucoma, were normal, whereas visual field defects
were present in patients with open-angle glaucoma. This is
particularly relevant in the assessment of the pupillary reflex arc,
as the pupil cycle time is intrinsically dependent upon both afferent
and efferent components of the reflex pathway. Afferent pupillary
defects have been described in open-angle glaucoma (322), and
attributed to defects in the anterior visual pathway usually proximal
to the optic chiasm (323). In this study, pupil cycle time was
not assessed in patients with open-angle glaucoma, as definitive
interpretation of results would not have been possible; the presence
of established lesions in the afferent limb of the reflex arc
(ie visual field defects) negates conclusions regarding the efferent








8.2 Patients and methods
Patients were included in the study on the basis of the following
criteria:
i. a history of closed-angle glaucoma
ii. ocular hypertension
a. with narrow irido-cornea I angles
b. with wide irido-corneal angles
After informed consent had been obtained, pupil cycle time was
measured in 70 age- and sex-matched control subjects (mean age
66.2 ± 10.1 years) and 313 patients with primary glaucoma
(mean age ± SD): 124 CAG (66.5 ± 10.1 years), 90 OHNA (67.5 ± 9.2
years), and 99 OHWA (64.8 ± 9.6 years). The control group consisted
of hospital staff, and patients attending the casualty department who
were subsequently determined to have no detectable abnormality, or
mild ocular changes within acceptable limits for an elderly
population; this included early macular degenerative changes and
minimal refractive errors. All subjects had a corrected visual
acuity of ^ 6/9 in each eye.
A comprehensive past, present and family history was obtained
from each subject, followed by systematic general medical examination
and ocular examination according to the protocol described on
pages 85-86. Pupil cycle time was measured 4 weeks after the
initial ocular examination. Eyes were excluded from assessment if
there was a history of:
i. eye operations - either intra- or extra-ocular. Only
unoperated eyes were included in the study. In patients
with closed-angle glaucoma, assessments were performed
only in unoperated fellow eyes; eyes which had sustained
closed-angle glaucoma were specifically excluded.
ii. eye trauma
iii. current ophthalmic drug treatment: only eyes not on treatment
were included in the study.
Subjects were also excluded from assessment on the basis of the
following criteria:
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i. on treatment with autonomic or somatic neurological effects
ii. a past hi story of:
a. medical disorders predisposing to autonomic nerve
dysfunction - except diabetes mellitus
b. neurological disease - including cardiovascular accidents
c. eye disease: the only exception to this stipulation
was the presence of ocular hypertension or closed-angle
glaucoma in those particular categories under examination
After applying the exclusion criteria, pupil cycle time was measured
in:
i. Control group: 122 eyes in 70 subjects
ii. CAG: 118 eyes in 118 patients
iii. OHNA: 165 eyes in 90 patients
iv. OHWA: 183 eyes in 99 patients
Edge-light pupil cycle time was measured according to the following
method. The patient was seated at the slit-lamp (Zeiss 30SL,
Carl Zeiss, Welwyn Garden City, England) in a room with very low,
constant background illumination (20 lux), and requested to fixate
straight ahead on an object at 6 metres. A 0.5 x 6 mm slit-beam was
positioned horizontally and elevated until it just overlapped the
margin of the pupil, then focussed on the iris-lens border.
The pupil constricted, then reflexly dilated in response to iris
blocking the light and thus removing afferent stimulation.
30 consecutive pupillary cycles were timed using a stop-watch; the
result divided by 30 is the duration of a single cycle of the
pupillary reflex arc. Infrequent, rapid "blinks" during measurement
do not significantly affect the pupil cycle time; prolonged "blinks"
necessitate repeat assessment. The pupil cycle time was measured
4 times for each eye separately (ie 4 x 30-cycles) and the result
averaged. The measurement of 30 cycles with subsequent division
to determine the duration of a single cycle reduces subjective
error in manual timing.
All assessments were performed on a single-blind basis.
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8.3 Results
The results of pupil cycle time assessment in 313 patients with
primary glaucoma and 70 age- and sex-matched control subjects
are described as follows:
8.31 Age-adjusted normal tolerance intervals for pupil cycle time
8.32 Pupil cycle time in the primary glaucomas
8.33 Absent pupillary oscillation in the primary glaucomas and
the age- and sex-matched control group
8.34 Pupil cycle time in the primary glaucomas; comparisons with
the age-adjusted normal tolerance limit
8.35 Significance of sex on pupil cycle time
8.36 Diabetes mellitus and pupil cycle time
8.37 Glaucoma treatment and pupil cycle time
Comparisons were made between the results of pupil cycle time
in right eyes versus left eyes, in the control group and each
category of the primary glaucomas separately; significance was
assessed by Student's unpaired t test. No significant differences
(p > 0.05) were present, in any category, between pupil cycle times
in right and left eyes.
8.31 Age-adjusted normal tolerance intervals for pupil cycle time
The results of pupil cycle time measurement in the age- and
sex-matched control group were assessed for dependence on age by
regression analysis. The data were fitted according to various
mathematical models using the computer programme SPSSx on an IBM 4341
computer to obtain a normal distribution after adjustment for age,
thus permitting determination of tolerance intervals. Logarithms of
the data were used to derive tolerance intervals for the reasons
stated on page 91. A log normal distribution was obtained;
tolerance intervals were calculated from the tog normal distribution
(after adjusting for age) by the method described on pages 91-92.
Log j 0(PCT) did not depend significantly on age. Li near regression
analysis, permitting determination of 2.5th, 5th, 95th, and 97.5th
percentiles, was calculated from:
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RLPCT = (Log j„PCT - (-0.02883 + 0.00019 x age))/0.05469
assumed to have the standard Normal distribution.
RLPCT = standardised residual logi0(PCT)
The logarithms of the percentiles (allowing for regression on age),
transformed back to natural values, with 2.5th, 5th, 95th, and 97.5th
percentiles, are shown in figure 10. The upper tolerance limit
for pupil cycle time at age 65 years, based on the 95th percentile
of the log normal distribution after regression for age, is 1190 ms.
8.32 Pupil cycle time in the primary glaucomas
The results of pupil cycle time assessment in 313 patients with
primary glaucoma and 70 age- and sex-matched control subjects
are shown in table 19. Sustained pupillary oscillation in response
to edge-light stimulation was absent in a significant percentage
of eyes examined; consequently, measurement of pupil cycle time
was possible in a proportionately decreased number of eyes:
i. Control group: 106 eyes in 61 subjects
ii. CAG: 64 eyes in 64 patients
iii. 0HNA: 107 eyes in 63 patients
iv. 0HWA: 151 eyes in 78 patients
Comparisons of mean PCT were made between the control group and
each category of the primary glaucomas separately; significance
was assessed by Student's unpaired t test. Dunnett's multiple
comparison procedure was used to obtain a corrected p value (p1).
The significance of the results of PCT assessment in 313 patients
with primary glaucoma compared with results in 70 age- and
sex-matched control subjects are as follows; the actual p value
plus the corrected p value are quoted for significant results.
PCT in patients with CAG (p < 0.001; p' < 0.01) and 0HNA (p < 0.001;
p' < 0.01) were significantly higher than the control group.
PCT in patients with 0HWA (p = 0.02; p' > 0.05) was also significantly
higher than the control group, however this was non-significant
after allowing for multiple comparisons.
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Table 19
RESULTS OF PUPIL CYCLE TIME ASSESSMENT IN 313 PATIENTS WITH PRIMARY
GLAUCOMA AND 70 AGE- AND SEX-MATCHED CONTROL SUBJECTS




(n=70) 0.97 ± 0.01
Closed-angle glaucoma
patients




(n=189) 1.03 ± 0.01
OHNA
(n=90) 1.05 ± 0.01
OHWA
(n=99) 1.01 ± 0.01
8.33 Absent pupillary oscillation in the primary glaucomas and
the age- and sex-matched control group
Pupillary oscillation was absent in a significant proportion of
eyes examined (table 20):
i. Control group: 16 eyes in 11 subjects
ii. CAG: 54 eyes in 54 patients
iii. OHNA: 58 eyes in 38 patients
iv. OHWA: 32 eyes in 19 patients
Comparisons were made between the prevalence of absent pupillary
oscillation in the control group and each category of the primary
glaucomas separately; significance was assessed by x2 test with
Yates' correction. To allow for multiple comparisons with a
control, significant p values were multiplied by the number of
comparisons made to obtain a corrected p value C p *); the actual
p value plus the corrected p value are quoted for significant
results.
The prevalence of absent pupillary oscillation was significantly
higher in patients with CAG (p < 0.001; p' < 0.001) and OHNA
(p < 0.001; p" < 0.001) than the control group. No significant
differences were present between the prevalence of absent pupillary
oscillation in the control group and patients with OHWA (p > 0.05).
8.34 Pupil cycle time in the primary glaucomas; comparisons with
the age-adjusted normal tolerance limit
The age-adjusted normal tolerance limit, ie the upper 95th percentile
of the log normal distribution after regression for age, was applied
to the results obtained from patients with primary glaucoma, to
determine the proportion of eyes in each glaucoma category outwith
this limit; results are shown in table 21. This refers only
to eyes where measurement of pupil cycle time was possible; eyes
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8.35 Significance of sex on pupil cycle time
Comparisons were made between the results of pupil cycle time
measurement in males versus females, in the control group and
each category of the primary glaucomas separately; significance
was assessed by Student's unpaired t test. No significant
differences were present between the results of male and female
subj ects.
8.36 Diabetes mellitus and pupil cycle time
The possible association between diabetes mellitus and pupil cycle
time was assessed by comparing the results of pupil cycle time
measurement in diabetic subjects (NIDDM, IGT, and NIDDM + IGT
separately) with results in non-diabetic subjects, in the control
group and each category of the primary glaucomas separately.
Significance was assessed by Student's unpaired t test.
No significant differences in results of pupil cycle time measurement
were present between diabetic and non-diabetic subjects in any
category.
8.37 Glaucoma treatment and pupil cycle time
The only drug treatments for glaucoma taken by patients included
in the study were guttae pilocarpine 2%/4% and/or guttae timolol
maleate 0.25%/0.5%. (NB Pupil cycle time was only measured in
eyes not on drug treatment, thus the purpose of this comparison
was to assess whether drug treatment to the contralateral eye
affected pupil cycle time in the untreated eye.) The possible
association between treatment and pupil cycle time was assessed
by comparing the results of pupil cycle time measurement in primary
glaucoma patients on treatment with the results in untreated primary
glaucoma patients; this was performed for guttae pilocarpine 2%/4%
and guttae timolol maleate 0.25%/0.5% separately, in each category
of the primary glaucomas. Significance was assessed by Student's
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unpaired t test. No significant differences (p > 0.05) in the
results of pupil cycle time measurement were present between primary
glaucoma patients treated with guttae pilocarpine 2%/4% and/or
guttae timolol maleate 0.25%/0.5% and primary glaucoma patients
not on treatment.
8.4 Discussion
Pupil cycle time enables the integrity of the pupillary reflex arc
to be accurately and objectively evaluated by a simple, non-invasive,
clinically-orientated technique. The duration of the cycle is
prolonged in older subjects; a mean pupil cycle time of 822 ± 69 ms
has been proposed for subjects aged < 50 years (315), and a mean
of 872 ± 83 ms in those aged 50-79 years (316). In the present
study, pupil cycle time was assessed in a control group with mean age
67.1 ± 11.5 years (range 30-91 years); although the reflex was
shown to be only minimally age-dependent, mean pupil cycle time
(ie 968 ± 131 ms) was significantly higher than previous descriptions.
Edge-light pupil cycle time, as originally described by Miller
and Thompson in the younger age group (315), represented the average
of 5 consecutive 30-cycle measurements (150 cycles). When the
pupil cycle time was determined in older subjects (316), the final
result represented the average of only 3 x 30-cycle measurements
(90 cycles). In the present study, a compromise figure of
4 x 30-cycle measurements (120 cycles) were employed in assessment.
Prolongation of pupil cycle time in older control subjects, indicated
by present results, may represent a manifestation of fatigue within
the reflex, which is precipitated by the increased number of
consecutive cycles, whilst not revealed by less-exacting assessments.
14.3% of eyes in control subjects were characterised by an absence
of sustained pupillary oscillation in response to edge-light
stimulation; consequently, definitive measurement of pupil cycle time
was not possible. This phenomenon has not been reported in previous
descriptions of pupil cycle time. The following 3 sub-groups
are included within this category:
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i. initial pupil oscillation, rapidly diminishing in amplitude
and velocity, with eventual pupil immobility prior to the
completion of 120 cycles
ii. irregular pupillary unrest or hippus, with minimal pupillary
"fibriIlating" oscillations which were impossible to quantify
iii. relative pupillary immobility, interrupted at irregular
intervals by segmental contractions of the sphincter pupillae
Age-adjusted normal tolerance intervals for pupil cycle time may
only be defined in subjects where measurement of pupil cycle time
is possible; appropriate consideration must be given to absence
of pupillary oscillation, however it is obviously impossible to
assign an absolute numerical value in this circumstance. An
effective compromise was obtained by enumerating subjects with
absent pupillary oscillation separately. In an elderly population,
pupil cycle time is not always a directly-measurable parameter,
however using this definition tolerance limits may be established -
with qualification. Whether the lack of quantifiable movement
results from subclinical sphincter innervationaI defects (316),
increased conduction time in anterior optic pathways (316), or
arteriosclerosis and deposition of hyaline in the iris stroma
and muscles (395), remains speculative, however it is present
in a significant proportion of control subjects.
In comparisons with the control group, pupil cycle time was
significantly prolonged in patients with CAG and OHNA; pupil cycle
time was also significantly prolonged in patients with OHWA, however
this failed to remain significant after allowing for multiple
comparisons. The prevalence of abnormal pupil cycle time, defined
by the 95th percentile of the log normal distribution after
regression on age, was significantly increased in patients with
CAG and OHNA. Thus impairment of pupil cycle time is specifically
associated with narrow-angle primary glaucomas: CAG and OHNA.
The prevalence of absent pupillary oscillation in response to
edge-light stimulation was also significantly increased in patients
with CAG and OHNA; the prevalence in patients with OHWA was not
significantly different from the control group. Pupil cycle time
was not significantly associated with diabetic status.
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Pupil cycle time assesses the integrity of the pupillary reflex arc
as a discrete and indivisible unit; inferences to localise any
defect within the reflex pathway revealed by prolongation of the
pupil cycle time may only be made by supplementing the data with
additional information relating to individual components of the
pathway. There was no evidence of retinal nerve fibre bundle
defects, following meticulous peripheral and central visual field
assessment, in all eyes of patients with ocular hypertension and
fellow eyes of patients with closed-angle glaucoma. Nerve fibre
bundle defects characteristic of glaucoma may affect the afferent
limb of the reflex arc; when afferent defects are not revealed
by standard techniques, prolonged pupil cycle time may be attributed
to defects in either the internuncial or efferent component of
the arc by reasonable implication. In the presence of generalised
cardiovascular parasympathetic dysfunction, one may reasonably
postulate co-existent parasympathetic dysfunction in the anterior
segment of the eye. However as localisation in this test is
not possible, one may equally postulate that pupil cycle time
is prolonged as a result of early defects in the afferent limb,
undetected by standard techniques. The only definite conclusion
from these results is that the duration of the pupillary reflex,
represented by the pupil cycle time, is prolonged in patients
with closed-angle glaucoma and the narrow-angle form of ocular
hypertension, implying impairment of the pupillary reflex arc:
the aetiology is not known.
Irrespective of the site of the lesion, the duration of the pupillary
reflex represents a simple and reproducible measure of ocular
nerve function - both afferent (sensory,somatic) and efferent
(motor,autonomic) - in patients with glaucoma. Thus pupil cycle
time can be effectively utilised in the objective evaluation of





The principles of denervation hypersensitivity are explained in
the introductory text. Adrenoceptor density, determined by
radioligand binding, is significantly increased at the postsynaptic
receptor site in autonomic denervation hypersensitivity (396,397).
This mechanism may be applied to the anterior segment of the eye,
where pupillary diameter is directly controlled by the autonomic
nervous system; parasympathetic nerves effect pupillary constriction
via the sphincter pupillae, and sympathetic nerves effect pupillary
dilation via the dilator pupillae. Pupillary diameter therefore
represents an external manifestation of relative autonomic activity
in the anterior segment of the eye. It has been shown that
2.5% methacholine is an effective determinant of parasympathetic
denervation hypersensitivity; topical guttae 2.5% methacholine
constricts Adie's tonic pupils, whilst normal pupils may not be
affected by concentrations up to 15% (333). 2.5% methacholine
was therefore used in the present study to determine the degree
of parasympathetic denervation hypersensitivity in the anterior
segment of patients with primary glaucoma.
Assessment of sympathetic denervation hypersensitivity in the
anterior segment has not been accurately defined. Various authors
have reported using 0.1% adrenaline (352), and 1% or 2% phenylephrine,
however 0.1% adrenaline has given conflicting results, and
1 %/2% phenylephrine effect a degree of mydriasis in the normal
pupil (353,354,355); detailed statistics of mydriatic efficacy
at these concentrations have not been established. It was therefore
decided to use low concentrations (0.1% and 0.5%) of topically-
applied guttae phenylephrine hydrochloride, a direct-acting alpha-
adrenoceptor agonist effecting pupillary dilation, to determine
whether anterior segment sympathetic denervation was a feature
of the primary glaucomas. Identical studies were concurrently
performed on an age- and sex-matched control group to determine
"normal" responses.
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9.2 Patients and methods
Patients were included in the study on the basis of the following
criteria:
i. a history of closed-angle glaucoma
ii. ocular hypertension
a. with narrow irido-cornea I angles
b. with wide irido-cornea I angles
iii. open-angle glaucoma
a. with narrow irido-cornea I angles
b. with wide irido-corneal angles
After informed consent had been obtained, pupillary responses to
guttae 2.5% methacholine, 0.1% phenylephrine and 0.5% phenylephrine
were assessed in 63 age- and sex-matched control subjects (mean age
60.3 ± 19.1 years) and 117 patients with primary glaucoma (mean age
± SD): 45 CAG (66.3 ± 10.1 years), 26 OHNA (67.1 ± 9.4 years),
26 OHWA (64.2 ± 9.8 years), 7 OAGNA (68.6 ± 8.8 years), and 9 OAGWA
(66.4 ± 8.5 years). The control group consisted of hospital staff,
and patients attending the casualty department who were subsequently
determined to have no detectable abnormality, or mild ocular changes
within acceptable limits for an elderly population; this included
early macular degenerative changes and minimal refractive errors.
All subjects had a corrected visual acuity of ^ 6/9 in each eye.
A comprehensive past, present and family history was obtained
from each subject, followed by systematic general medical examination
and ocular examination according to the protocol described on
pages 85-86. Assessment of pupillary denervation hypersensitivity
was performed at least 4 weeks after the initial ocular examination.
Eyes were excluded from assessment if there was a history of:
i. eye operations - either intra- or extra-ocular. Only
unoperated eyes were included in the study. In patients
with closed-angle glaucoma, assessments were performed
only in unoperated fellow eyes; eyes which had sustained
closed-angle glaucoma were specifically excluded,
i i. eye trauma
iii. current ophthalmic drug treatment: only eyes not on treatment
were included in the study.
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Subjects were also excluded from assessment on the basis of the
following criteria:
i. on treatment with autonomic or somatic neurological effects
ii. a past hi story of :
a. medical disorders predisposing to autonomic nerve
dysfunction - except diabetes mellitus
b. neurological disease - including cardiovascular accidents
c. eye disease: the only exception to this stipulation
was the presence of ocular hypertension or closed-angle
glaucoma in those particular categories under examination
9.21 Assessment of parasympathetic denervation hypersensitivity
Pupil diameters were recorded photographically. Subjects' eyes
were photographed between 9-11am under standard lighting conditions;
the subject faced a surface with measured luminance of 20 apostilbs,
whilst constant background luminous flux of 1000 lumens was maintained
in a white-walled room 2.5m x 3.5m. The subjects remained seated
in the room for 5 minutes prior to assessment. They were then
requested to sit at a small table on which was placed an ophthalmic
head-rest (plate 13) against which they rested their foreheads,
thereby effecting constant, reproducible positions for photography
(398). A scale was positioned against the lower eyelid, in the
perpendicular plane of the iris (plates 14 and 15). (The scale was
constructed using Rotring engineering-drawing equipment, with lines
of width 0.1 mm at 1 cm intervals.) The subjects fixated at
6 metres, then a photograph at x3 magnification was taken of both
eyes together using a Nikon F camera with Medical Nikkor 120mm f4
lens (plate 16), and Kodak ektachrome professional film (ASA 200).
The camera settings were fixed; focussing was effected by movement of
the camera. The subject's head was tilted back, and one drop of
2.5% methacholine was placed in the conjunctival sac of the right eye;
if the right eye had previously sustained closed-angle glaucoma, or
had a history of eye trauma/eye operations/drug treatment, the left
eye was assessed. The subjects remained in the room throughout the
test. 45 minutes later, the subjects were repositioned on the head¬
rest and a second photograph taken in a similar manner.
The photographic slides were projected on to a white screen at
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5 metres, producing a final magnification of x17. Horizontal
pupillary diameters were measured to an accuracy of ± 0.5 mm,
and corrected to actual values by comparison with relative
magnification of the scale; this resulted in measurements of actual
pupillary diameters to ±0.03 mm. The horizontal pupillary diameter
45 minutes after installation of guttae in the tested eye was
divided by the horizontal pupillary diameter before installation
of guttae, and the result expressed as the 2.5% methacholine ratio:
2.5% methacholine ratio = horiz. pupil diameter 45 min post-test
horiz. pupil diameter pre-test
The fellow (non-tested) eyes could not be used as experimental
controls for the following reasons:
i. CAG: the non-tested eye in patients with CAG had sustained
CAG, and thus was not an acceptable model for
experimental control
ii. OAG: the non-tested eye in patients with OAG had either
a history of eye operation(s), or on treatment with
topical glaucoma medication; in either case, these
eyes were not acceptable as experimental controls.
The concurrent assessment of an age- and sex-matched control group
provided effective standards for comparison. One eye was tested
in each subject, and all assessments were performed on a single-blind
basis.
The constituents of the 2.5% methacholine solution are detailed
in appendix 1.
9.22 Assessment of sympathetic denervation hypersensitivity
The same technique was used to assess denervation of the sympathetic
nervous system in the anterior segment of the eye, replacing
2.5% methacholine by 0.1% phenylephrine and 0.5% phenylephrine
on separate occasions. Two weeks elapsed between each of the
3 ocular assessments of denervation: 2.5% methacholine, 0.1%
phenylephrine, and 0.5% phenylephrine. All 3 assessments were
performed on the same eye in each subject. Guttae 0.5% thymoxamine
hydrochloride was instilled in the tested eye at the conclusion
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of each 0.1% phenylephrine and 0.5% phenylephrine test, to reverse
pupil dilation and negate possible complications of mydriasis (164).
The 0.1% phenylephrine and 0.5% phenylephrine ratios were separately
calculated in the same manner as the 2.5% methacholine ratio ie
horizontal pupillary diameter (in the tested eye) 45 minutes after
installation of guttae divided by the horizontal pupillary diameter
(in the tested eye) before installation of guttae.
The age- and sex-matched control group were concurrently assessed.
One eye was tested in each subject, and all assessments were
performed on a single-blind basis.
The constituents of the 0.1% phenylephrine and 0.5% phenylephrine
solutions used in assessment are detailed in appendix 2.
9.3 Results
The results of pupillary responses to 2.5% methacholine, 0.1%
phenylephrine, and 0.5% phenylephrine in 117 patients with primary
glaucoma and 63 age- and sex-matched control subjects are described
as follows:
9.31 Age-adjusted normal tolerance intervals for 2.5% methacholine
ratio, 0.1% phenylephrine ratio, and 0.5% phenylephrine ratio
9.32 2.5% methacholine ratio, 0.1% phenylephrine ratio, and 0.5%
phenylephrine ratio in the primary glaucomas
9.33 Significance of sex on denervation hypersensitivity
9.34 Diabetes mellitus and denervation hypersensitivity
9.35 Glaucoma treatment and denervation hypersensitivity
Comparisons were made, for 2.5% methacholine ratio/0.1% phenylephrine
ratio/0.5% phenylephrine ratio separately, between the ratios in right
eyes versus left eyes, in the control group and each category of
the primary glaucomas separately; significance was assessed by
Student's unpaired t test. No significant differences (p > 0.05)
were present, in any category, between 2.5% methacholine/0.1 %
phenylephrine/0.5% phenylephrine ratios in right and left eyes.
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9.31 Age-adjusted normal tolerance intervals for 2.5% methacholine
ratio, 0.1% phenylephrine ratio, and 0.5% phenylephrine ratio
2.5% methacholine ratios, 0.1% phenylephrine ratios, and 0.5%
phenylephrine ratios in the age- and sex-matched control group
were separately assessed for dependence on age by regression analysis.
The data were fitted according to various mathematical models
using the computer programme SPSSx on an IBM 4341 computer to
obtain a normal distribution on age, thus permitting determination
of tolerance intervals. Logarithms of the data were used to
derive tolerance intervals for the reasons stated on page 91.
A log normal distribution was obtained for the results of each test;
tolerance intervals were calculated from the log normal distribution
(after adjusting for age) according to the method described on
pages 91-92.
i. 2.5% methacholine ratio
Log10(2.5% methacholine ratio) was shown to depend significantly
on age. Linear regression analysis, permitting determination
of 2.5th, 5th, 95th, and 97.5th percentiles, was calculated
f rom:
RLM2,5 = (log10M2.s - (0.01756 - 0.00076 x age))/0.05241
assumed to have the standard Normal distribution.
RLM2i5 = standardised residual logl0(2.5% methacholine ratio)
The logarithms of the percentiles (allowing for regression on
age), transformed back to natural values, with 2.5th, 5th, 95th,
and 97.5th percentiles, are shown in figure 11. The lower tolerance
limit for 2.5% methacholine ratio at age 65 years, based on the
5th percentile of the log normal distribution after regression
on age, is 0.76.
ii. 0.1% phenylephrine ratio
Logl0(0.1% phenylephrine ratio) was shown to depend
significantly on age. Linear regression analysis, permitting
determination of 2.5th, 5th, 95th, and 97.5th percentiles,
was calculated from:
RLP0-l = (log j 0P0-1 - (-0.01766 + 0.00047 x age))/0.04028
assumed to have the standard Normal distribution.
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RLPo.i = standardised residual logl0(0.1% phenylephrine ratio)
The logarithms of the percentiles (allowing for regression on age),
transformed back to natural values, with 2.5th, 5th, 95th, and 97.5th
percentiles, are shown in figure 12. The upper tolerance limit
for 0.1% phenylephrine ratio at age 65 years, based on the 95th
percentile of the log normal distribution after regression on
age, is 1.20.
iii. 0.5% phenylephrine ratio
Log10(0.5% phenylephrine ratio) was shown to depend
significantly on age. Linear regression analysis, permitting
determination of 2.5th, 5th, 95th, and 97.5th percentiles,
was calculated from:
RLPo.s = (log10P0,5 - (-0.05084 + 0.00213 x age))/0.05214
assumed to have the standard Normal distribution.
RLPos = standardised residual log10(0.5% phenylephrine ratio)
The logarithms of the percentiles (allowing for regression on age),
transformed back to natural values, with 2.5th, 5th, 95th, and 97.5th
percentiles, are shown in figure 13. The upper tolerance limit
for 0.5% phenylephrine ratio at age 65 years, based on the 95th
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9.32 2.5% methacholine ratio, 0.1% phenylephrine ratio, and 0.5%
phenylephrine ratio in the primary glaucomas
The results of pupillary responses to 2.5% methacholine, 0.1%
phenylephrine, and 0.5% phenylephrine in 117 patients with primary
glaucoma and 63 age- and sex-matched control subjects are shown
in table 22. In each test of denervation hypersensitivity,
comparisons were made between the results of the control group
and each category of the primary glaucomas separately; significance
was assessed by Student's unpaired t test. Dunnett's multiple
comparison procedure was used to obtain a corrected p value (p1),
to prevent incorrect conclusions from multiple comparisons with
a control. The significance of the results of pupillary responses
to 2.5% methacholine, 0.1% phenylephrine, and 0.5% phenylephrine
in 117 patients with primary glaucoma compared with results in
63 age- and sex-matched control subjects is summarised in the
following paragraphs; the actual p value plus the corrected p value
(p') are quoted for significant results.
9.321 2.5% methacholine ratio
2.5% methacholine ratios were significantly lower than the control
group in patients with 0HWA (p < 0.001; p' < 0.01), 0AGNA (p < 0.01;
p' < 0.05), and 0AGWA (p < 0.01; p' < 0.05). 2.5% methacholine
ratios were also significantly lower than the control group in
patients with CAG (p = 0.02; p' > 0.05) and 0HNA (p = 0.02;
p' > 0.05), however these were not significant after allowing
for multiple comparisons.
9.322 0.1% phenylephrine ratio
0.1% phenylephrine ratios were significantly higher than the control
group in patients with 0AGNA (p < 0.001; p' < 0.01) and 0HWA
(p < 0.01; p' < 0.05). 0.1% phenylephrine ratios were also
significantly higher than the control group in patients with CAG
(p = 0.013; p' > 0.05), however this just failed to retain
significance after multiple comparisons were taken into account.
0.1% phenylephrine ratios were not significantly higher than the
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control group in patients with OHNA (p = 0.05; p' > 0.05) and
OAGWA (p > 0.05).
9.323 0.5% phenylephrine ratio
0.5% phenylephrine ratios were significantly higher than the control
group in patients with CAG (p < 0.001; p' < 0.01), OHNA (p < 0.002;
p' < 0.01), 0HWA (p < 0.002; p' < 0.01), and 0AGNA (p < 0.001;
p' < 0.01). 0.5% phenylephrine ratios were not significantly
different from the control group in patients with OAGWA (p > 0.05).
9.33 Significance of sex on denervation hypersensitivity
Comparisons were made, for 2.5% methacholine ratio/0.1% phenylephrine
ratio/0.5% phenylephrine ratio separately, between the results
in males versus females, in the control group and each category
of the primary glaucomas separately; significance was assessed
by Student's unpaired t test. No significant differences (p > 0.05)
were present, in any category, between the 2.5% methacholine ratio/
0.1% phenylephrine ratio/0.5% phenylephrine ratio in male and
female subjects.
9.34 Diabetes mellitus and denervation hypersensitivity
The possible association between diabetes mellitus and denervation
hypersensitivity was assessed by comparing the results of each
test of denervation hypersensitivity (2.5% methacholine/0.1%
phenylephrine/0.5% phenylephrine) in diabetic subjects (NIDDM, IGT,
NIDDM + IGT separately) with results in non-diabetic subjects,
in the control group and each category of the primary glaucomas
separately. Significance was assessed by Student's unpaired t test.
No significant differences (p > 0.05) in results of denervation
hypersensitivity tests were present between diabetic and non-diabetic
subjects in any category.
144
Table22
2.5%METHACHOLINERATIO,0.1PH NYLEP R NEIA D0.5%PHENYLEPHRINERA II117PATIEN SWI PRIMARYGLAUCOMAAND63GE-SEX-MATCHEDCONTR LUBJ TS (Groupmeanvalues±SEM) Controlsubjects (n=63)2.5%Methacholine ratio 0.95±010.1%Phenylephrine ratio 1.02±0 1
0.5%Phenylephrine ratio 1.17±0 03
Closed-angleglaucoma patients (n=45)0.91±021. 80.3003 Ocularhypertensive patients All (n=56)0.87±.011. 80 21.310 03 OHNA (n=26)0.89±011.0701.30 03 OHWA (n=30)0.85±021.100 021.310 04 Open-angleglaucoma patients All (n=16)0.84±01.130 051.30 0 OAGNA (n=7)0.84±051.20 111.530 15 OAGWA (n=9)0.84±071.060 31.160 07
9.35 Glaucoma treatment and denervation hypersensitivity
The only drug treatments for glaucoma taken by patients included
in the study were guttae pilocarpine 2%/4% and/or guttae timolol
maleate 0.25%/0.5%. (NB Denervation hypersensitivity was only
assessed in eyes not on drug treatment, thus the purpose of this
comparison was to assess whether drug treatment to the contralateral
eye affected responses to 2.5% methacholine/0.1% phenylephrine/
0.5% phenylephrine in the untreated eye.) The possible association
between treatment and denervation hypersensitivity was assessed
by comparing the results of each test of denervation hypersensitivity
separately (2.5% methacholine ratio/0.1% phenylephrine ratio/0.5%
phenylephrine ratio) in primary glaucoma patients on treatment
with the results in untreated primary glaucoma patients; this
was performed for guttae pilocarpine 2%/4% and guttae timolol
maleate 0.25%/0.5% separately, in each category of the primary
glaucomas. Significance was assessed by Student's unpaired t test.
No significant differences (p > 0.05) in the results of denervation
hypersensitivity tests were present between primary glaucoma patients
treated with guttae pilocarpine 2%/4% and/or guttae timolol
maleate 0.25%/0.5% and primary glaucoma patients not on treatment.
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9.4 Discussion
NeuropharmacologicaL manipulations are effectively utilised in
the localisation of defects in autonomic innervation of the iris
musculature. Observations of hypersensitive reactions to topical
cholinergic and adrenergic agonists in parasympathetic and sympathetic
denervated irides (329,330,332) resulted in the use of dilute
guttae methacholine as a pathognomonic test of pupillotonia (333,334),
and subsequently to the definitive treatise on denervation
hypersensitivity by Cannon and Rosenbluth in 1949 (336). The
efficacy of the "Mecholyl test" in the detection of anterior segment
parasympathetic denervation has been confirmed by several studies
(399,400). Although various pharmacological agents have been
used in the diagnosis of sympathetic neuropathy of the anterior
segment (346,352), "normal" responses are not established; definitive
conclusions are therefore not possible. Phenylephrine is a direct-
acting sympathomimetic amine, a specific alpha-agonist which effects
mydriasis by aIpha-adrenoceptor stimulation of the sympathetically-
innervated dilator pupillae (398). Studies in subjects with
Horner's syndrome have confirmed that pupillary responses to
phenylephrine are enhanced in the presence of sympathetic denervation
(401). Guttae 1% and 2% phenylephrine have been utilised in
this context, however mydriasis - to a variable degree - is a
"normal" response (346), and thus the promotion of these concentrations
as diagnostic in the determination of sympathetic denervation
hypersensitivity in the anterior segment is open to reasonable doubt.
Responses to guttae 0.1% phenylephrine and 0.5% phenylephrine
have not, to my knowledge, been previously reported. Mydriatic
ratios in an age-matched control group confirmed that responses
to 0.1% phenylephrine and 0.5% phenylephrine are age-dependent,
with mean ± SD increase in post-phenyLephrine pupil diameter in
a ratio of 1.03 ± 0.04 mm (0.1% phenylephrine) and 1.22 ± 0.05 mm
(0.5% phenylephrine) at age 65 years. Similarly, responses to
guttae 2.5% methacholine are significantly related to age, with
a post-methacholine pupil diameter ratio of 0.93 ± 0.05 mm in
the control group at age 65 years. The determination of autonomic
denervation in the anterior segment would therefore seem to be
facilitated by neuropharmacological manipulation with these
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concentrations of autonomic neurotransmitters.
Pupillary constriction following administration of topical
2.5% methacholine was significantly greater than the control group
in each category of the primary glaucomas - CAG, OHNA, OHWA, OAGNA,
OAGWA - although CAG and OHNA just failed to retain significance
after allowing for multiple comparisons with a control. These
results support the hypothesis of parasympathetic denervation
of the iris in the primary glaucomas.
Assessment of ocular sympathetic integrity confirms that the pupil
demonstrates increased sensitivity to low concentrations of
phenylephrine in several of the primary glaucomas. Pupillary
mydriasis following topical 0.1% phenylephrine was significantly
greater than the control group in patients with CAG, OHWA, and OAGNA;
mydriatic ratios in patients with OHNA just failed to reach
statistical significance (p = 0.05). Pupillary mydriasis following
topical 0.5% phenylephrine was significantly greater than the
control group in patients with CAG, OHNA, OHWA, and OAGNA.
Increased sensitivity to minute concentrations of sympathomimetic
amines was not present in patients with OAGWA.
A high incidence of parasympathetic denervation of the iris has
been reported in patients with diabetes me 1litus (402); measurable
miotic responses to 2% methacholine were noted in 81% of diabetic
subjects compared with 8% of a comparable control group. The
increased response to methacholine in subjects with diabetes mellitus
was confirmed by Hayashi and Ishikawa (1979) who also demonstrated
an increased mydriatic response to 1% adrenaline, suggesting
concomitant sympathetic neuropathy (403). This is of particular
relevance in view of the significant association between diabetes
mellitus and the primary glaucomas.
In this study, the presence of autonomic denervation hypersensitivity
was not significantly related to diabetic status. Thus although
both diabetes mellitus and anterior segment autonomic neuropathy
are significantly associated with primary glaucoma, autonomic
denervation is apparently not directly associated with diabetes.
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These results must be interpreted with caution, as autonomic
neuropathy is unlikely to be an isolated complication of diabetes
mellitus in the anterior segment; lesions of connective tissue,
blood vessels and smooth muscle are frequently present in diabetic
irides (404). Fujii, Ishikawa and Uga (1977) noted autonomic
nerve endings to be virtually non-existent in diabetic irides
compared with control subjects, confirming the presence of autonomic
neuropathy; three pathological manifestations of myopathy were
described in the iris muscles (dilator and sphincter pupillae)
of diabetic patients: lamellar structures, vacuoles, and lipid
droplets (404). Quantitative assessments of autonomic integrity
are dependent upon an intact effector; restrictions of structural
mobility may conceal concomitant denervation hypersensitivity
by preventing responses to topical neurotransmitters.
Parasympathetic denervation hypersensitivity, manifest as
significantly-increased pupillary responses to topical 2.5%
methacholine, is associated with CAG, OH (NA and WA), and OAG
(NA and WA). Sympathetic denervation hypersensitivity is associated
with CAG, OH (NA and WA), and OAGNA; responses to concentrations
of direct-acting sympathomimetic amines suggesting autonomic
denervation were not significantly different from normal in patients
with OAGWA. Tests based upon pupillary responses to topical agents,
although apparently assessing the efficacy of individual components
of the autonomic nervous system, do not definitively localise
parasympathetic and sympathetic dysfunction, as pupillary diameter
is determined by relative sympathetic and parasympathetic activity
in the anterior segment; significantly-increased pupil constriction
in response to 2.5% methacholine may be facilitated by relatively-
decreased sympathetic efficacy in patients with primary glaucoma.
Similarly, significantly-increased pupil mydriasis in response
to 0.1% phenylephrine and 0.5% phenylephrine may be facilitated
by relatively-decreased parasympathetic efficacy in patients with
primary glaucoma. The most important conclusion from these results
is that relative autonomic efficacy in the anterior segment of
the eye is impaired in the primary glaucomas; inferences regarding
individual components of the autonomic nervous system may only
be made with allowance for possible facilitatory effects resulting
149
from impairment of the antagonist.
One may conclude that parasympathetic neuropathy of the iris is
associated with the primary glaucomas. Although proximally-situated
lesions in the intei—neurone autonomic efferent outflow effect
lesser degrees of hypersensitive reactions, responses to diagnostic
neuropharmacologicaI tests of denervation are maximal in lesions
of the postganglionic neurone (346); with responses of such a
significant degree in primary glaucoma patients, one must assume
the most likely site of autonomic neuropathy to be the postganglionic
neurone, with consequent increase in either the number or activity
of receptors on the effector (smooth muscle) surface. Similar
considerations are applicable to the sympathetic innervation of
the iris musculature, with the exception of patients with OAGWA;
sympathetic denervation hypersensitivity is not a feature of these
patients. Autonomic neuropathy is not characteristically a
localised disorder; it is unlikely that significant autonomic
neuropathy in the anterior segment of the eye is restricted to
the iris.
The relevance of anterior segment autonomic neuropathy in the
primary glaucomas will be examined within the context of previous
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The essential anterior segment event precipitating irido-corneal
contact, and consequently angle-closure, is postulated to be a
change in autonomic activity - with particular emphasis on
parasympathetic tone (155). The depth of the anterior chamber
is not a static dimension, and may show rapid and transient changes
(159); alterations in depth are directly related to the pupil block
force (52,103), itself a manifestation of autonomic activity in
the anterior segment. The pathogenesis of angle-closure is
described in the introductory text; the salient points are as
follows. The vector force, representing the resolution of the
constituent elements of pupil block, increases iris-lens apposition.
In eyes without a peripheral iridectomy, aqueous flow from the
site of production (ciliary processes) to that of escape (trabecular
meshwork and uveoscleral route) can only occur via the pupil;
increased pupillary block thus results in decreased aqueous flow
from the posterior to the anterior chamber. As facility of outflow
remains unaltered, impedance of aqueous flow via the pupil results
in the development of a pressure differential across the iris-lens
diaphragm, with increasing pressure in the posterior chamber
(effected by continuing aqueous production with impaired outflow)
and decreasing pressure in the anterior chamber (continuing outflow
with impaired inflow). In a biological system capable of marked
variation, changes in the dimensions of the anterior chamber
necessarily follow; for example, the volume of the anterior chamber
decreases by 16% in the fellow eye of a patient with closed-angle
glaucoma during the course of a provocative test with pilocarpine
and phenylephrine (54). Anterior translational movement of the
iris-lens diaphragm facilitates irido-corneal contact and thus
subsequent angle-closure: if the anterior chamber shallows by 0.2 mm,
the distance between peripheral iris and cornea decreases by 0.08 mm;
if the anterior chamber shallows by 0.33 mm, the irido-corneal gap
narrows by 0.12 mm (103). As irido-corneal separation in eyes
with narrow angles is only approximately 0.15 mm (155), relatively-
minor anterior displacement of the iris-lens diaphragm may cause
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disproportionate decreases in the irido-corneaL interval, with
eventual irido-corneal contact. The pilocarpine-phenylephrine
provocative test, effecting maximal parasympathetic and sympathetic
stimulation in the anterior segment, has a sensitivity of 93%
and a predictive value of 94% (160). Selective pharmacological
manipulation of the autonomic nervous system in the anterior segment
of the eye thus satisfies the requirements of an effective model
of angle-closure, supporting the hypothesis that events preceding
irido-cornea I apposition occur as a direct result of changes in
autonomic activity.
Having established this fundament a I principle, one must determine
the predisposition in certain individuals to develop the necessary
change in ocular autonomic activity precipitating angle-closure.
Assessment of cardiovascular autonomic reflexes correlates closely
with autonomic function in other systems (216,217), and thus
effectively provides an objective, quantifiable, and reproducible
measure of generalised autonomic function. On this basis, the
present results indicate that systemic autonomic dysfunction is
associated with the primary glaucomas, with significantly-increased
prevalence in patients with narrow-angles. Impairment of systemic
autonomic integrity is restricted to the parasympathetic component
of the autonomic nervous system - although results of sympathetic
assessment must be viewed within the context of the limited
sensitivity of sympathetic cardiovascular reflex tests compared
with those of the parasympathetic nervous system, the former only
becoming positive during advanced stages of sympathetic neuropathy.
The distribution of systemic parasympathetic dysfunction is similar
to that of abnormal glucose tolerance in the primary glaucomas,
with increased prevalence in narrow-angle categories. A salient
difference between both features associated with primary glaucoma
was that the prevalence of parasympathetic dysfunction was
significantly increased relative to the control group in every
category of the primary glaucomas studied, with particularly elevated
levels in those with narrow angles, however the prevalence
of abnormal glucose tolerance was only significantly increased
in narrow-angle categories.
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A similar pattern emerges from the results of pupil cycle time
assessment in the primary glaucomas; pupil cycle time was
significantly prolonged only in narrow-angle categories (CAG and
OHNA). The duration of pupil cycle time in OHWA was not
significantly different from the control group after allowing
for multiple comparisons. As previously explained, the exact
site of the lesion cannot be definitively localised in an assessment
of the reflex arc as a single unit, however as concurrent detailed
visual field assessment revealed no evidence of afferent defects
in patients with CAG, OHNA and OHWA, one may reasonably postulate
the lesion prolonging the duration of the pupillary reflex to
be located within the efferent parasympathetic component, a
hypothesis supported by the evidence of concomitant systemic
parasympathetic dysfunction in these patients.
Impairment of autonomic integrity in the anterior segment of the
eye was confirmed by the demonstration of denervation hypersensitivity
in the irides of primary glaucoma patients. Hypersensitive
responses to cholinergic agonists were present in each category
of the primary glaucomas studied; hypersensitive responses to
adrenergic agonists were present in CAG, OHNA, OHWA, and OAGNA,
but significantly not present in patients with OAGWA. Although
lesser degrees of increased response to concentrations of neuro¬
transmitters indicative of denervation are associated with proximal
nerve lesions of the efferent outflow, hypersensitive responses
are maximal in lesions of the postganglionic neurone (335); the
significant responses associated with glaucoma imply the probable
site of degeneration to be the postganglionic neurone, although
co-existent proximal lesions cannot be excluded.
The association between diabetes mellitus and the primary glaucomas
has been accurately defined by specific determination of diabetes
prevalence in each of the major categories of primary glaucoma.
Concurrent examination of a comparable age-matched control group
permits existing data to be viewed in perspective, whilst prevalence
levels have been determined in categories where data was previously
inconclusive or absent (ie OH and CAG respectively). The type
of diabetes mellitus associated with primary glaucoma is specifically
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type 2 diabetes (NIDDM) and impaired glucose tolerance; the
prevalence of type 1 diabetes (IDDM) in the primary glaucomas
is similar to that in the control group.
Significantly-increased prevalence of abnormal glucose tolerance
is restricted to primary glaucomas with narrow i rido-corneal angles:
CAG and OHNA. Accurate comparisons with previous studies, employing
different diagnostic criteria, is not possible, however several
salient features are worthy of note. The prevalence of diabetes
mellitus in patients with OAG has been reported as 18.3% (112)
and 20% (132); unfortunately, control values were not concurrently
determined. These statistics compare favourably with the presently-
defined prevalence of abnormal glucose tolerance in patients with
OAGWA (the commonest form of OAG), 23.8%, which is not significantly
different from the prevalence of abnormal glucose tolerance in
the comparable control group (17.5%). Similarly, the reported
prevalence of diabetes mellitus in patients with OAG by studies
not specifically determining diabetic status by OGTT was 8% (131)
and 7.6% (122) - compared with diabetes prevalence in the present
control group of 8.1%.
The association between diabetes mellitus and the primary glaucomas
has been confirmed, although detailed investigation revealed the
association to be different from previous assumptions. The
prevalence of diabetes mellitus - specifically NIDDM and IGT -
was only significantly increased in CAG and OHNA. Glycosylated
haemoglobin levels were significantly increased only in narrow-
angle primary glaucomas: CAG, OHNA, and OAGNA. Significant,
though less direct, associations with wide-angle categories were
present in familial history, with significantly increased prevalence
of familial NIDDM in patients with CAG and OHWA. Of more
importance is the obvious link connecting CAG, OH, and OAG; the
common association with NIDDM suggests that these discrete categories
within the heterogeneous primary glaucomas are unlikely to represent
mutually-exclusive entities, with more than merely similar external
manifestations in the form of raised intraocular pressure.
The role of diabetes mellitus in the pathogenesis of glaucoma
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is probably multifactorial; diabetic effects on autonomic nerve
function are likely to be prominent in this context. Systemic
parasympathetic dysfunction is a characteristic feature - in variable
proportions dependent upon category - of the primary glaucomas,
and diabetes mellitus - also significantly associated with primary
glaucoma - is the commonest cause of autonomic neuropathy in this
country (170). The prevalence of abnormal cardiovascular
parasympathetic function parallels that of diabetes mellitus in
the primary glaucomas; parameters of parasympathetic function
were significantly associated with diabetes me Ilitus in patients
with OHNA and OHWA.
Severe systemic complications may occur secondary to diabetes
mellitus, principally vasculopathy, nephropathy, retinopathy and
neuropathy (somatic and autonomic), although almost every system
can be affected. Adverse effects of diabetes mellitus are equally
ubiquitous in the eye; anterior and posterior segments are frequently
involved. Although complications in the posterior segment, with
potentially-blinding retinopathy, are more comprehensively documented,
anterior segment structures are also affected - with inevitable
consequences in the pathogenesis of glaucoma. The lens in diabetic
eyes is characteristically large (134), thus facilitating closure
of the irido-corneaI angle by mechanical shallowing of the anterior
chamber. Rapid changes in lens dimensions, resulting in varying
refraction, are associated with fluctuating levels of plasma glucose
in diabetics (405). Parasympathetic neuropathy of the anterior
segment, determined by pupillary responses to 2% methacholine,
is reported to be present in 81% of unselected diabetic patients
(402); denervation hypersensitivity, determined by pupillary
responses to 0.1% adrenaline, implying significant neuropathy
of the sympathetic nervous system, have an estimated prevalence
of 28.9% in diabetics with background retinopathy, although only
2.4% in diabetics without retinopathy (403). Pupillary abnormalities
are well-recognised complications of diabetes mellitus, particularly
impaired reflex responses to light, and excessive miosis (406,407);
these have been variously attributed to somatic neuropathy (408)
and autonomic neuropathy (409). The efficacy of pupillary responses
has been correlated with diabetic control; pupiIlographic studies
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demonstrated a direct relationship between efficacy of pupil response
and co-existent metabolic stability (410).
Diabetes mellitus has been implicated in the aetiology of iritis
for over 100 years (411). Whittington and Lawrence (1951) described
a rare albuminous iritis associated with diabetes mellitus, and
characterised by dilated iris vessels which subsided with the
termination of iritis, in marked contrast to the established features
of rubeosis iridis (412). A recent study reported the presence
of iritis in 30% of diabetics with autonomic neuropathy, postulating
an association between diabetic autonomic neuropathy and iritis
based on a common immunological aetiology from cross-reaction
of insulin antibodies and nerve growth factor (413).
Iridopathy is a recognised complication of diabetes mellitus
(414,415); in addition to glycogenous atrophy of the iris (122),
lesions may be present in connective tissue (415), smooth muscle
(404), and blood vessels (416,417). Subsequent impairment of
iris mobility necessarily influences methods of ocular autonomic
function assessment dependent upon measurement of end-organ responses
to determine neurological integrity. This is particularly relevant
in the assessment of denervation hypersensitivity; significant
neuropathy may be present though not revealed on specific testing
because of concomitant restrictive iridopathy.
Diabetes mellitus is significantly associated with the primary
glaucomas; several aetiological mechanisms are implicated in the
pathogenesis of glaucoma, resulting from the ubiquitous nature
of diabetic complications in anterior segment structures, however
present evidence suggests autonomic dysfunction to be the most
significant.
Accurate determination of autonomic integrity in the primary
glaucomas was obtained by the integration of separate, though
complementary, assessment techniques. Several well-defined trends
consistently emerged from the results of each section. Systemic
autonomic dysfunction, specifically localised to the parasympathetic
nervous system, was significantly associated with CAG, OH, and 0AG,
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with increased prevalence in narrow-angle categories.
Parasympathetic neuropathy of the anterior segment, by the diagnostic
criterion of denervation hypersensitivity, was also established
as a feature of each major category of the primary glaucomas;
sympathetic neuropathy of the anterior segment, by the same criterion,
was a significant feature of CAG, OHNA, OHWA, and OAGNA. The
integrity of the pupillary reflex arc, assessed by pupil cycle time,
was impaired only in narrow-angle primary glaucomas. Thus autonomic
dysfunction, systemic and localised, is significantly associated
with the primary glaucomas. Parasympathetic dysfunction is present,
at both systemic and local level, in every category studied;
sympathetic dysfunction is only demonstrable in ocular structures -
and specifically not in OAGWA.
The prevalence of autonomic nerve dysfunction in each of the major
categories of the heterogeneous group of disorders encompassed
within the title of "primary glaucomas" confirms the existence
of an association between these formerly-distinct entities, and
inevitably suggests the presence of a common aetiological factor
in pathogenesis. Marked similarities between these apparently-
dissimilar constituents of the primary glaucoma population have
been previously shown in responses to autonomic provocation,
observations which are amenable to logical explanation on the
basis of the present results. The role of autonomic dysfunction
in the aetiology of CAG, OH, and OAG necessitates a brief reiteration
of pathophysiological mechanisms in angle-closure. Closure of
the irido-cornea I angle in the anterior chamber is, by definition,
a dynamic process. The relative contribution of anterior
translational movement of the iris-lens diaphragm and peripheral
iris bombe remains a source of debate, however the basic aetiological
factor common to both mechanisms is pupil block, a direct result
of relative parasympathetic and sympathetic activity in the anterior
segment. Pupil block causes pressure inequalities between the
posterior and anterior chambers, with consequent shallowing of
the anterior chamber. It may be resolved into 3 separate components:
i. force due to contraction of the sphincter muscle
ii. force due to contraction of the dilator muscle
iii. modulus of elasticity of the iris stroma
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Contraction of antagonistic iris musculature is a dynamic variable;
thus pupil block represents a constantly-changing vector, dependent
upon the relative emphases of the 3 contributing elements.
Sphincter and dilator pupillae (the effectors of parasympathetic
and sympathetic nerve stimulation) though diametrically opposite
in effects on pupil diameter, are not of equal potential magnitude;
the maximally-stimulated sphincter muscle may develop twice the
power of the maximally-stimulated dilator muscle (151). In
consequence, parasympathetic tone has been proposed as the major
determinant of pupil block (155). Impairment of parasympathetic
nerve function effects a partial dilation of the pupil, thereby
increasing pupil block. It has been shown that pupil block force
is maximal at a pupil diameter of 3.8-4.2 mm, with exponential
decrease in pupil block force as the pupil diameter either increases
or decreases from this value. A concomitant denervation of
sympathetic nerve function in the anterior segment would render
the pupil relatively immobile; in the presence of a mid-dilated
pupil, maximal pupil block would be sustained, with inevitable
dimensional changes in the anterior chamber possibly terminating
in overt angle-closure.
Angle-closure i s not exclusively restricted to CAG; this principle
is of fundamental importance in the determination of common
aetiological factors in the pathogenesis of the primary glaucomas.
In OH and OAG, autonomic provocation by simultaneous installation
of guttae 2% pilocarpine and 10% phenylephrine produces significant
partial closure of the anterior chamber angle, with consequent
impairment of aqueous outflow. Responses to pilocarpine-
phenylephrine provocation in patients with OAG were similar to
"normal" eyes in only 22% of cases; positive provocative tests
were significantly associated with narrow angles (418). In OH,
45% of subjects demonstrated closure of all or part of the irido¬
corneal angle following autonomic provocation; results were directly
related to angular configuration, with angle-closure in 88% of
patients with grade 1 angles (Shaffer angle-grading), 69% of patients
with grade 2 angles, and 11% of patients with grade 3 angles (419).
Therefore angle-closure is not an all-oi—none phenomenon; it is
only when the angle is virtually completely closed that intraocular
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pressure rises precipitously, manifesting the characteristic signs
of CAG. Intermittent partial angle-closure produces intermittentLy¬
ra i sed intraocular pressure, with inevitable damage to outflow
mechanisms; repeated episodes result in impaired facility of outflow,
which also causes increased intraocular pressure, thus generating
a self-perpetuating pathological cycle (419). Whilst field defects
are not present, the condition is OH; when field defects occur,
the diagnosis becomes OAG.
The configuration of the anterior chamber angle is of marked
importance; a narrow irido-cornea I angle facilitates angle-closure
by permitting a lesser anterior trans lationa I movement of the
iris-lens diaphragm to effect angle-closure. However it is
essential to note that a narrow angle is faci litatory, not diagnostic.
Angle-closure, both complete (103) and partial (418), may occur
in patients with wide-angles, although not as frequently as in
those with narrow-angles (419). If an eye has a narrow angle
and no other features associated with glaucoma, the risk of
subsequent angle-closure developing is minimal; of 50 eyes with
narrow angles from "normal" subjects assessed by autonomic
provocation using guttae 2% pilocarpine and 10% phenylephrine,
only 1 (2%) developed acute CAG (102). However if features
associated with glaucoma are present, the risk of angle-closure
rises precipitously; in patients with CAG, OH, and OAG, the
probability of angle-closure during pilocarpine-phenylephrine
provocation was inversely related to the magnitude of the irido¬
corneal interval (161,418,419). This probability is closely
paralleled by the proportionate distribution of systemic and ocular
autonomic dysfunction and abnormal glucose tolerance in the primary
glaucomas, with increased prevalence in narrow-angle categories.
Thus the narrow angle in isolation is not necessarily important,
however in conjunction with established features of glaucoma it
assumes marked prognostic significance.
A sequence of events in the pathogenesis of glaucoma may be
postulated; angle-closure, mediated by autonomic activity in the
anterior segment, has been proposed as a common aetiological
mechanism in the primary glaucomas, a hypothesis supported by
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results of autonomic provocation in patients with CAG, OH, and OAG.
Autonomic dysfunction, particularly of the parasympathetic nervous
system, is significantly associated with the primary glaucomas,
thereby providing a logical explanation for the aforementioned
experimental observations. Autonomic dysfunction in the anterior
segment would result in a mid-dilated, relatively-immobile pupil,
with inevitable consequences: maximal pupil block and anterior
translational movement of the iris-lens diaphragm facilitating
angle-closure, particularly in patients with narrow angles.
In addition to effects on angle-closure, autonomic dysfunction
may also affect the outflow mechanism directly. Parasympathetic
nerve stimulation has been shown to increase facility of outflow
by inducing ciliary muscle contraction on the scleral spur, thereby
actively "opening" the trabecular meshwork. In the presence
of parasympathetic dysfunction, as in primary glaucoma, one may
assume this mechanism to be impaired. This has been suggested
by the results of previous studies; in the early stages of autonomic
provocation, facility of outflow may rise dramatically in response
to parasympathetic stimulation by pilocarpine (158). Diminished
outflow would exert inevitable effects on intraocular pressure,
as previously described.
The aetiology of autonomic nerve dysfunction in the primary glaucomas
is not known. Results of several autonomic function tests
were significantly associated with diabetes mellitus, and autonomic
dysfunction may be secondary to diabetes mellitus in these cases;
as diabetes mellitus is the commonest cause of autonomic neuropathy
in this country, this assumption is reasonable. However, in
the majority of cases there was no obvious predisposing factor;
recognised causes of secondary autonomic dysfunction were excluded
(table 1). In the absence of evidence to the contrary, one may
therefore postulate a primary autonomic dysfunction in these
patients. The classification of "primary autonomic failure"
encompasses patients in whom symptoms and signs of autonomic nerve
dysfunction are present, without known predisposing pathology;




Impairment of autonomic nerve function is a significant feature
of the primary glaucomas. Assessment based upon cardiovascular
autonomic reflexes, established as an effective index of generalised
autonomic integrity, demonstrated the presence of significant
systemic parasympathetic dysfunction in each category, with increased
prevalence in narrow-angle primary glaucomas. In contrast,
sympathetic nerve function was intact, within the limits of
sensitivity for these tests. Ocular autonomic function was inferred
from objective assessment of denervation hypersensitivity, and
evaluation of the pupillary reflex arc by measurement of pupil
cycle time. Determination of denervation hypersensitivity
permitted assessment of localised parasympathetic and sympathetic
nerve function: parasympathetic neuropathy of the anterior segment,
by the diagnostic criterion of pupil responses to guttae 2.5%
methacholine, was present in each category of the primary glaucomas;
sympathetic neuropathy of the anterior segment, by the diagnostic
criteria of pupil responses to guttae 0.1% phenylephrine and 0.5%
phenylephrine, was present in all categories except OAGWA.
Significant impairment of the pupillary reflex arc was restricted
to narrow-angle primary glaucomas.
Anatomical configuration of the anterior chamber angle is considered
of essential diagnostic importance in the pathogenesis of angle-
closure; recently, this principle has been questioned, with the
demonstration of angle-closure in patients with wide angles, and
the relatively-insignificant proportion of patients (2%) with
narrow angles alone (in the absence of any other feature associated
with glaucoma) who exhibit positive results to autonomic provocative
testing. The results of the present study link these seemingly-
incompatible assertions. Currently-proposed mechanisms of angle-
closure are based on relative autonomic activity in the anterior
segment of the eye; the prevalence of autonomic dysfunction in
the primary glaucomas provides a logical explanation for previous
experimental observations of dynamic angle-closure during provocative
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testing, the details of which are elaborated in the discussion.
The possible effects of autonomic dysfunction are shown to concur
with present concepts of pathogenetic mechanisms in glaucoma.
Autonomic dysfunction, at both systemic and local level, is
significantly associated with narrow angles in the primary glaucomas.
It would appear that the narrow angle in glaucoma is facilitatory,
permitting a lesser degree of anterior translational displacement
of the iris-lens diaphragm to effect angle-closure. However
narrow angles are probably not pathognomonic in isolation, the
pathogenesis of angle-closure depending upon concomitant predisposing
features - possibly involving changes in the autonomic integrity
of the anterior segment. The prevalence of diabetes mellitus
in narrow-angle primary glaucomas (CAG and OHNA) supports this
assertion. Diabetes mellitus is a well-recognised cause of
autonomic dysfunction, and present results of cardiovascular
autonomic function are significantly related to diabetic status
in several of the primary glaucomas; autonomic dysfunction may
represent an effect of diabetes mellitus on the pathogenesis of
glaucoma in these patients. Diabetic complications may also be
present in other anterior segment structures - including blood
vessels, connective tissue, and smooth muscle - with inevitable
impairment of iris function. These alternative adverse effects
of diabetes mellitus may be equally implicated in the subsequent
development of glaucoma, as previously described.
The precise aetiology of disordered autonomic function in the
primary glaucomas is not known. Although autonomic dysfunction
may be secondary to diabetes mellitus in a proportion of cases,
no predisposing cause is apparent in the majority of primary glaucoma
patients. In the absence of evidence to the contrary, one may
therefore presume primary glaucoma to represent a presentation
of primary autonomic dysfunction. The angular configuration,
irrespective of glaucoma category (CAG, OH, and OAG), is shown to be
of central importance in the association between primary glaucoma
and autonomic function, suggesting that, on the basis of pathogenetic
mechanisms, effective classification of the primary glaucomas
is enhanced by angle assessment. Probably the most significant
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APPENDIX 3
Several points in the text require further clarification:
3.1 Definition of the primary glaucoma and control samples
i. Control subjects
The control group comprised 85 subjects (mean age 66.1 ± 10.2 years),
83 subjects attending the casualty department with no detectable
abnormalities (mean age 66.5 ± 10.2 years) and 2 members of hospital
staff (mean age 58.6 years). 74 subjects consented to undergo
oral glucose tolerance test to assess diabetic status, 84 subjects
were able to supply details regarding family history of diabetes,
70 subjects were eligible to be included in the assessment of pupil
cycle time - after application of the exclusion criteria stipulated
on p. 120 - and 63 subjects consented to assessment of anterior
segment denervation hypersensitivity. Control subjects were
attending for refraction, or had been referred by an optician for
an ophthaImological opinion; no detectable abnormality was present
in all subjects, following comprehensive ocular assessment. As
attendance for routine refraction in an older age group, with
progressiveIy-increasing presbyopia, is normal, this represents
a self-selected control sample with no subjective bias.
ii. Primary glaucoma patients
All patients studied were attending the Glaucoma Unit at St Paul's
Eye Hospita I, Liverpool. All patients diagnosed to have primary
glaucoma in St Paul's Eye Hospital are referred to the Glaucoma
Unit for initial assessment; the present sample is therefore a
representative, consecutive series of well-documented cases from
a single Teaching Health Authority. Detailed definition of the
patients in each category are as follows:
a. Closed-angle glaucoma: 124 consecutive cases of closed-angle
glaucoma, presenting between 1975 and 1983.
b. Ocular hypertension: 189 consecutive cases of ocular
hypertension referred to the Glaucoma Unit between 1979 and 1982.
c. Open-angle glaucoma: 67 consecutive cases of open-angle
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glaucoma referred to the Glaucoma Unit between 1981 and 1982.
Patients with closed-angle glaucoma presented with characteristic
symptoms of this condition (p. 11), necessitating hospital admission.
Ocular hypertension is asymptomatic; all patients in this category
were diagnosed by assessment of intraocular pressure during routine
refraction by an optician, with subsequent referral to the Glaucoma
Unit. Open-angle glaucoma is symptomatic when visual field loss
is detected by the subject, however this is a late stage in the
disease process and represents a very small proportion of patients.
Almost all patients currently referred to St Paul's Eye Hospital
are asymptomatic of glaucoma, diagnosis occurring during either
routine optician refraction, or following ophthalmoscopy by a general
practitioner in the investigation of an unrelated illness. It
can be seen that both the control group and the OH/OAG categories
were self-selected in a comparable manner ie following routine
optician refraction, which is normally a biennial appointment in
subjects of this age category. Primary glaucoma patients - excluding
CAG - were thus detected at the asymptomatic stage in almost all
cases. Patients with CAG were self-select ed by the nature of
this condition; this sample of 124 consecutive cases is the largest
published, to date. Treatment, prior to study, of patients with
CAG and OAG is shown in table 23.
3.2 Diabetes mellitus in the primary glaucomas
Diabetic status was determined in accordance with National Diabetes
Data Group and World Health Organisation criteria (365,366).
Oral glucose tolerance test is an invasive procedure, with concomitant
risks of significant side-effects, which many patients consider
unpleasant. It was therefore decided that one could not ethically
subject patients to a repeat procedure of this nature unless the
result would materially influence prognosis and treatment. As
sustained elevated glucose concentration during the OGTT on more
than one occasion is required to establish a diagnosis of diabetes
mellitus or impaired glucose tolerance, if the initial test is
norma I, a diagnosis of DM/IGT could not be made irrespective of
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the result of a second test. There was therefore considered to
be no moral justification for submitting patients to this procedure
a second time in this instance. If, however, the first test was
abnormal, a second test is essential to substantiate a potentially
serious diagnosis.
In determining the presence of diabetes mellitus in the family
history, all subjects were questioned personally by myself on two
occasions, with a one-month interval between visits. On the first
visit, in addition to direct questioning, the patients were asked
to specifically inquire into evidence of diabetes mellitus from
all first-degree relatives, prior to the return visit.
Patients with narrow angles - principally CAG and OHNA - are at
significant risk of developing CAG if maximal dilation is employed;
dilation is therefore normally achieved by installation of guttae
10% phenylephrine, with immediate reversal by guttae 0.5% thymoxamine.
Maximal dilation is not safe in these patients, and is only performed
in exceptional circumstances. Unfortunately, these are the
categories in which the prevalence of type 2 diabetes mellitus
and impaired glucose tolerance are significantly elevated. However
there is a relevant corollary which must be taken into consideration
in this particular study; the Glaucoma Unit in St Paul's Eye Hospital
is managed exclusively by Mr R Mapstone - and all patients are
seen by either Mr Mapstone or myself. This point is of essential
importance in the present circumstance. In all patients with
glaucoma, examination of the posterior segment is mandatory on
each clinic visit. As these patients have been followed-up by
a Senior Consultant Ophthalmic Surgeon a_lone, specialising in gIaucoma,
for a period of up to eight years, it is inconceivable that
significant retinopathy could have been overlooked - and therefore
the absence of marked retinopathy in these patients assumes greater
significance.
On the basis of the present results, primary glaucoma is not
associated with type 1 diabetes mellitus, although these patients
are frequently characterised by more severe autonomic neuropathy
than in type 2 diabetes mellitus. There are a number of significant
219
facts which may explain this apparent paradox. Patients.with type 1
diabetes mellitus are generally younger with more severe complications,
particularly retinopathy; diabetic retinopathy is postulated to
confer protection against the subsequent development of glaucoma (122).
Proliferative retinopathy was first noted to be less common in
cases of diabetes with raised tension by Grafe in 1924 (109).
The exact relationship between intraocular pressure and retinopathy
in patients with diabetes mellitus remains unclear; a detailed
review of the literature on this subject is given on page 22.
There is evidence to suggest that autonomic neuropathy is a
significant factor in the pathogenesis of primary glaucoma - but
only in conjunction with several other features, none of which
are pathognomonic in isolation. The anatomical configuration
of the anterior chamber angle is of paramount importance in this
respect. If the anterior segment of the eye is subjected to maximal
autonomic provocation with guttae 2% pilocarpine and guttae 10%
phenylephrine, the volume of the anterior chamber decreases by
16% (54), however a relatively-greater decrease occurs peripherally
than centrally. In normal subjects, diurnal variation in the
dimensions of the anterior chamber has been demonstrated;
anterior chamber depth and volume measurements in the evening were
significantly lower than morning values, with particular emphasis
on the periphery of the anterior chamber: axial depth decreased
by 2.1%, peripheral depth by 21.1%, and anterior chamber volume
by 5.7%. (420) Thus a narrow angle, although not pathognomonic
in isolation, permits lesser decreases in anterior chamber depth
to produce angle-closure. Anterior transI ationa I movement of
the iris-lens diaphragm facilitates i ri do-cornea I contact and thus
subsequent angle-closure: if the anterior chamber shallows by 0.2 mm,
the distance between peripheral iris and cornea decreases by 0.08 mm;
if the anterior chamber shallows by 0.33 mm, the irido-cornea I
gap narrows by 0.12 mm (103). As i r i do-cornea I separation in
eyes with narrow angles is only approximately 0.15 mm (155),
relatively-minor anterior displacement of the iris-lens diaphragm
may cause disproportionate decreases in the i rido-cornea I interval,
with eventual irido-cornea I contact. Although narrow angles are
relatively-rare in the population (1.1%), the angle narrows with
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age; narrow angles are present in 4% of those aged 78-82 years,
5% in the age category 83-87 years, and 10% in the age group
88-92 years (68). Type 1 diabetics have a si gni f i cantly-lower
life expectancy than type 2 diabetics, and therefore one would
reasonably expect a far higher proportion of narrow angles in patients
with type 2 diabetes mellitus.
The pathogenesis of glaucoma is based on the concept of pupil block,
which represents an external manifestation of relative parasympathetic
and sympathetic activity in the anterior segment. Pupil block
is recognised to be maximal at mid-dilatation; as the sphincter
pupillae may develop twice the power of the dilator pupillae, pupil
dilation is facilitated by parasympathetic dysfunction - which
is a significant feature of patients with primary glaucoma. Resting
pupil diameter is diminished in patients with type 1 diabetes mellitus;
assessment of topical denervation hypersensitivity in these patients
with guttae 2% phenylephrine suggested the small pupil in diabetic
patients to primarily result from neuropathy of sympathetic
innervation (421). Thus it is possible that relatively-increased
anterior segment sympathetic neuropathy cf parasympathetic neuropathy
in patients with type 1 diabetes may serve a protective function;
pupillary constriction is therapeutically desirable in the treatment
of primary glaucoma, the basis of current treatment with
parasympathomimetics. The important factor in pupil block is
re^at^ve autonomic activity; present results suggest that in
predisposed individuals parasympathetic function is relatively
more impaired than sympathetic function, precipitating maximal
pupil block and therefore anterior translation of the iris-lens
diaphragm, with ultimate angle-closure.
Studies recently completed in the Glaucoma Unit have shown that
patients with type 1 diabetes mellitus, with either background
or proliferative retinopat hy, are characterised by deep anterior
chambers with wide irido-cornea I angles; of 50 consecutive patients
examined, all had an angle width of £ 3 (Shaffer system). In
this circumstance, even the presence of significant anterior segment
neuropathy would not effect angle-closure in the presence of wide
ang les.
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It can be seen that there are several reasons which may be reasonably
forwarded to explain the association between exclusively type 2
diabetes mellitus and primary glaucoma. The most important point
is that glaucoma is undoubtedly a multifactorial disease; isolated
features are insufficient to precipitate primary glaucoma. It
is well-established that the prevalence of closed-angle glaucoma
in patients with narrow angles alone is comparable to that in the
general population. Similarly, the presence of autonomic neuropathy
in the absence of narrow angles does not result in primary glaucoma.
Narrow angles are rare in the general population (1.1%); there
is no evidence to suggest that the prevalence in type 1 diabetics
differs from normal - and current evidence suggests the opposite
conclusion. However it must be emphasised that narrow angles
occur in 100% of patients with CAG and OHNA, and thus the eye is
predisposed to angle-closure in the presence of concomitant autonomic
neuropathy. Relative autonomic neuropathy in the anterior segment
determines pupil block force, and therefore predisposition to angle-
closure; patients with primary glaucoma have significant emphasis
on parasympathetic neuropathy, however it may be that type 1 diabetics
have a concomitant emphasis on anterior segment sympathetic neuropathy
- as suggested by recent observations (421) - producing a small
pupil which serves a protective function regarding intraocular
pressure.
There is no published data regarding the prevalence of primary
glaucoma in patients with primary autonomic failure, however
considering that this is a very recent association - and the numerical
limitations of the population - this is not surprising.
3.3 Anterior segment neuropathy
Ratios of relative pupil diameter before and after assessment of
denervation hypersensitivity were used, rather than actual pupil
measurement, for a number of reasons. Direct measurement of pupil
diameter is only possible after allowing for magnification by the
cornea; this may only be determined by assessment of corneal curvature
by keratometry (representing approximately 43 dioptres in "normal"
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eyes) plus accurate measurement of anterior chamber depth. In
normal patients, keratometry is often assumed to be constant, however
patients with CAG and OHNA are often significantly hypermetropic,
with reduced corneal diameters, increased corneal curvature, and
reduced anterior chamber depth - all summating to relatively increased
corneal magnification of pupil diameter. Thus when ratios of
pupil diameter are used, inaccuracies inherent in the determination
of absolute measurements are eliminated, as the relative corneal
magnification is obviously equivalent both before and after assessment
in the same eye.
All provocative tests in the assessment of glaucoma are based on
the responses of the anterior segment to maximal stress - usually
autonomicaIly mediated. Intermittent closed-angle glaucoma is
characterised by a normal anterior chamber between episodes.
There is thus no obvious benefit to be derived from determining
pupil position, or any other anterior segment parameter at rest -
probably because the "rest" position varies under different levels
of illumination. Most episodes of closed-angle glaucoma occur
in the evening. The rationale of all current predictive provocative
tests is to determine anterior chamber responses in a dynamic
situation; the most important aspect of pupil block is the length
of time it is sustained. For example, the pupils of a normal
subject dilate in darkness, and for a short period pupil block
force is maximal, however pupillary mid-dilation is rapidly passed,
and pupil block decreases accordingly. In patients with CAG,
the period of pupil block force is sustained for a considerable
length of time due to significant anterior segment autonomic
neuropathy; if the subject has narrow angles, a potentially dangerous
situation may rapidly develop. There is thus no advantage to
be gained from assessing pupil size at rest, on the basis of current
glaucoma concepts.
The age-adjusted normal tolerance limit, ie the lower 5th percentile
in the case of 2.5% methacholine ratio and the upper 95th percentile
of the log normal distribution after regression on age in the 0.1%
and 0.5% phenylephrine ratios, was applied to the results obtained
from patients with primary glaucoma, to determine the proportion
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of eyes outwith this Limit; results are shown in table 24.
Increased responses to topically-applied drugs may be due to increased
reactions of the effector as a result of denervation hypersensitivity
in primary glaucoma patients, however this assumes that the
concentration of drug reaching the iris musculature is equivalent
in both primary glaucoma and control subjects. Identical drug
preparations were used in both groups. Corneal permeability is
intrinsically dependent upon the integrity of the corneal epithelium
and endothelium. Damage to corneal epithelium will markedly increase
topical drug penetration into the anterior chamber; intraocular
pressure was determined by applanation tonometry at least one month
prior to assessment to preclude this possibility. Corneal epithelium
is dependent upon both intact sensory innervation and an adequate
pre-corneal tear film; there is no confirmed evidence of abnormality
in either of these features in patients with primary glaucoma.
Corneal endothelial damage causes increased hydration of the cornea;
the cornea is normally maintained in a state of partial dehydration
by an active transport mechanism, involving sodium/potassium pumps
in the endothelium. There was no evidence of clinical endothelial
impairment in the primary glaucoma patients included in this study.
Acute elevation of intraocular pressure - as in acute closed-angle
glaucoma - may result in corneal oedema, however the sudden increase
in intraocular pressure in this situation characteristica I ly precludes
topical medication; current glaucoma teaching stipulates that topical
therapy is ineffective due to poor corneal drug penetration in
acute closed-angle glaucoma, and should only be employed after
intraocular pressure has been lowered by either intravenous
acetazolamide or mannitol. Thus acutely-raised intraocular pressure
clinically impaires drug penetration. The final variable in the
estimation of drug responses is the muscle effector, however in
intermittent closed-angle glaucoma this is frequently damaged by
segmental ischaemia. There is therefore no evidence to suggest
extrinsic causes of increased drug responses in primary glaucoma
patients - rather the opposite; as iris musculature may be damaged
by ischaemia during intermittent closed-angle glaucoma, denervation
hypersensitivity, determined by pupil responses to topical agents,
is probably underestimated in these patients.
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3.4 The association between primary autonomic failure and primary
glaucoma
It has been shown that results of several autonomic function tests
were significantly associated with diabetes mellitus, however in
the majority of cases there was no obvious predisposing factor;
the most important category in this respect was closed-angle glaucoma,
in which the results of autonomic function tests were specifically
not associated with diabetes mellitus. In the absence of evidence
to the contrary, a primary autonomic dysfunction is postulated
in these patients. This statement is obviously entirely dependent
on the comparisons between the control group and the primary glaucoma
sample. As previously explained, with the obvious exception of
closed-angle glaucoma which is a disease characterised by acute
symptomatology, both patients (OH and OAG) and control group were
self-selected on an equivalent basis - almost exclusively following
routine optician refraction which is perfectly normal in this
presbyopic age category - and not selected due to the disease process.
Thus the reason for self-selection was not the actual disease;
this was an incidental finding on examination. One may therefore
reasonably assume that the groups are seIf-selected on a similar
basis, and are as evenly matched as possible.
On the basis of present results, there is undoubted Iy a significant
association - of some nature - between primary glaucoma and autonomic
dysfunction. Substantial previous experimental evidence, detailed
in the text, supports the concept of autonomic neuropathy as a
primary aetiological factor in the pathogenesis of angle-closure:
i. Autonomic provocation, the basis of diagnosis in the primary
glaucomas, has a sensitivity of 93% and a predictive value
of 94%. As there are few false negatives, a reasonable
inference is that the event involved in the pathogenesis
of the disease process is similar to those occurring during
a positive provocative test. Normal provocative tests occur
in only 22% of patients with open-angle glaucoma. Partial
angle-closure is present in 45% of patients with ocular
hypertension, with increased prevalence in narrow-angle
categories.
225
ii. Autonomic effects on aqueous dynamics are recognised to be
of central importance in the ultimate determination of
intraocular pressure. The most-frequently prescribed
medications in the treatment of glaucoma - pilocarpine, timolol,
guanethidine, adrenaline - exert primary actions via manipulation
of the autonomic nervous system in the anterior segment.
Response to treatment, assessed by lowering of intraocular
pressure, is significantly greater in primary glaucoma patients
with abnormal results of cardiovascular autonomic function
tests.
To assume that the demonstration of significant autonomic dysfunction
associated with primary glaucoma is unrelated to the disease process
would require one to totally disregard all current concepts of
the pathogenesis of glaucoma. Age-related changes in the autonomic
nervous system are documented, however the nature of selection
of controls and patients (not selected on the basis of disease
process, but asymptomatic at the time of diagnosis) has eliminated
this variable within the limits of experimental accuracy. As
there is no evidence of bias in selection of either control group
or patient sample, there is no reason to suppose that pre-selection
has influenced the results. All ocular hypertensive patients,
and most open-angle glaucoma patients, are completely asymptomatic
at the time of discovery, therefore this primary glaucoma group
represents a sample of patients which are randomly selected from
the glaucoma population; open-angle glaucoma patients seldom present
with symptoms directly attributable to the disease except in the
late stages of the disease process. As both control and patient
samples were self-selected on an identical basis, this represents
the ultimate situation a researcher can obtain in precluding
subjective bias of comparable experimental samples.
Primary autonomic failure encompasses patients in whom symptoms
and signs of autonomic nerve dysfunction are present, without known
predisposing cause; primary glaucoma may be included in this category -
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